ID	Action	Drugs	knownaction	approved	investigational	experimental	nutraceutical	illicit	withdrawn	Categories	Class	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	2	3	3	3	3	3	3	3	k	Anova.p	KruskalWallis.p	x	x	x	x	x	x
O14646	antagonist	Epirubicin	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Anthracycline Topoisomerase Inhibitor__Anthracyclines__Anthracyclines and Related Substances__Antibiotics, Antineoplastic__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Carbohydrates__Cardiotoxic antineoplastic agents__Cytotoxic Antibiotics and Related Substances__Enzyme Inhibitors__Glycosides__Hepatotoxic Agents__Immunosuppressive Agents__Myelosuppressive Agents__Naphthacenes__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__UGT2B7 substrates	O14646	1.106169e-01	0.4005345070	0.3648133697	0.0151574385	-0.1899176894	0.1158137873	-0.0729888507	0.5026005753	0.3419130241	3.215148e-01	0.3387076308	0.2173882897	0.0944230578	0.5470131804	0.2785896219	0.2311739856	0.1385756997	0.2858092664	-9.084290e-02	0.0841312982	0.0099847477	-0.0961834378	0.1187670129	-0.0392195929	0.0022821440	0.0224930153	-0.2508471630	-0.2310023812	-0.1982002853	-1.725835e-01	0.1960600625	-0.2919296640	-0.0293334395	-0.5471664032	0.0372496923	-0.0482484002	0.1687241406	-0.0756884298	-0.0512203013	0.0877418410	-0.2115956313	0.3167089902	0.0359182414	0.1390792587	-0.1593558781	0.2008281850	-0.4448724353	-0.0245920958	0.2886934997	4.223123e-01	0.2791917360	-0.1244141886	-0.3686690512	-0.1356542863	0.2838282561	0.1708511251	0.1173656252	0.5983487357	1.920498e-02	0.3002018214	0.0889063679	1.325622e-01	0.1983310659	-1.223910e-01	-0.0003428551	0.1059780783	0.3041528903	3.852499e-01	-0.1403028840	-0.1826633502	-0.2008933239	-5.620269e-02	-0.2383420383	-3.211073e-02	2.569416e-02	-0.2998557504	-0.0700998677	2.246725e-02	-0.0493590342	0.0856186681	-0.2182365488	0.0049007566	0.4546121003	1.701107e-03	-0.2958901864	0.2171192391	-0.3135181705	1.736444e-01	207	6.777705e-03	8.052918e-03	O14646	30	0.00677770466595942	A	0	0
O14980	inhibitor	Selinexor	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__OATP1B3 inhibitors	O14980	6.475464e-01	-0.1357123201	0.5791624513	0.2783714788	0.8357762300	0.4025740019	0.5669614742	0.1927976955	0.4406136331	4.563461e-01	0.3348797226	0.6208931636	0.5102586657	0.2316806616	0.3565620627	0.4294864674	0.6344842032	0.9581148941	6.886304e-01	0.7233065514	0.7993854905	0.6400358544	0.4973435200	-0.1037670831	0.8608535381	0.4915573813	0.0874798023	0.5788816501	0.5114102827	3.938548e-01	0.4422728475	0.2033364575	0.7759356816	0.6279422413	0.4532559678	0.7513027426	0.4214613203	0.7256219039	0.6813846608	0.5422182099	0.3978133318	0.2458975027	0.5794672093	0.8030110470	0.6706054358	0.4696103549	0.7321307340	0.6072248876	0.4612080111	5.389230e-01	0.6523410944	0.4497801882	0.5582693009	0.2054360783	0.5848920274	0.7278487697	0.4697586324	0.1950891173	4.240555e-01	0.5447894854	0.2003817258	6.741526e-01	0.5207740343	6.522882e-01	0.7287741284	0.7284736682	0.7052599675	6.841550e-01	0.2935421575	0.9666105061	-0.2171814391	3.463722e-01	0.6247601060	4.738362e-01	4.063383e-01	0.6362606912	0.8318712222	5.496846e-01	0.4859806094	0.7379168326	0.7112066671	-0.2928567719	0.3528961292	4.597421e-02	-0.0442767835	0.2664500089	0.4695664774	4.426389e-01	267	1.554826e-03	8.295609e-03	O14980	43	0.00155482581545235	0	B	C
O76074	inhibitor	Sildenafil;Theophylline;Pentoxifylline;Tadalafil;Vardenafil;Dipyridamole;Avanafil;Udenafil	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Agents Causing Muscle Toxicity__Amides__Cardiovascular Agents__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 Inhibitors (weak)__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (weak)__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Drugs Used in Erectile Dysfunction__Enzyme Inhibitors__Heterocyclic Compounds, Fused-Ring__OATP1B1/SLCO1B1 Inhibitors__P-glycoprotein inhibitors__P-glycoprotein substrates__Phosphodiesterase 5 Inhibitors__Piperazines__Purines__Sulfonamides__Sulfones__Sulfur Compounds__Urological Agents__Urologicals__Vasodilating Agents__Agents that reduce seizure threshold__Alkaloids__Anti-Asthmatic Agents__Autonomic Agents__Bronchodilator Agents__Cardiovascular Agents__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 Substrates__Drugs for Obstructive Airway Diseases__Enzyme Inhibitors__Heterocyclic Compounds, Fused-Ring__Narrow Therapeutic Index Drugs__Neurotransmitter Agents__Peripheral Nervous System Agents__Phosphodiesterase 5 Inhibitors__Phosphodiesterase Inhibitors__Purinergic Agents__Purinergic Antagonists__Purinergic P1 Receptor Antagonists__Purines__Purinones__Respiratory Smooth Muscle Relaxants__Respiratory System Agents__Vasodilating Agents__Xanthine derivatives__Xanthines and Adrenergics__Alkaloids__Antioxidants__Antiplatelet agents__Blood Viscosity Reducer__Cardiovascular Agents__Compounds used in a research, industrial, or household setting__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 Substrates__Drugs for Obstructive Airway Diseases__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Free Radical Scavengers__Hematologic Activity Alteration__Hematologic Agents__Hemorrheologic Agents__Heterocyclic Compounds, Fused-Ring__Peripheral Vasodilators__Phosphodiesterase 5 Inhibitors__Phosphodiesterase Inhibitors__Protective Agents__Purine Derivatives__Purines__Purinones__Radiation-Protective Agents__Vasodilating Agents__Xanthine derivatives__Antihypertensive Agents__Antihypertensives for Pulmonary Arterial Hypertension__Carbolines__Cardiovascular Agents__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Drugs Used in Erectile Dysfunction__Enzyme Inhibitors__Genito Urinary System and Sex Hormones__Heterocyclic Compounds, Fused-Ring__Indoles__Phosphodiesterase 5 Inhibitors__Phosphodiesterase Inhibitors__Pyridines__Urological Agents__Urologicals__Vasodilating Agents__Cardiovascular Agents__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 Substrates__Drugs Used in Erectile Dysfunction__Enzyme Inhibitors__Genito Urinary System and Sex Hormones__Imidazoles__P-glycoprotein inhibitors__P-glycoprotein substrates__Phosphodiesterase 5 Inhibitors__Phosphodiesterase Inhibitors__Piperazines__Potential QTc-Prolonging Agents__QTc Prolonging Agents__Urological Agents__Urologicals__Vasodilating Agents__Anticoagulants__Antiplatelet agents__Blood and Blood Forming Organs__BSEP/ABCB11 Substrates__Cardiovascular Agents__Decreased Platelet Aggregation__Enzyme Inhibitors__Hematologic Agents__Hypotensive Agents__Miscellaneous Vasodilatating Agents__OATP1B1/SLCO1B1 Inhibitors__OATP1B3 inhibitors__P-glycoprotein inhibitors__P-glycoprotein substrates__Phosphodiesterase 5 Inhibitors__Phosphodiesterase Inhibitors__Platelet Aggregation Inhibitors Excl. Heparin__Pyrimidines__Vasodilating Agents__Cyclic Nucleotide Phosphodiesterases, Type 5__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 Substrates__Drugs Used in Erectile Dysfunction__Genito Urinary System and Sex Hormones__Phosphodiesterase 5 Inhibitors__Urologicals__Vasodilating Agents__Amides__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 Substrates__Drugs Used in Erectile Dysfunction__Enzyme Inhibitors__Genito Urinary System and Sex Hormones__Phosphodiesterase 5 Inhibitors__Phosphodiesterase Inhibitors__Sulfones__Sulfur Compounds__Urologicals__Vasodilating Agents	O76074	-1.342924e+00	-1.4944381753	-0.8961015964	-0.7144108908	-0.1795823209	-0.6148694910	-0.7916085932	-0.4334627995	-0.7513714548	-7.421171e-01	-1.1149025859	-0.6983961509	-1.0179154527	-1.1166939184	-0.7527169040	-0.7537411510	-0.4986709667	-0.4355132507	-6.769515e-01	-0.6018433351	-0.5242686147	-0.2949817277	-0.4626327728	-0.7467661131	-0.9606620642	-0.8634891930	-0.9890066864	-0.2789470360	-0.6702885096	-2.372305e-01	-0.6798519850	-0.4353332578	0.3643416996	-0.1662235458	0.0391158199	-0.2885359960	-0.5380903573	-0.3372437096	-0.5314674177	-0.4246137310	-0.1783366587	-0.3623389946	-0.5269760161	0.1450489654	0.1611730141	-0.5775380573	0.2496574193	-0.3533655191	-0.0849142850	-9.242624e-01	-0.7331969363	-0.9746024965	0.0177868850	0.3403768506	-0.7584815962	-0.5177532125	-0.7669829585	-1.0043197932	-2.457805e-01	-0.4684692637	-0.9143992819	-5.529437e-01	-0.7631905104	1.983957e-01	-0.5866122360	-0.5738485863	-0.6743511667	-8.777117e-01	-0.1326530338	-0.1252822808	-0.6101408214	-6.565659e-01	-0.3944913868	3.341862e-01	-5.137766e-01	-0.4682298338	-0.3929471987	-5.142321e-01	-0.8077191276	-0.8118934430	-0.2044195565	-1.2531294290	-1.0227220889	-5.478357e-01	-1.0079550321	-0.8693257578	-0.5670439769	-4.847131e-01	769	5.018543e-04	1.878355e-03	O76074	102	0.000501854201212594	A	0	C
O95749	inhibitor	Zoledronic acid;Minodronic acid	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Bisphosphonates__Bone Density Conservation Agents__Drugs Affecting Bone Structure and Mineralization__Drugs for Treatment of Bone Diseases__Imidazoles__Musculo-Skeletal System__Organophosphonates__Organophosphorus Compounds__Organophosphonates__Organophosphorus Compounds	O95749	3.240177e-01	0.9474247574	0.2998754008	0.0629538157	1.1110852459	0.3593863012	0.8472063810	-0.1796413823	0.5148886209	7.680105e-01	0.0215656335	0.7708969974	0.6303177726	0.3885044205	0.4840947678	0.5446520272	0.5974953396	0.7684693674	5.725104e-01	0.7874947984	0.4712409300	1.2279863403	0.4264028179	0.8431426000	0.6443809799	0.6702970832	0.3644786318	0.3630453944	0.7266617603	1.228938e+00	0.6715529612	-0.0099315860	0.3672372053	0.2490734848	0.0488089575	0.7000539782	0.9358854296	1.1050026406	0.2330566949	0.5443189119	0.3224387344	0.6115444996	0.5199959635	0.4941082034	0.7405148200	0.7857287105	0.5030662299	0.3584974837	0.6092164369	3.352723e-01	0.2668664056	0.2963524606	0.6268563690	0.0315578896	0.3552852545	-0.0636312585	0.3821488841	0.6270098128	1.011956e+00	0.7749798088	0.2321918353	1.054038e+00	0.9317079948	8.189567e-01	0.4479394664	0.4238022585	0.2090408489	4.656704e-01	0.4625310748	0.8833081755	-0.5795950302	1.866974e-01	0.4153622698	4.032815e-02	4.568439e-01	0.4831854190	0.0305212986	9.323683e-01	0.0621599780	0.6954763987	0.2830932182	-0.5279944430	0.1914499712	-3.475584e-02	-0.0808079957	0.1244072164	0.2517428937	6.275215e-01	935	5.546401e-03	1.119630e-02	O95749	125	0.0055464006103254	0	B	C
P00325	inhibitor	Fomepizole	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Antidotes__Compounds used in a research, industrial, or household setting__Cytochrome P-450 CYP2A6 Inhibitors__Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Inducers__Cytochrome P-450 CYP2E1 Inducers (strength unknown)__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Protective Agents__Pyrazoles	P00325	-1.941049e+00	-2.9167411167	-1.9812229526	-1.0278471748	0.3197248836	0.1007978474	-0.5705783612	-0.8051396797	-1.4761739071	-2.343950e+00	-1.5151552534	-1.5689872255	-1.2662632836	-2.1738425658	-2.4126672477	-2.4895736867	-1.3892938365	0.4549865558	-1.768797e+00	-1.4664748030	-1.2458857847	-1.7117672155	-1.5622942501	-0.2095345041	-1.6551328132	-1.1221729821	-1.7750240064	0.3277822128	0.0368065806	-6.358361e-01	-1.6840861398	-0.3570118159	0.6397619749	-1.0147427281	-0.6057365872	-0.5599276163	-0.5363581710	0.2326014201	-0.0099883206	-0.5195503142	0.5138987862	-0.0999893180	-0.2104007654	0.5805126013	0.6792047518	-0.2551270347	1.5881625512	-0.9120818860	-0.5146549269	-1.272627e+00	-0.6135764982	-1.2800884839	0.5093430238	0.8301655756	0.0161386794	-1.6478225777	-0.9970369491	-1.8404182023	-9.016438e-01	-2.3243078204	-0.7217727199	-1.205694e+00	-1.5278345414	8.042275e-01	-1.3908455720	-1.3747835322	-2.0665089582	-8.833188e-01	0.0767023481	0.4214203161	-1.0486216545	-1.426209e+00	-1.1574906732	5.914590e-01	-9.795272e-01	0.0638664930	-0.4087970951	-1.231825e+00	-2.9252407694	-1.3972601874	-0.7143483170	-1.2712526879	-2.4448928556	-1.784798e+00	-0.8724738113	-1.9328982418	-1.5505026450	-5.745384e-01	988	3.982619e-04	3.124787e-04	P00325	132	0.00039826217419279	A	0	C
P00390	inhibitor	Carmustine	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Alkylating Activity__Alkylating Drugs__Antineoplastic Agents__Antineoplastic Agents, Alkylating__Antineoplastic and Immunomodulating Agents__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Immunosuppressive Agents__Myelosuppressive Agents__Nitroso Compounds__Nitrosourea Compounds__Nitrosoureas__Noxae__Toxic Actions	P00390	3.017189e-01	0.0200352678	0.4305667391	0.3279995022	0.7697939822	0.3266399523	0.8791919016	-0.0215431263	0.0535111602	1.064519e-01	0.3628865993	0.1815699954	0.6860239923	-0.1333705973	0.0487461414	0.0643763264	0.2431696705	0.7250099456	1.460373e-01	0.4321014578	0.6228042311	0.6668506737	0.1803535927	0.9062366607	0.3192395109	0.2257281108	0.4933173202	0.6271104202	1.0814043043	4.902742e-01	0.4935915275	1.0682394912	1.3809054721	0.6777371483	0.1890958074	0.1403344336	1.0606208030	1.1234295319	0.5707003242	0.9318089464	0.4993543526	0.4201187322	0.7501843847	1.0284855584	0.8878154644	0.9389726117	0.8052123978	0.4806386824	0.9756789570	4.828312e-01	0.4038750093	0.1796304580	0.9006128368	0.5697590697	0.2665107821	0.2764011117	0.6785336806	0.2092893600	9.514753e-01	0.7018550209	0.3815595278	3.770802e-01	0.3026920550	6.478938e-01	0.4214369467	0.2752394476	-0.0006859453	9.160583e-01	0.6287953721	1.3113590059	-0.1529892877	2.709343e-01	0.4396422976	5.677359e-01	5.229206e-01	0.8625513259	0.3952826474	5.642598e-01	0.2546458730	0.8470984312	0.7795346162	0.2434464550	-0.3625810821	2.314372e-01	0.2342515149	0.2039407720	0.1697289362	1.015577e+00	993	5.116232e-04	4.600479e-04	P00390	133	0.000511622426673086	A	0	C
P00736	inhibitor	Human C1-esterase inhibitor;Conestat alfa	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Blood and Blood Forming Organs__Blood Proteins__C1 inhibitors__Carbohydrates__Complement C1 Inactivator Proteins__Complement Inactivating Agents__Complement Inactivator Proteins__Complement System Proteins__Decreased Vascular Permeability__Drugs Used in Hereditary Angioedema__Enzyme Inhibitors__Glycoconjugates__Glycoproteins__Immunologic Factors__Immunoproteins__Kallikrein Inhibitors__Peptides__Protease Inhibitors__Proteins__Serine Protease Inhibitors__Serpins__Blood and Blood Forming Organs__C1 inhibitors__Drugs Used in Hereditary Angioedema__Protease Inhibitors	P00736	1.398496e-01	0.6897520778	-0.8999067984	-0.3423363476	-0.7786537067	-0.4212784535	-0.0071667687	-0.5763380307	-1.1175641219	2.835070e-01	0.1732509936	-0.2315069265	-1.0816601866	0.0603308874	-0.6550803027	-0.5970707190	-0.2022104715	-0.5761847419	5.844904e-02	-0.2261225463	-0.0212993003	-0.3039784138	-0.3392556599	-1.1016599297	-0.5396591017	-0.1573762932	0.0990947120	-0.3420854893	-0.8676600579	-8.219622e-01	-0.1481380655	-0.9255529838	-0.7842712255	-0.0137833969	-1.0223182173	-0.1456555969	-0.2884236905	-0.8009236052	-0.1616439283	-0.6872630029	-0.0939271276	-0.2102684698	-0.2261910070	-0.9699876151	-0.2225557559	-0.7980817431	0.1612558611	-0.6505392135	-0.4403368161	-4.036884e-01	-0.6311352569	-0.2664845077	0.1905200274	0.3216578822	-0.8229301092	-0.4535635200	-0.2108626955	-1.6892092865	-1.180882e+00	0.1866041405	-0.0671253957	-6.991579e-01	-0.5692763677	2.130262e-01	-0.9346065759	-0.8243287104	-0.2004598361	-4.866789e-01	-0.1461221925	-0.2412216749	-1.0864402678	-5.218565e-01	0.7220296765	-1.272544e-01	1.523116e-01	-0.4843398441	-1.2461366436	-2.972710e-01	0.0713128937	-0.7698656894	0.0278261480	-0.5112936910	0.6253216254	-1.740061e-02	0.2899452047	0.1218764007	0.8955258618	-1.756926e-01	1008	5.685269e-03	1.965713e-02	P00736	134	0.0056852693361171	0	B	C
P03952	inhibitor	Ecallantide;Human C1-esterase inhibitor;Conestat alfa;Gabexate;Lanadelumab	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Antirheumatic Agents__Blood and Blood Forming Organs__Central Nervous System Agents__Drugs Used in Hereditary Angioedema__Kallikrein Inhibitors__Kallikreins, antagonists &amp; inhibitors__Peripheral Nervous System Agents__Plasma Kallikrein Inhibitor__Sensory System Agents__Amino Acids, Peptides, and Proteins__Blood and Blood Forming Organs__Blood Proteins__C1 inhibitors__Carbohydrates__Complement C1 Inactivator Proteins__Complement Inactivating Agents__Complement Inactivator Proteins__Complement System Proteins__Decreased Vascular Permeability__Drugs Used in Hereditary Angioedema__Enzyme Inhibitors__Glycoconjugates__Glycoproteins__Immunologic Factors__Immunoproteins__Kallikrein Inhibitors__Peptides__Protease Inhibitors__Proteins__Serine Protease Inhibitors__Serpins__Blood and Blood Forming Organs__C1 inhibitors__Drugs Used in Hereditary Angioedema__Protease Inhibitors__Amidines__Anticoagulants__Enzyme Inhibitors__Guanidines__Hematologic Agents__Protease Inhibitors__Serine Protease Inhibitors__Amino Acids, Peptides, and Proteins__Antibodies__Antibodies, Monoclonal__Antibodies, Monoclonal, Humanized__Blood and Blood Forming Organs__Blood Proteins__Complement Inactivating Agents__Drugs Used in Hereditary Angioedema__Globulins__Immunoglobulins__Immunoproteins__Proteins__Serum Globulins	P03952	3.003230e-01	0.1342698634	-1.3061206980	-0.0987917533	-0.0828030431	-0.4389597440	0.8084992150	-1.1684240918	-1.2417910823	-2.940808e-01	-0.3582188628	-0.5705793100	-1.0499488434	-0.2550383002	-0.5763597541	-0.4765049730	-0.3639117136	-0.3186634010	4.131324e-02	-0.1156180128	-0.0451889783	-0.2427058603	-0.4965244218	-0.6254926090	-1.0216532117	-0.1450673106	-0.6899990761	-0.0371165711	-0.7195765579	-9.103611e-01	-0.3051980937	-1.0628288493	-0.2856868323	-0.3071255078	-1.1157149171	-0.1174736703	-0.8603775189	-0.7813717321	-0.0868359910	-0.3541188960	-0.3618993059	-0.4517928127	-0.1797057543	-0.3195562415	0.2455532706	-1.1365330906	0.5286089727	-0.3366700221	-0.5438425777	-6.130130e-01	-1.2256404758	-0.5368011393	0.6060685258	-0.3318538215	-0.8980488712	-0.6610877909	-0.2266736442	-1.2831943489	-4.249853e-01	0.1594797571	-0.3793411210	-5.310806e-01	-0.9392811313	6.287225e-01	-0.9624464574	-0.6124005835	-0.3159463531	-4.734021e-01	0.4625310748	-0.0038287923	-1.5999932474	-8.309695e-01	-0.3529722581	-3.416715e-01	2.893585e-01	-0.3574995993	-0.4046461524	-3.044492e-01	0.4259286034	-0.3446878416	0.5973964509	-0.4809734634	1.0018322027	3.084482e-01	0.3286776898	0.6237106077	0.2796809589	-2.153881e-01	1139	4.645739e-03	1.391817e-02	P03952	140	0.00464573964436902	0	B	C
P04275	binder;binding	Antihemophilic factor, human recombinant;Simoctocog alfa;Antihemophilic Factor (Recombinant), PEGylated;Susoctocog alfa;Efmoroctocog alfa;Lonoctocog alfa;Moroctocog alfa	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Biological Factors__Blood and Blood Forming Organs__Blood Coagulation Factors__Blood Proteins__Carbohydrates__Disaccharides__Hemophilia A__Hemostatics__Human Antihemophilic Factor__Increased Coagulation Activity__Oligosaccharides__Polysaccharides__Proteins__Not Available__Alcohols__Amino Acids, Peptides, and Proteins__Biological Factors__Blood Coagulation Factors__Blood Proteins__Compounds used in a research, industrial, or household setting__Drugs that are Mainly Renally Excreted__Ethylene Glycols__Glycols__Hemostatics__Macromolecular Substances__Pegylated agents__Polymers__Proteins__Recombinant Proteins__Blood and Blood Forming Organs__Blood Coagulation Factors__Hemostatics__Hemostatics__Hemostatics__Amino Acids, Peptides, and Proteins__Biological Factors__Blood Coagulation Factors__Blood Proteins__Hemostatics__Proteins__Recombinant Proteins	P04275	-1.533389e+00	-1.5063911128	-1.0602380609	-1.1367959822	-0.4426604610	-1.3141049126	-1.2229548863	-1.6446813661	-1.1394155463	-1.996609e+00	-1.4173779251	-1.6374779358	-1.1633486096	-1.7439967008	-1.2538379408	-1.4174275672	-1.1685099893	-0.8367689859	-1.479756e+00	-1.8266235403	-1.2705851867	-1.2948281819	-1.1516419877	-1.1696224595	-1.3324184384	-0.9750736853	-1.2245247461	-0.4440730932	-0.7899840581	-1.761877e+00	-1.5192306910	-1.5367561671	0.0544498462	-0.8605905952	-0.4682897130	-0.8709218811	-0.7900094900	-1.3363623381	-0.8581672471	-1.0678500515	-0.0967905662	-0.2414266703	-0.8972975941	-0.5922243307	-0.0541886855	-1.1409677315	-0.3682319572	-1.6790589430	-0.6593506544	-1.578072e+00	-1.2658754631	-1.0924722053	-0.3987890968	0.0728232505	-0.9376109349	-1.3898352615	-1.2903302555	-1.2975950538	-9.616754e-01	-1.1783725091	-0.6031211870	-1.029703e+00	-1.4051070485	-8.840030e-01	-0.9380859910	-0.6955870788	-1.4795328095	-1.609679e+00	-0.6162413196	-0.7197095216	-1.0704470560	-5.655810e-01	-1.0752290095	-7.265568e-01	-1.242191e+00	-1.7468133864	-1.2281520102	-1.257174e+00	-1.4832380740	-1.3062014512	-1.0883554333	0.0381142536	-1.0356889040	-1.837818e+00	-0.7223184489	-1.2573158087	-1.2579534905	-7.352801e-01	1170	5.010298e-03	6.240744e-03	P04275	145	0.00501029495412522	A	0	0
P05362	UnKnown	Hyaluronic acid	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Adjuvants, Immunologic__Carbohydrates__Cicatrizants__Compounds used in a research, industrial, or household setting__Dermatologicals__Glycosaminoglycans__Immunologic Factors__Lubricants__Musculo-Skeletal System__Nasal Preparations__Ophthalmologicals__Polysaccharides__Preparations for Treatment of Wounds and Ulcers__Protective Agents__Sensory Organs__Surgical Aids__Viscoelastic Substances__Viscosupplements	P05362	-8.175100e-01	-0.0633828410	-0.6183097978	-0.9100025387	-1.0743174966	-1.0691831871	-1.1182231672	-0.1462894088	-0.1272867647	-9.985479e-01	-0.1034450674	-0.6250999289	-0.2806370584	-0.8118362545	-0.8428626433	-0.9188774290	-1.0168859970	-0.1560334570	-1.195316e+00	-0.8926720153	-0.9338668721	-0.9723944345	-0.6621848395	-1.0166389308	-0.9455497781	-0.6040727819	-1.1750797553	-0.9832564046	-1.0611130451	-8.323317e-01	-0.6966091202	-0.5370079809	-0.9957090041	-1.2100270887	-0.6964580074	-0.9693659031	-0.2957943783	-0.6054029868	-1.3780176192	-1.1462621309	-1.1284086719	-0.9875109329	-1.2754968937	-0.9937305442	-0.7349954010	-0.6662115720	-0.7340049888	-0.8243248415	-1.2875091812	-8.000777e-01	-0.5442784703	-0.7566075198	-1.0882831116	-1.2289584052	-0.9812401735	-0.9217210761	-1.2036224646	-0.2382543428	-1.542502e+00	-1.1983526514	-0.9374238054	-1.297719e+00	-0.8926129667	-1.238532e+00	-1.0516304293	-1.0050576893	-0.8662709465	-1.118561e+00	-1.1621430599	-1.0605262314	-0.3138728606	-9.427669e-01	-1.3974156397	-1.120703e+00	-1.052590e+00	-0.7118941827	-1.4626607423	-7.560338e-01	-0.8890048281	-0.9709354276	-1.2106626310	-0.5071319827	-0.8301323434	-5.892541e-01	-1.0488298108	-0.4814076513	-1.2164916060	-1.427597e+00	1208	7.143316e-03	2.660914e-02	P05362	148	0.00714330950681233	A	0	0
P06756	UnKnown	Antithymocyte immunoglobulin (rabbit);Levothyroxine	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Antibodies__Antibody-Surface Protein Interactions__Antineoplastic and Immunomodulating Agents__Biological Products__Blood__Blood Proteins__Body Fluids__Complex Mixtures__Fluids and Secretions__Globulins__Hemic and Immune Systems__Immune Sera__Immunoglobulin G__Immunoglobulins__Immunologic Factors__Immunoproteins__Immunosuppressive Agents__Increased T Lymphocyte Destruction__Lymphocyte Function Alteration__Miscellaneous Therapeutic Agents__Proteins__Selective Immunosuppressants__Serum__Serum Globulins__Agents used to treat hypothyroidism__Amino Acids__Amino Acids, Aromatic__Amino Acids, Cyclic__Amino Acids, Peptides, and Proteins__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (moderate)__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Hormones__Hormones, Hormone Substitutes, and Hormone Antagonists__Narrow Therapeutic Index Drugs__OATP1B1/SLCO1B1 Inhibitors__OATP1B3 inhibitors__P-glycoprotein inducers__Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins__Thyroid Products__Thyroxine-binding globulin substrates__UGT1A1 Substrates__UGT1A1 substrates with narrow therapeutic index	P06756	3.181797e-01	0.1984190236	-0.2445911383	-0.0098864263	-0.4958700965	0.0164400562	-0.4648221859	-0.0656909611	-0.3582885745	-1.178504e-01	-0.5438369943	0.0853629643	-0.2651995491	0.1850672540	-0.1744977553	-0.1819195755	-0.0964001801	-0.4445084045	2.565958e-01	-0.0925800227	-0.3566620093	-0.2406876885	0.0118394747	-0.2246010131	-0.0977633336	0.0419929324	0.7579819471	-0.3098858282	-0.4185335428	-4.871450e-01	-0.0628193941	0.1388910525	-0.1072828882	0.2923779848	-0.0858266404	-0.2064466831	-0.2153096038	-0.6090748743	-0.4728407002	-0.6552547496	-0.0849503371	-0.0808085861	-0.2043591732	-0.4965173001	-0.2500700841	-0.7705660322	-0.1037191982	-0.6650829822	-0.4157366072	-3.063284e-01	-0.2148566353	0.1803131173	-0.3879787044	0.6273950616	-0.2263553691	-0.3426080262	-0.0876926337	-0.4391839547	-4.220580e-01	-0.0382475280	0.1328761857	-5.517804e-01	-0.0905365562	-1.230848e-01	-0.2673257865	-0.2097890128	-0.2168636315	-4.670433e-01	0.0161561131	-0.1252822808	0.1119797390	2.505194e-02	0.3090055995	2.167598e-01	9.918628e-02	0.0867371707	-0.4647907183	-6.798295e-02	-0.0833947713	-0.4560232994	-0.3619927072	0.4963893934	0.1651603627	2.838541e-01	0.1767730258	0.8821777315	0.3885152955	-2.697790e-01	1252	4.483806e-04	7.229111e-03	P06756	151	0.000448380640514563	0	B	C
P07195	inhibitor	Stiripentol	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Anticonvulsants__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 Inhibitors (strong)__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strong)__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dioxoles__Drugs that are Mainly Renally Excreted__Miscellaneous Anticonvulsants__Nervous System	P07195	1.959151e-01	-0.1683217416	1.3775726289	0.5609822230	0.8325182111	0.9362556223	0.8555741074	0.2704471467	-0.1026278735	4.590577e-01	0.3869500655	0.7884131031	0.2372212207	0.3654566653	1.2475401204	1.1702623521	0.9437612871	1.0601293704	5.609391e-01	1.5599522229	0.9107876354	0.8671246004	0.8108394345	0.4369250506	1.1758230925	0.5322133751	0.1519623899	0.9412548705	1.6180839494	1.485404e+00	0.7105416626	0.2625025681	1.5528082004	2.6168551371	0.1890958074	0.7948907831	0.7741365323	0.9498183766	0.8543799299	0.9155266039	0.6594767334	1.0663320246	0.7761405555	1.2446086289	1.0246705813	1.5044389734	1.1703520309	0.6819062982	1.0230647448	1.056401e+00	0.9550158094	0.8153368109	1.0342329069	0.4919574087	1.0687614376	0.5131836680	1.0756508290	1.9038515173	3.403695e-01	1.1922252669	0.3279376287	9.482074e-01	0.5946337561	7.085231e-01	0.3572676384	0.4993291256	0.3995269421	2.440578e+00	0.8474687109	0.9959852571	-0.0969731154	8.852482e-01	0.7964415748	5.363080e-01	8.727224e-01	2.2246503553	1.0458234674	9.586913e-01	0.3561963930	-0.0451506831	0.5189587158	-0.2846620709	-0.0884754291	3.912331e-02	0.3923325978	0.6280730374	0.1990858734	6.590488e-01	1259	3.803463e-03	4.539487e-03	P07195	153	0.00380346407518208	0	0	C
P07225	inhibitor	Sodium tetradecyl sulfate	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Acids__Acids, Noncarboxylic__Alcohols__Alkanes__Alkanesulfonates__Alkanesulfonic Acids__Antivaricose Therapy__Cardiovascular Agents__Compounds used in a research, industrial, or household setting__Fatty Alcohols__Hydrocarbons, Acyclic__Lipids__Pharmaceutical Preparations__Pharmaceutical Solutions__Sclerosing Agents for Local Injection__Sclerosing Solutions__Solutions__Sulfonic Acids__Sulfur Acids__Sulfur Compounds__Surface-Active Agents__Vasoprotectives	P07225	-4.347194e-01	0.2053010603	-1.1880713783	-0.7795747321	-1.2417691545	-1.1830549724	-0.4833792297	-1.6887105314	-1.2936646144	-4.378601e-01	-0.8006490715	-1.0469984599	-1.1816213198	-0.4699830431	-0.9128919133	-1.0620304607	-0.3823985209	-1.4370193174	-5.610423e-01	-1.0225442207	-0.7535907607	-0.7121074169	-0.5524081074	-0.9879300694	-1.3561083676	-0.4987139008	0.1317659924	-0.6332314492	-1.0412599642	-1.658048e+00	-0.8738540441	-1.4599128380	-0.9559419695	-0.5347903223	-1.6980268459	-0.8197974072	-0.7513878468	-0.9932344977	-0.9888701635	0.0349806910	-0.4455056607	-1.4204677138	-0.4806364332	-1.3618867737	-0.6092453585	-1.5316811426	-0.2306678243	-0.8357915345	-1.0822342560	-1.203116e+00	-1.4727737482	-1.1526413925	0.0225519791	-0.8778572565	-1.4977269931	-0.7442572995	-0.9224870369	-1.4319438952	-6.649790e-01	-0.4933684189	-0.8765795081	-8.552607e-01	-1.2100010015	-5.333103e-01	-1.1098222637	-1.2451713040	-0.6291007334	-1.018559e+00	-0.6434205738	-0.4707004841	-1.8441941203	-1.111361e+00	-0.2314462008	-1.192720e+00	-1.968529e-01	-1.2021363990	-1.1536576897	-1.235794e+00	-0.5242372466	-1.0768179202	-0.3619927072	-0.2414346943	0.4532432598	-6.606848e-01	-0.1027240566	-0.0244360069	0.1892240705	-1.269361e+00	1263	2.034945e-03	2.388879e-02	P07225	155	0.00203494553256938	0	B	C
P07900	inhibitor	Alvespimycin	yes	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	Amides__HSP90 Heat-Shock Proteins__Lactams__Quinones	P07900	5.592151e-01	0.6834249824	0.9004646327	0.3833604515	0.7589443871	0.4872183639	1.0077864139	0.4381777134	0.3366660058	6.766122e-01	0.5082961288	1.1501229638	0.0779343966	0.3265000950	0.6619757733	0.6735528586	0.6215480853	1.0147618981	5.561245e-01	0.6716670317	0.7778463658	1.3135321295	0.5658794024	0.9579135685	0.9734148599	0.2894899715	0.2140134683	0.2114667747	0.5375560664	6.246405e-01	0.7221027593	0.4632803937	0.6626634598	0.6678098560	0.4343807552	0.5838989150	0.4257402143	0.7752429203	0.5547556767	0.5905326333	0.3882869811	0.6115444996	0.5681646164	0.8042167699	0.2754127174	0.3914915029	0.4575649792	0.5724388690	0.4452698885	5.811562e-01	0.5714203090	0.5077132728	0.2377191027	0.1580652357	0.7448233691	0.4404224907	0.7324881021	0.5783333988	7.368084e-01	0.5591716559	0.2451905012	8.570369e-01	0.7335221074	3.241649e-01	0.4126995278	0.6859195305	0.5705210703	6.600777e-01	0.1627206311	0.6699050217	0.0903494796	2.812076e-01	0.8768126031	4.900535e-01	5.819345e-01	0.7884329158	0.4697742145	6.604102e-01	0.4141086258	0.6748198613	0.7437046810	-0.1213383580	0.3460079221	3.382522e-01	0.2778651593	0.4813928900	0.1708374461	4.136893e-01	1288	7.368195e-04	3.011786e-03	P07900	158	0.000736819491272852	0	B	C
P08637	antagonist;agonist;binding	Human immunoglobulin G;Catumaxomab;Benralizumab	yes	TRUE	TRUE	FALSE	FALSE	FALSE	TRUE	Amino Acids, Peptides, and Proteins__Antibodies__Antigen Neutralization__Blood Proteins__Globulins__Human Immunoglobulin G__Immunoglobulin G__Immunoglobulin Isotypes__Immunoglobulins__Immunoglobulins, Intravenous__Immunologic Factors__Immunoproteins__Passively Acquired Immunity__Proteins__Serum__Serum Globulins__Amino Acids, Peptides, and Proteins__Antibodies__Antibodies, Monoclonal__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Blood Proteins__Gastrointestinal Agents__Globulins__Immunoglobulins__Immunoproteins__Proteins__Serum Globulins__Amino Acids, Peptides, and Proteins__Anti-Asthmatic Agents__Antibodies__Antibodies, Monoclonal__Blood Proteins__Drugs for Obstructive Airway Diseases__Globulins__Immunoglobulins__Immunoproteins__Interleukin 5 Receptor alpha-directed Antibody Interactions__Interleukin-5 Receptor alpha-directed Cytolytic Antibody__Intreleukin Antagonists__Proteins__Respiratory System Agents__Serum Globulins	P08637	-3.185134e-01	0.6799793772	-0.3006618981	0.7623803097	-0.2178827333	-0.8410916273	0.4080456266	-0.1563663930	-0.2343220305	-8.655818e-02	1.9782303909	-0.2710712591	-0.1496695896	1.0130290255	0.4165838232	0.2419009344	0.0162749564	-0.5228084753	-5.741492e-02	0.0276739884	0.3625115925	0.3550301266	0.0777120516	-0.1325795353	-1.0432319577	0.0665041013	-0.4871182934	-0.0607313908	-1.0239645302	-8.978755e-01	0.2878654936	-1.1430613045	0.2625025681	-0.7600244197	-0.4809257877	-0.1266144732	0.3548880747	-0.1355369714	-0.9690801437	-0.4212061991	-0.1665537098	-0.1550542713	-0.3797850219	0.0160950766	-0.4799274362	-0.0810410454	-0.8787018817	0.0149221757	-0.2858155935	-2.051323e-01	-0.2338935660	0.3033288075	0.1612754192	-0.8520864666	-0.6526294272	-0.3237375287	0.2673119461	-0.0970435005	-1.266929e+00	0.0955103036	0.6108907503	8.208389e-02	-0.3391454427	2.083885e-01	-0.2353213169	-0.3966416236	-0.2183939813	3.297665e-01	-1.3287960819	-0.8987517407	-0.7768702410	-9.037828e-02	-0.9788725166	-8.207187e-01	8.073271e-02	0.0207170065	-1.2387645106	1.314889e-01	0.2071575379	0.0872275020	-0.2472976427	0.0049007566	0.8425160333	6.926535e-01	0.2649979388	0.4310423754	0.1973336196	-3.716617e-01	1339	2.527557e-04	1.278440e-03	P08637	169	0.000252755684045472	A	0	C
P08913	agonist;antagonist;UnKnown	Norepinephrine;Mirtazapine;Dipivefrin;Brimonidine;Clonidine;Guanabenz;Dexmedetomidine;Epinephrine;Phentolamine;Pseudoephedrine;Benzphetamine;Phenoxybenzamine;Oxymetazoline;Apraclonidine;Methyldopa;Guanfacine;Ephedra sinica root;Yohimbine;4-Methoxyamphetamine;Metamfetamine;Periciazine;Dronedarone;Lofexidine;Droxidopa;Xylometazoline;Naphazoline;Moxonidine;Racepinephrine;DL-Methylephedrine	yes	TRUE	TRUE	TRUE	TRUE	TRUE	FALSE	Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic and Dopaminergic Agents__Adrenergic beta-1 Receptor Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-3 Receptor Agonists__Adrenergic beta-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alcohols__Alpha-and Beta-adrenergic Agonists__Amines__Amino Alcohols__Autonomic Agents__Benzene Derivatives__Biogenic Amines__Biogenic Monoamines__Cardiac Stimulants Excl. Cardiac Glycosides__Cardiac Therapy__Cardiovascular Agents__Catecholamines__Catechols__COMT Substrates__Epinephrine and similars__Ethanolamines__Neurotransmitter Agents__Norepinephrine, antagonists &amp; inhibitors__OCT1 substrates__OCT2 Inhibitors__OCT2 Substrates__OCT2 substrates with narrow therapeutic index__Peripheral Nervous System Agents__Phenols__Sympathomimetics__Vasoconstrictor Agents__Adrenergic Agents__Adrenergic alpha-2 Receptor Antagonists__Adrenergic alpha-Antagonists__Adrenergic Antagonists__Agents that produce hypertension__Anti-Anxiety Agents__Antidepressive Agents__Antidepressive Agents, Tetracyclic__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (weak)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Heterocyclic Compounds, Fused-Ring__Histamine Agents__Histamine Antagonists__Histamine H1 Antagonists__Miscellaneous Antidepressants__Nervous System__Neurotransmitter Agents__Potential QTc-Prolonging Agents__Psychoanaleptics__Psychotropic Drugs__QTc Prolonging Agents__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin 5-HT2 Receptor Antagonists__Serotonin 5-HT3 Receptor Antagonists__Serotonin Agents__Serotonin Modulators__Serotonin Receptor Antagonists__Tranquilizing Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic beta-1 Receptor Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-3 Receptor Agonists__Adrenergic beta-Agonists__Alcohols__Amines__Amino Alcohols__Antiglaucoma Preparations and Miotics__Benzene Derivatives__Biogenic Amines__Biogenic Monoamines__Catecholamines__Catechols__Cholinesterase substrates__Ethanolamines__Mydriatics__Neurotransmitter Agents__Ophthalmics__Ophthalmologicals__Phenols__Sensory Organs__Sympathomimetics in Glaucoma Therapy__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Antiglaucoma Preparations and Miotics__Cardiovascular Agents__Central Nervous System Depressants__Dermatologicals__Heterocyclic Compounds, Fused-Ring__Hypotensive Agents__Misc. Skin and Mucous Membrane Agents__Ophthalmologicals__Quinoxalines__Sensory Organs__Sympathomimetics in Glaucoma Therapy__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Analgesics__Anesthetics__Anesthetics, General__Antiadrenergic Agents, Centrally Acting__Antiglaucoma Preparations and Miotics__Antihypertensive Agents__Antimigraine Preparations__Autonomic Agents__Bradycardia-Causing Agents__Cardiovascular Agents__Central alpha-2 Adrenergic Agonist__Central Alpha-agonists__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 Substrates__Hypotensive Agents__Imidazoles__Imidazoline Receptor Agonists__Imidazolines__Narrow Therapeutic Index Drugs__Nervous System__Neurotransmitter Agents__Ophthalmologicals__P-glycoprotein substrates__P-glycoprotein substrates with narrow therapeutic index__Peripheral Nervous System Agents__Sensory Organs__Sensory System Agents__Sympatholytics__Sympathomimetics in Glaucoma Therapy__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Amidines__Antihypertensive Agents__Cardiovascular Agents__Central alpha-2 Adrenergic Agonist__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 Substrates__Guanidines__Neurotransmitter Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anesthetics__Anesthetics, General__Bradycardia-Causing Agents__Central alpha-2 Adrenergic Agonist__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Hypnotics and Sedatives__Hypotensive Agents__Imidazoles__Miscellaneous Anxiolytics Sedatives and Hypnotics__Nervous System__Neurotransmitter Agents__Peripheral Nervous System Agents__Psycholeptics__Sensory System Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic and Dopaminergic Agents__Adrenergic beta-1 Receptor Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-3 Receptor Agonists__Adrenergic beta-Agonists__Adrenergics, Inhalants__Agents producing tachycardia__Agents that produce hypertension__Alpha-and Beta-adrenergic Agonists__Amines__Anti-Asthmatic Agents__Antiglaucoma Preparations and Miotics__Autonomic Agents__Benzene Derivatives__Biogenic Amines__Biogenic Monoamines__Bronchodilator Agents__Cardiac Stimulants Excl. Cardiac Glycosides__Cardiac Therapy__Cardiovascular Agents__Catecholamines__Catechols__COMT Substrates__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Dental Agents__Drugs for Obstructive Airway Diseases__Epinephrine and similars__Hemostatics__Hyperglycemia-Associated Agents__Local Hemostatics__Mydriatics__Nasal Preparations__Neurotransmitter Agents__OCT1 substrates__OCT2 Inhibitors__OCT2 Substrates__OCT2 substrates with narrow therapeutic index__Ophthalmologicals__Peripheral Nervous System Agents__Phenols__Respiratory System Agents__Stomatological Preparations__Sympathomimetic (Adrenergic) Agents__Sympathomimetics__Sympathomimetics in Glaucoma Therapy__Sympathomimetics, Plain__Vasoconstrictor Agents__Adrenergic Agents__Adrenergic alpha-1 Receptor Antagonists__Adrenergic alpha-Antagonists__Adrenergic Antagonists__Agents that produce hypertension__Antidotes__Antihypertensive Agents__Cardiovascular Agents__Drugs that are Mainly Renally Excreted__Hypotensive Agents__Imidazoles__Imidazoline Derivatives__Neurotransmitter Agents__Non-selective Alfa-adrenergic Blocking Agents__Peripheral alpha-1 blockers__Peripheral Vasodilators__Sympatholytic (Adrenergic Blocking) Agents__Vasodilating Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic beta-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alcohols__Alpha-and Beta-adrenergic Agonists__Amines__Amino Alcohols__Amphetamines__Anti-Asthmatic Agents__Autonomic Agents__Bronchodilator Agents__Cardiovascular Agents__Ethylamines__Hyperglycemia-Associated Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Nasal Decongestants__Nasal Decongestants for Systemic Use__Nasal Preparations__Norepinephrine Releasing Agent__Peripheral Nervous System Agents__Phenethylamines__Propanolamines__Propanols__Respiratory System Agents__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetic (Adrenergic) Agents__Sympathomimetics__Vasoconstrictor Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic Uptake Inhibitors__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamines__Antidepressive Agents__Appetite Suppression__Autonomic Agents__Central Nervous System Agents__Central Nervous System Depressants__Central Nervous System Stimulants__Cytochrome P-450 CYP2B6 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__Dopamine Agents__Dopamine Uptake Inhibitors__Ethylamines__Increased Sympathetic Activity__Membrane Transport Modulators__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Peripheral Nervous System Agents__Phenethylamines__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetic Amine Anorectic__Sympathomimetics__Adrenergic Agents__Adrenergic alpha-1 Receptor Antagonists__Adrenergic alpha-Antagonists__Adrenergic Antagonists__Agents that produce hypertension__Amines__Antihypertensive Agents__Cardiovascular Agents__Ethylamines__Hypotensive Agents__Neurotransmitter Agents__OCT1 inhibitors__OCT2 Inhibitors__Peripheral alpha-1 blockers__Peripheral Vasodilators__Vasodilating Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Autonomic Agents__Cardiovascular Agents__Decongestants and Antiallergics__Imidazoles__Increased Sympathetic Activity__Nasal Decongestants__Nasal Preparations__Neurotransmitter Agents__Ophthalmologicals__Peripheral Nervous System Agents__Respiratory System Agents__Sensory Organs__Sympathomimetics__Sympathomimetics Used as Decongestants__Sympathomimetics, Plain__Vasoconstriction__Vasoconstrictor Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Antiglaucoma Preparations and Miotics__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 Substrates__EENT Drugs, Miscellaneous__Hypotensive Agents__Imidazoles__Imidazolines__Neurotransmitter Agents__Ophthalmics__Ophthalmologicals__Sensory Organs__Sympathomimetics in Glaucoma Therapy__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents Causing Muscle Toxicity__Amines__Amino Acids__Amino Acids, Aromatic__Amino Acids, Cyclic__Amino Acids, Essential__Amino Acids, Peptides, and Proteins__Antihypertensive Agents__Autonomic Agents__Benzene Derivatives__Bradycardia-Causing Agents__Cardiovascular Agents__Catecholamines__Catechols__Central alpha-2 Adrenergic Agonist__Central Alpha-agonists__COMT Substrates__Dihydroxyphenylalanine__Drugs that are Mainly Renally Excreted__Hypotensive Agents__Neurotransmitter Agents__Peripheral Nervous System Agents__Phenols__Phenylalanine__Sympatholytics__Acids, Carbocyclic__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Amidines__Antiadrenergic Agents, Centrally Acting__Antihypertensive Agents__Bradycardia-Causing Agents__Cardiovascular Agents__Central alpha-2 Adrenergic Agonist__Central Alpha-agonists__Central Nervous System Depressants__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Guanidines__Hypotensive Agents__Imidazoline Receptor Agonists__Neurotransmitter Agents__Phenylacetates__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alpha-and Beta-adrenergic Agonists__Herbs and Natural Products__Hyperglycemia-Associated Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Sympathomimetic (Adrenergic) Agents__Adrenergic Agents__Adrenergic alpha-2 Receptor Antagonists__Adrenergic alpha-Antagonists__Adrenergic Antagonists__Agents that produce hypertension__Alkaloids__Antidepressive Agents__Autonomic Agents__Central Nervous System Depressants__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__Dopamine Antagonists__Dopamine D2 Receptor Antagonists__Drugs Used in Erectile Dysfunction__Genito Urinary System and Sex Hormones__Heterocyclic Compounds, Fused-Ring__Indole Alkaloids__Indoles__Mydriatics__Neurotransmitter Agents__Other Miscellaneous Therapeutic Agents__P-glycoprotein inhibitors__Peripheral Nervous System Agents__Secologanin Tryptamine Alkaloids__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin 5-HT1 Receptor Antagonists__Serotonin 5-HT2 Receptor Antagonists__Serotonin Agents__Serotonin Receptor Antagonists__Urological Agents__Urologicals__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Amines__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Ethylamines__Hallucinogens__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Phenethylamines__Psychotropic Drugs__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic Uptake Inhibitors__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamine Anorectic__Amphetamines__Antidepressive Agents__Appetite Suppression__Autonomic Agents__Central Nervous System Agents__Central Nervous System Depressants__Central Nervous System Stimulants__Central Nervous System Stimulation__Centrally Acting Sympathomimetics__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Dopamine Agents__Dopamine Uptake Inhibitors__Drugs that are Mainly Renally Excreted__Ethylamines__Increased Sympathetic Activity__Membrane Transport Modulators__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Nervous System__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Peripheral Nervous System Agents__Phenethylamines__Psychoanaleptics__Psychostimulants, Agents Used for Adhd and Nootropics__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetics__Adrenergic alpha-1 Receptor Antagonists__Adrenergic alpha-Antagonists__Adrenergic Antagonists__Agents that produce hypertension__Antipsychotic Agents__Antipsychotic Agents (First Generation [Typical])__Central Nervous System Depressants__Dopamine Antagonists__Heterocyclic Compounds, Fused-Ring__Nervous System__Neurotoxic agents__Phenothiazines__Phenothiazines With Piperidine Structure__Psycholeptics__Sulfur Compounds__Adrenergic alpha-1 Receptor Antagonists__Adrenergic alpha-Antagonists__Adrenergic Antagonists__Agents that produce hypertension__Antiarrhythmic agents__Antiarrhythmics, Class III__Benzofurans__Bradycardia-Causing Agents__Cardiac Therapy__Cardiovascular Agents__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (moderate)__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (moderate)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Inhibitors__Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Heterocyclic Compounds, Fused-Ring__Highest Risk QTc-Prolonging Agents__OAT3/SLC22A8 Inhibitors__OATP1B1/SLCO1B1 Inhibitors__OATP1B3 inhibitors__OCT1 inhibitors__OCT2 Inhibitors__P-glycoprotein inhibitors__QTc Prolonging Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Antidepressive Agents__Antihypertensive Agents__Cardiovascular Agents__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Drugs Used in Addictive Disorders__Drugs Used in Opioid Dependence__Hypotensive Agents__Imidazoles__Imidazolines__MATE 1 Inhibitors__MATE inhibitors__Moderate Risk QTc-Prolonging Agents__Nervous System__Neurotransmitter Agents__Peripheral Nervous System Agents__QTc Prolonging Agents__Sensory System Agents__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin 5-HT2 Receptor Agonists__Serotonin Agents__Serotonin Receptor Agonists__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic and Dopaminergic Agents__Adrenergic beta-1 Receptor Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-3 Receptor Agonists__Adrenergic beta-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alcohols__Amines__Amino Acids__Amino Acids, Neutral__Amino Acids, Peptides, and Proteins__Amino Alcohols__Anti-Dyskinesia Agents__Benzene Derivatives__Biogenic Amines__Biogenic Monoamines__Cardiac Stimulants Excl. Cardiac Glycosides__Cardiac Therapy__Catecholamines__Catechols__Central Nervous System Agents__Drugs that are Mainly Renally Excreted__Epinephrine and similars__Ethanolamines__Increased Blood Pressure__Phenols__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Antiarrhythmic agents__Antihistamine Drugs__Calcium Channel Blockers__Cardiovascular Agents__Decongestants and Antiallergics__Nasal Decongestants__Nasal Preparations__Ophthalmologicals__Respiratory System Agents__Sensory Organs__Sympathomimetics Used as Decongestants__Sympathomimetics, Plain__Vasoconstrictor Agents__Vasodilating Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Cardiovascular Agents__Decongestants and Antiallergics__Imidazoles__Nasal Decongestants__Nasal Preparations__Neurotransmitter Agents__Ophthalmologicals__Respiratory System Agents__Sensory Organs__Sympathomimetics Used as Decongestants__Sympathomimetics, Plain__Vasoconstrictor Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Antiadrenergic Agents, Centrally Acting__Antihypertensive Agents__Cardiovascular Agents__Hypotensive Agents__Imidazoline Receptor Agonists__Sympatholytics__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic beta-1 Receptor Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-3 Receptor Agonists__Adrenergic beta-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alcohols__Alpha-and Beta-adrenergic Agonists__Amines__Amino Alcohols__Anti-Asthmatic Agents__Autonomic Agents__Benzene Derivatives__Biogenic Amines__Biogenic Monoamines__Bronchodilator Agents__Cardiovascular Agents__Catecholamines__Catechols__Epinephrine and similars__Ethanolamines__Mydriatics__Neurotransmitter Agents__Peripheral Nervous System Agents__Phenols__Respiratory System Agents__Sympathomimetics__Vasoconstrictor Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Drugs that are Mainly Renally Excreted	P08913	-1.337178e-01	-0.2196156736	-0.7536095997	0.2063423080	0.0270853363	0.0417002470	-0.4755717478	-0.3102276933	-0.8104754882	-7.598516e-01	0.5952315663	0.0869951983	-0.3801268114	-0.1722381307	-0.4323692532	-0.3028003069	-0.3160043748	-0.0657892233	1.529786e-01	0.1829582508	-0.2358017019	-0.5355190529	-0.0247734673	-0.0579535168	-0.2955207085	-0.5183006732	-0.0580135952	0.6476267091	-0.0777660628	-4.801798e-01	0.0203685571	0.3921197575	0.2488233955	0.6237139000	0.6097341732	0.3754124428	-0.4273490821	-0.1873122542	0.4920328139	0.2839171880	0.8653612197	0.7686469700	-0.0751530282	0.5321785285	-0.2500700841	0.6120228376	0.6473289217	-0.0839132635	0.4833295835	-1.345642e-02	-0.5460619368	0.2531605550	1.5433120715	1.6947247726	0.2872557119	-1.0933499355	-0.0123073572	-1.1088765471	1.115005e-01	-0.4427913170	0.4539245356	3.067164e-01	-0.1342117406	7.408129e-01	1.1188671972	-0.4494525898	-0.4586503045	5.718684e-02	-0.5777121163	0.3062666616	0.5777027932	3.290535e-01	0.4423482519	7.970066e-01	2.944931e-01	-0.0959358459	-0.1399083336	-3.554899e-01	-0.6306727703	-0.6730142630	-0.5219714303	0.9935163853	-0.0767490090	6.871009e-01	1.1884159048	-0.0363077771	0.5948469837	1.182311e+00	1354	7.660549e-04	1.492963e-03	P08913	173	0.000766055190570401	A	B	C
P09038	agonist;antagonist;other/unknown	Sucralfate;Pentosan polysulfate;Sirolimus	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Alimentary Tract and Metabolism__Aluminium Compounds__Aluminum Complex__Anti-Ulcer Agents__Carbohydrates__Drugs for Acid Related Disorders__Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)__Drugs that are Mainly Renally Excreted__Gastrointestinal Agents__Glycosides__Metal cations__Metal divalent cations__Organometallic Compounds__Protectants__Sulfur Compounds__Thioglycosides__Acids__Acids, Noncarboxylic__Anticoagulants__Antivaricose Therapy__Carbohydrates__Genito Urinary System and Sex Hormones__Glycosaminoglycans__Hematologic Agents__Miscellaneous Therapeutic Agents__Polysaccharides__Sulfur Acids__Sulfur Compounds__Sulfuric Acids__Urologicals__Vasoprotectives__Agents causing angioedema__Anti-Bacterial Agents__Anti-Infective Agents__Antibiotics, Antineoplastic__Antifungal Agents__Antineoplastic and Immunomodulating Agents__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 Substrates__Decreased Immunologic Activity__Hyperglycemia-Associated Agents__Immunologic Factors__Immunosuppressive Agents__Kinase Inhibitor__Lactones__Macrolides__mTOR Inhibitor Immunosuppressant__mTOR Inhibitors__Myelosuppressive Agents__Narrow Therapeutic Index Drugs__OATP1B1/SLCO1B1 Inhibitors__Ophthalmologicals__P-glycoprotein inducers__P-glycoprotein inhibitors__P-glycoprotein substrates__P-glycoprotein substrates with narrow therapeutic index__Polyketides__Protein Kinase Inhibitors__Selective Immunosuppressants__Sensory Organs	P09038	-1.935457e+00	-2.1296813188	-1.5462762918	-0.7870082228	-0.9025234657	-1.0579459960	-1.4565045652	-1.3228126325	-1.0295324953	-2.165519e+00	-1.8884919375	-1.8724147475	-0.9337015376	-1.8193176528	-2.1565017276	-2.2691584759	-1.1918324580	-1.3372246877	-1.862841e+00	-1.7124310738	-1.4846434937	-1.6990423482	-1.8888661874	-1.7758572650	-1.1843807523	-1.8768639992	-1.0967938116	-0.4717507620	-0.8827771271	-1.349106e+00	-1.4179449729	-0.8061213690	-1.0251592696	-1.2164721628	-0.6072242983	-1.1496938700	-1.2679723390	-1.0973563262	-0.5847456150	-1.5065746684	-0.8115266354	-0.8422602122	-0.4125784963	-1.2521643426	-0.9535929850	-0.8950278184	-1.7833185487	-1.0908540789	-0.9201339761	-1.283032e+00	-1.6856329358	-1.2116283198	-1.3508064286	-0.4415238954	-0.6526294272	-1.1272751314	-0.8439676476	-0.8667601916	-1.015667e+00	-1.4991968439	-1.2686249954	-1.491136e+00	-1.1967920601	-7.801847e-01	-1.0398638831	-1.2822590093	-1.9883646205	-1.394981e+00	-0.3960085240	-0.8224599202	-0.7219015299	-1.241573e+00	-1.1991658898	-5.195214e-01	-1.616877e+00	-1.2643165785	-1.3742466073	-1.493659e+00	-1.2726406412	-2.5367703959	-0.9479314423	-0.7052679451	-1.9810619999	-1.492199e+00	-1.0380914675	-1.4923473649	-1.5012038958	-1.221013e+00	1358	2.458639e-04	7.724416e-04	P09038	174	0.000245863806104748	A	0	0
P09871	inhibitor	Human C1-esterase inhibitor;Conestat alfa	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Blood and Blood Forming Organs__Blood Proteins__C1 inhibitors__Carbohydrates__Complement C1 Inactivator Proteins__Complement Inactivating Agents__Complement Inactivator Proteins__Complement System Proteins__Decreased Vascular Permeability__Drugs Used in Hereditary Angioedema__Enzyme Inhibitors__Glycoconjugates__Glycoproteins__Immunologic Factors__Immunoproteins__Kallikrein Inhibitors__Peptides__Protease Inhibitors__Proteins__Serine Protease Inhibitors__Serpins__Blood and Blood Forming Organs__C1 inhibitors__Drugs Used in Hereditary Angioedema__Protease Inhibitors	P09871	1.730829e-01	0.6743900665	-0.9023519283	-0.3286953832	-0.4798277087	-0.2654751364	-0.0837812556	-0.5562178399	-1.1394155463	2.398172e-01	0.0422612324	-0.2224270929	-1.0589090312	0.1448730193	-0.6202877557	-0.4956282415	-0.1952321639	-0.4907419405	2.162986e-01	-0.0465897952	0.0519886405	-0.2798358953	-0.0143761589	-0.9606020733	-0.4263645358	-0.0698022460	0.1693550255	-0.3521817699	-0.7771564920	-6.509389e-01	-0.1543323479	-0.7764733005	-0.7640432681	0.0695736533	-0.9570181832	0.0390603238	-0.6891956725	-0.6755750512	0.0270591639	-0.5791075507	0.0891925889	-0.1951207134	-0.1591621999	-0.9498531606	-0.3032225710	-0.7394681477	0.2196986440	-0.5585173118	-0.2651631761	-3.931773e-01	-0.6291831049	-0.1874816889	0.1768396381	0.3062381163	-0.7338347388	-0.5694733908	-0.2028151878	-1.4152840220	-1.002698e+00	0.1359714722	0.0570654271	-5.767253e-01	-0.4918639254	3.031782e-01	-0.7535592057	-0.6033348181	-0.2339338988	-4.670433e-01	-0.1235121894	-0.2556782624	-1.0532326167	-3.563857e-01	0.7423914327	-9.309379e-02	2.185281e-01	-0.4999845646	-0.7345875118	-3.524893e-02	0.0302549274	-0.5259413541	0.2788885320	-0.5357911383	0.5715735207	1.712420e-01	0.3898034538	0.1946687279	0.8447437592	-2.046702e-01	1391	7.786751e-03	1.927223e-02	P09871	181	0.00778675228842304	0	B	C
P09917	inhibitor	Masoprocol;Mesalazine;Diethylcarbamazine;Zileuton;Sulfasalazine;Meclofenamic acid;Balsalazide	yes	TRUE	TRUE	FALSE	FALSE	FALSE	TRUE	Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Antioxidants__Benzene Derivatives__Benzyl Compounds__Catechols__Central Nervous System Agents__Compounds used in a research, industrial, or household setting__Cyclooxygenase Inhibitors__Enzyme Inhibitors__Lignans__Lipoxygenase Inhibitors__Peripheral Nervous System Agents__Phenols__Protective Agents__Sensory System Agents__Agents causing hyperkalemia__Agents that produce hypertension__Aminosalicylate__Aminosalicylic Acids__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Benzene Derivatives__Hydroxybenzoates__Intestinal Antiinflammatory Agents__Nephrotoxic agents__Non COX-2 selective NSAIDS__Phenols__Salicylates__Acids, Acyclic__Anthelmintics__Anti-Infective Agents__Antihelminthic__Antinematodal Agents__Antiparasitic Agents__Antiparasitic Products, Insecticides and Repellents__Carbamates__Cholinesterase Inhibitors__Enzyme Inhibitors__Filaricides__Lipoxygenase Inhibitors__Piperazine and Derivatives__Piperazines__Agents to Treat Airway Disease__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Central Nervous System Agents__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Decreased Leukotriene Production__Enzyme Inhibitors__Hormone Antagonists__Hormones, Hormone Substitutes, and Hormone Antagonists__Leukotriene Antagonists__Lipoxygenase Inhibitors__Peripheral Nervous System Agents__Sensory System Agents__UGT1A9 Substrates__Agents causing hyperkalemia__Agents that produce hypertension__Alimentary Tract and Metabolism__Amides__Aminosalicylate__Analgesics__Analgesics, Non-Narcotic__Anti-Infective Agents__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents__Antirheumatic Agents__BCRP/ABCG2 Inhibitors__BCRP/ABCG2 Substrates__Central Nervous System Agents__Gastrointestinal Agents__Genito Urinary System and Sex Hormones__Gynecological Antiinfectives and Antiseptics__Immunosuppressive Agents__Intestinal Antiinflammatory Agents__Methemoglobinemia Associated Agents__Nephrotoxic agents__Non COX-2 selective NSAIDS__OATP1B1/SLCO1B1 Inhibitors__OATP1B3 inhibitors__Peripheral Nervous System Agents__Salicylates__Sensory System Agents__Sulfonamides__Sulfones__Sulfur Compounds__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Amines__Aminobenzoates__Analgesics__Analgesics, Non-Narcotic__Aniline Compounds__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antiinflammatory Preparations, Non-Steroids for Topical Use__Antirheumatic Agents__Benzene Derivatives__Benzoates__Central Nervous System Agents__Cyclooxygenase Inhibitors__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Fenamates__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__OAT1/SLC22A6 inhibitors__ortho-Aminobenzoates__Peripheral Nervous System Agents__Sensory System Agents__Thyroxine-binding globulin substrates__Topical Products for Joint and Muscular Pain__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Alimentary Tract and Metabolism__Aminobenzoates__Aminosalicylate__Aminosalicylic Acids__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents__Benzene Derivatives__Benzoates__Central Nervous System Agents__Colitis, Ulcerative__Gastrointestinal Agents__Hydrazines__Hydroxy Acids__Hydroxybenzoates__Inflammatory Bowel Diseases__Intestinal Antiinflammatory Agents__meta-Aminobenzoates__Nephrotoxic agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Phenols__Prodrugs__Salicylates__Sensory System Agents	P09917	3.547614e-01	0.3936639703	-0.1376337701	0.7107629067	-0.1229136500	-0.2804656493	-0.2181554043	0.6820042744	0.0170336302	-5.579353e-01	0.3897366726	0.0611958471	-0.3707926579	0.0596534047	0.0232062156	-0.1976651027	-0.0894709754	-0.2439463193	-1.505926e-02	0.0375997446	0.0309538539	-0.4294958900	-0.4449844567	-0.1586003257	-0.2276297035	0.0485756319	0.5955270262	0.7280274216	0.8952000620	-3.385778e-01	0.3166546996	0.4369959198	-0.4082611097	1.2943994207	0.0231477638	0.1357381350	0.5309978447	-0.2899491389	-0.0281811719	0.2541857500	0.7190051268	-0.5047461329	0.6662600741	0.0908979830	0.3638649556	0.4883471305	0.1055958318	-0.0815130012	-0.1079486654	1.221667e-01	0.0428631392	0.9517844494	0.2122909514	-0.4400910174	-0.0817425067	-0.5177532125	0.2299695572	0.4506588910	-5.657202e-01	-0.5851869083	0.2121819311	-1.770901e-01	0.1826292650	-3.489755e-01	0.0118300037	-0.7333167242	-0.3726578606	2.510634e-01	0.1651761271	0.0306138696	0.6801560259	7.770889e-02	-0.4826392793	5.503184e-02	-6.491512e-02	-0.1289612708	-0.2718961072	-9.353031e-03	0.1065674612	0.3392814095	-0.0118986396	0.8554823497	0.2544747234	6.129184e-01	0.7369019747	0.5642901280	1.1086622336	-2.670186e-01	1395	5.976702e-03	1.494328e-02	P09917	184	0.00597670031507472	0	B	C
P10721	antagonist;inhibitor;agonist	Sorafenib;Imatinib;Sunitinib;Pazopanib;Regorafenib;Lenvatinib;Ancestim	yes	TRUE	TRUE	FALSE	FALSE	FALSE	TRUE	Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Inhibitors__BCRP/ABCG2 Substrates__Benzene Derivatives__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (moderate)__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors (strong)__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strong)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Immunosuppressive Agents__Kinase Inhibitor__Miscellaneous Therapeutic Agents__Myelosuppressive Agents__Nicotinic Acids__OATP1B1/SLCO1B1 Inhibitors__P-glycoprotein inhibitors__P-glycoprotein substrates__Phenylurea Compounds__Potential QTc-Prolonging Agents__Protein Kinase Inhibitors__Pyridines__QTc Prolonging Agents__Tyrosine Kinase Inhibitors__UGT1A1 Inhibitors__UGT1A9 Inhibitors__UGT1A9 Substrates__Vitamin B Complex__Vitamins__Acids, Carbocyclic__Amides__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Inhibitors__BCRP/ABCG2 Substrates__Benzamides and benzamide derivatives__Benzene Derivatives__Benzoates__BSEP/ABCB11 Substrates__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (moderate)__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (weak)__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Inhibitors__Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Inhibitors__Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Highest Risk QTc-Prolonging Agents__Immunosuppressive Agents__Kinase Inhibitor__Myelosuppressive Agents__OCT1 substrates__OCT2 Inhibitors__P-glycoprotein inhibitors__P-glycoprotein substrates__Piperazines__Protein Kinase Inhibitors__Pyrimidines__QTc Prolonging Agents__Tyrosine Kinase Inhibitors__Angiogenesis Inhibitors__Angiogenesis Modulating Agents__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Inhibitors__Blood Glucose Lowering Agents__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Growth Inhibitors__Growth Substances__Hepatotoxic Agents__Heterocyclic Compounds, Fused-Ring__Hypoglycemia-Associated Agents__Immunosuppressive Agents__Indoles__Kinase Inhibitor__P-glycoprotein inhibitors__P-glycoprotein substrates__Potential QTc-Prolonging Agents__Protein Kinase Inhibitors__QTc Prolonging Agents__Tyrosine Kinase Inhibitors__Amides__Angiogenesis Inhibitors__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (weak)__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (weak)__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (weak)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Hepatotoxic Agents__Immunosuppressive Agents__Kinase Inhibitor__Moderate Risk QTc-Prolonging Agents__OATP1B1/SLCO1B1 Inhibitors__P-glycoprotein substrates__Protein Kinase Inhibitors__QTc Prolonging Agents__Receptors, Vascular Endothelial Growth Factor, antagonists &amp; inhibitors__Sulfones__Sulfur Compounds__Tyrosine Kinase Inhibitors__UGT1A1 Inhibitors__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Inhibitors__Benzene Derivatives__Bradycardia-Causing Agents__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Hepatotoxic Agents__Kinase Inhibitor__P-glycoprotein inhibitors__P-glycoprotein substrates__Protein Kinase Inhibitors__Tyrosine Kinase Inhibitors__UGT1A1 Inhibitors__UGT1A9 Inhibitors__UGT1A9 Substrates__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__Benzene Derivatives__BSEP/ABCB11 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (moderate)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (weak)__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (weak)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Heterocyclic Compounds, Fused-Ring__Kinase Inhibitor__Moderate Risk QTc-Prolonging Agents__OAT1/SLC22A6 inhibitors__OAT3/SLC22A8 Inhibitors__OATP1B1/SLCO1B1 Inhibitors__OCT2 Inhibitors__P-glycoprotein substrates__Protein Kinase Inhibitors__QTc Prolonging Agents__Receptor Tyrosine Kinase Inhibitors__Tyrosine Kinase Inhibitors__Adjuvants, Immunologic__Amino Acids, Peptides, and Proteins__Antineoplastic and Immunomodulating Agents__Biological Factors__Colony-Stimulating Factors__Cytokines__Drugs that are Mainly Renally Excreted__Hematopoietic Cell Growth Factors__Intercellular Signaling Peptides and Proteins__Peptides__Proteins	P10721	-1.322157e+00	-1.3982333607	-0.9633200300	-1.5249067823	-1.4693070597	-0.9519711290	-0.6458048826	-0.8208756352	-1.1813199618	-2.067434e+00	-1.2787528280	-1.7034362593	-0.8547038574	-1.5771396624	-1.4360186821	-1.5400473966	-1.7571392793	-0.8102426869	-1.421491e+00	-1.5898966098	-1.0048264025	-1.3586547016	-1.2932228993	-1.0273800341	-0.8716594860	-1.4097788819	-0.2853853733	-1.1556716226	-0.0552052903	-5.942735e-01	-0.8345923312	0.9616504510	-0.4409456929	0.9407651471	-0.6396374078	-0.8768980720	-0.9008448856	-1.1210715794	-0.3086243563	-0.4917640134	0.7473763387	-0.8546956471	-0.6882200018	-1.6464513052	-0.0856143016	-0.5646912144	0.3627216893	-1.1243954134	-0.8569724000	-1.127437e+00	-1.4618272661	-0.9098692551	-0.7159546903	-0.1787100073	-0.4540801433	-0.2902698871	-1.0431791991	-1.3395339185	-1.265284e+00	-1.3480600459	-1.0548337325	-3.598581e-01	-1.3811124295	-1.278325e+00	-1.1746077607	-1.5535082665	-1.2787266541	-1.079490e+00	-0.8804242244	-0.6304983678	-0.4456287986	-2.067172e-01	-0.9192696356	-6.409936e-01	-1.203403e+00	-1.1902007475	-1.0693108898	-9.182087e-01	-1.4367143956	-1.3710168758	-1.1535013812	-0.1038436636	-2.4987930195	-6.297140e-01	-0.7439211495	-1.4234270656	-0.8217421620	-6.810512e-01	1436	9.240817e-04	3.296920e-04	P10721	193	0.000924081105917266	A	0	0
P11388	inhibitor	Amsacrine;Dexrazoxane;Valrubicin;Teniposide;Daunorubicin;Etoposide;Doxorubicin;Levofloxacin;Idarubicin;Podofilox;Mitoxantrone;Sparfloxacin;Fleroxacin;Lucanthone;Aldoxorubicin;Finafloxacin	yes	TRUE	TRUE	TRUE	FALSE	FALSE	TRUE	Acridines__Aminoacridines__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Cardiotoxic antineoplastic agents__Compounds used in a research, industrial, or household setting__Heterocyclic Compounds, Fused-Ring__Immunosuppressive Agents__Indicators and Reagents__Intercalating Agents__Laboratory Chemicals__Myelosuppressive Agents__P-glycoprotein inhibitors__Cardiotonic Agents__Cardiovascular Agents__Compounds used in a research, industrial, or household setting__Cytoprotective Agent__Detoxifying Agents for Antineoplastic Treatment__Diketopiperazines__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Immunosuppressive Agents__Miscellaneous Therapeutic Agents__Myelosuppressive Agents__Piperazines__Protective Agents__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Anthracyclines__Anthracyclines and Related Substances__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Carbohydrates__Cytotoxic Antibiotics and Related Substances__Enzyme Inhibitors__Glycosides__Naphthacenes__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__Carbohydrates__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors (weak)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Glucosides__Glycosides__Immunosuppressive Agents__Myelosuppressive Agents__Neurotoxic agents__P-glycoprotein substrates__Podophyllotoxin Derivatives__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Anthracycline Topoisomerase Inhibitor__Anthracyclines__Anthracyclines and Related Substances__Antibiotics, Antineoplastic__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__BSEP/ABCB11 Substrates__Carbohydrates__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Inducers__Cytochrome P-450 CYP3A5 Inducers (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Cytotoxic Antibiotics and Related Substances__Enzyme Inhibitors__Glycosides__Immunosuppressive Agents__Myelosuppressive Agents__Naphthacenes__P-glycoprotein inducers__P-glycoprotein inhibitors__P-glycoprotein substrates__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Antineoplastic Agents__Antineoplastic Agents, Phytogenic__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__Benzene Derivatives__Benzyl Compounds__Carbohydrates__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Glucosides__Glycosides__Immunosuppressive Agents__Lignans__Myelosuppressive Agents__Naphthalenes__P-glycoprotein inhibitors__P-glycoprotein substrates__Podophyllotoxin__Podophyllotoxin Derivatives__Tetrahydronaphthalenes__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__UGT1A1 Substrates__Anthracycline Topoisomerase Inhibitor__Anthracyclines__Anthracyclines and Related Substances__Antibiotics, Antineoplastic__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__BSEP/ABCB11 Substrates__Carbohydrates__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Cytotoxic Antibiotics and Related Substances__Enzyme Inhibitors__Glycosides__Immunosuppressive Agents__Myelosuppressive Agents__Naphthacenes__P-glycoprotein inducers__P-glycoprotein inhibitors__P-glycoprotein substrates__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Alimentary Tract and Metabolism__Anti-Bacterial Agents__Anti-Infective Agents__Anti-Infective Agents, Urinary__Antibacterials for Systemic Use__Antiinfectives for Systemic Use__Chemically-Induced Disorders__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Drugs for Acid Related Disorders__Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Fluoroquinolones__Heterocyclic Compounds, Fused-Ring__MATE 1 Inhibitors__MATE 1 Substrates__MATE 2 Inhibitors__MATE inhibitors__MATE substrates__Moderate Risk QTc-Prolonging Agents__OAT1/SLC22A6 Substrates__OCT2 Inhibitors__Ophthalmologicals__P-glycoprotein inhibitors__P-glycoprotein substrates__QTc Prolonging Agents__Quinolines__Quinolone Antimicrobial__Quinolones__Renal Agents__Sensory Organs__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Anthracycline Topoisomerase Inhibitor__Anthracyclines__Anthracyclines and Related Substances__Antibiotics, Antineoplastic__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Carbohydrates__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Cytotoxic Antibiotics and Related Substances__Enzyme Inhibitors__Glycosides__Immunosuppressive Agents__Myelosuppressive Agents__Naphthacenes__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Antimitotic Agents__Antineoplastic Agents, Phytogenic__Antiviral Agents__Benzene Derivatives__Benzyl Compounds__Decreased Mitosis__Dermatologicals__Keratolytic Agents__Lignans__Misc. Skin and Mucous Membrane Agents__Mitosis Modulators__Naphthalenes__Tetrahydronaphthalenes__Tubulin Modulators__Analgesics__Anthracenes__Anthracyclines and Related Substances__Anthraquinones__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__Cardiotoxic antineoplastic agents__Central Nervous System Agents__Cytochrome P-450 CYP2E1 Inducers__Cytochrome P-450 CYP2E1 Inducers (strength unknown)__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Cytotoxic Antibiotics and Related Substances__Enzyme Inhibitors__Immunosuppressive Agents__Myelosuppressive Agents__P-glycoprotein inducers__P-glycoprotein inhibitors__P-glycoprotein substrates__Peripheral Nervous System Agents__Quinones__Sensory System Agents__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Anti-Bacterial Agents__Anti-Infective Agents__Antibacterials for Systemic Use__Antiinfectives for Systemic Use__Antituberculosis Agents__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Enzyme Inhibitors__Fluoroquinolones__Heterocyclic Compounds, Fused-Ring__Highest Risk QTc-Prolonging Agents__P-glycoprotein substrates__QTc Prolonging Agents__Quinolines__Quinolones__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Anti-Bacterial Agents__Anti-Infective Agents__Antibacterials for Systemic Use__Antiinfectives for Systemic Use__Antineoplastic Agents__Enzyme Inhibitors__Fluoroquinolones__Heterocyclic Compounds, Fused-Ring__Potential QTc-Prolonging Agents__QTc Prolonging Agents__Quinolines__Quinolones__Topoisomerase II Inhibitors__Topoisomerase Inhibitors__Anthelmintics__Anti-Infective Agents__Antiparasitic Agents__Antiplatyhelmintic Agents__Heterocyclic Compounds, Fused-Ring__Schistosomicides__Sulfur Compounds__Thioxanthenes__Xanthenes__Xanthones__Anthracyclines__Antineoplastic Agents__Carbohydrates__Cardiotoxic antineoplastic agents__Glycosides__Hydrazines__Naphthacenes__Anti-Bacterial Agents__Anti-Infective Agents__Anti-Infective Agents, Urinary__Antineoplastic Agents__Enzyme Inhibitors__Fluoroquinolones__Heterocyclic Compounds, Fused-Ring__Quinolines__Quinolone Antimicrobial__Quinolones__Renal Agents__Topoisomerase II Inhibitors__Topoisomerase Inhibitors	P11388	6.281356e-01	0.8370165669	1.4464906804	0.9394399039	0.1509380837	0.0717391465	2.1937925335	1.6386751344	0.7291078364	1.435144e+00	0.9651361592	0.8045776779	0.2153953310	1.8390140068	1.5603349032	2.0257816496	1.5590583475	1.3502099611	1.342522e-01	1.2359816722	0.7275835130	1.9297070319	0.4007045597	0.6669835218	0.4869423190	0.3363169845	0.3824442578	0.1257603767	0.0830743064	1.823169e-01	0.6409636185	0.2398902780	-0.3015946483	0.9734665872	-0.0934213370	1.0963890701	0.2411074156	0.2667554264	0.0465173889	0.7659291772	0.6444288470	0.5024244836	-0.1128415449	-0.3324418329	0.3179471115	0.2755317886	0.5440772012	0.6144096185	0.0699154902	3.904596e-01	0.3909368937	0.6582293642	0.3621966919	0.5195897593	0.2914464626	1.6766242205	0.2106454850	1.1375174972	1.776479e-02	0.6085442156	1.1759552552	6.151215e-01	1.8453300791	1.971024e-01	0.3674189414	1.0046146553	1.8036786754	1.036118e+00	-0.4721874350	0.5411586511	1.0816553339	4.141883e-01	0.2492403725	-6.809894e-02	5.158062e-01	0.1781800209	-0.5027078072	1.244924e+00	0.5554647054	-0.2372991099	-0.0064481272	0.3707221515	1.0857907511	-6.977612e-01	0.0550456775	1.0057591947	0.2040748371	7.752074e-01	1467	6.211701e-05	7.220353e-04	P11388	200	6.21170265825507e-05	A	B	0
P11532	inducer	Golodirsen	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Drugs that are Mainly Renally Excreted__Oligonucleotides, Antisense	P11532	-1.483505e+00	-1.3583407527	-1.0207337051	-0.5617367048	-0.3593814450	-0.3599281459	-0.7838903652	-0.8350734540	-0.2940436617	-1.318513e+00	-1.0574810741	-1.0748970178	-1.3981572391	-1.4070809833	-1.1989900251	-1.2883302194	-0.8070799714	-0.3527717664	-7.169614e-01	-1.1022776510	-1.1767361478	-1.0412801047	-1.1374564814	-0.7680166893	-0.8174082972	-1.1510801923	0.3487850684	0.4612518298	-0.1155645342	-3.054260e-01	-1.1408459053	0.4938465030	0.2702139325	0.1490349598	0.6610931081	-0.6609402414	-1.2190611229	-0.4781105662	-0.5820498655	-0.2946699202	0.2712777860	-0.0414930129	-0.4151711221	-0.0427404045	0.3556623263	-0.0558516932	0.2056139620	-0.5617441810	0.5954766892	-8.865385e-01	-0.4335192498	-1.0965158482	0.4776739363	0.9739360326	0.1236791050	-0.7260271967	-0.6934049425	-0.6214150622	-3.977051e-01	-1.1374718083	-0.7456701479	-8.194689e-01	-0.5974557279	-4.266702e-02	-0.6076232037	-0.4193488765	-1.4982733421	-9.201092e-01	0.2823468287	-0.3336650739	0.6567845772	-3.090904e-01	-0.2613694868	5.073770e-02	-9.994078e-01	-0.6907246204	-0.2928190310	-9.200497e-01	-1.2249213652	-1.3226777097	-0.2543974865	-0.4182437212	-1.1443881859	-3.406581e-01	-0.5195656792	-0.7605756085	-0.6062597187	-2.720466e-01	1471	4.545850e-05	1.049351e-04	P11532	201	4.54585053048202e-05	A	0	0
P14735	inhibitor	Bacitracin	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Acids, Carbocyclic__Amino Acids, Peptides, and Proteins__Anti-Bacterial Agents__Anti-Infective Agents__Anti-Infective Agents, Local__Antibacterials for Systemic Use__Antibiotics for Topical Use__Antiinfectives for Systemic Use__Bacitracins__Benzene Derivatives__Benzoates__Decreased Cell Wall Synthesis &amp; Repair__Dermatologicals__Hydroxy Acids__Hydroxybenzoates__Nephrotoxic agents__Peptides__Peptides, Cyclic__Phenols__Throat Preparations	P14735	3.609708e-01	0.4777521937	0.3757150896	0.4035951844	0.6391204050	0.0619578411	0.3246480401	-0.1114006247	0.5312905819	4.480001e-01	0.4335762813	0.3275754356	0.4993701928	0.3396805735	0.7772379228	0.5128527462	0.9181479339	0.6452288305	3.235894e-01	0.5715579225	0.5010442167	0.6558784945	0.2320004910	0.8843198374	0.5021564324	0.7803124263	0.2802357740	0.4164116223	0.6361156858	4.860755e-01	0.5937601166	0.1526219291	0.5678361947	0.4404164109	0.1679381094	0.0980613251	0.9082664376	0.5842092897	0.5731714050	0.6677589786	0.4103016663	0.2502314925	0.7418522667	0.3803924725	0.4753823508	0.2904267090	0.3433229353	0.7557510005	0.2998127025	3.882979e-01	0.5396566836	0.3983575775	0.3232294091	0.1197713563	0.3264436499	0.6120951972	0.5530959795	0.4205510793	5.963574e-01	0.8908863001	0.4137557968	2.650617e-01	0.2941443351	5.025604e-01	0.4993332550	0.4660565084	0.5952138375	5.983011e-01	0.3231846089	0.6592389135	0.3768248058	3.516240e-01	0.1634079587	-5.647440e-02	6.393349e-01	0.8987050404	0.3615499927	7.094068e-01	0.4151151382	0.5624882761	0.4293804952	0.1646983421	-0.0522482022	-7.888049e-02	0.0693252998	0.1083096014	0.2588653989	3.396459e-01	1575	2.644321e-04	1.307099e-03	P14735	212	0.000264432057502763	0	B	C
P15260	binder	Interferon gamma-1b	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Biological Factors__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Cytokines__Immunosuppressive Agents__Intercellular Signaling Peptides and Proteins__Interferon gamma__Interferons__Lymphokines__Macrophage-Activating Factors__Myelosuppressive Agents__Peptides__Proteins	P15260	-7.518100e-01	-0.3788182850	-0.6548849710	-1.2993362946	-0.5407292089	-0.9959400729	-0.7679700464	0.3836890784	-0.5578161332	-3.020370e-01	-0.3414647189	-0.5153422527	-0.6656137435	-0.5554138393	-0.9996666104	-0.9288970187	-1.2909670667	-0.7352474777	-9.094356e-01	-0.8890048281	-0.6353373207	-0.9097841954	-0.3250209762	-1.0291863369	-1.0345340028	-0.8999067984	-1.1033573809	-0.9832564046	-1.2390125863	-9.435675e-01	-0.5084343246	-0.8273449668	-1.4599128380	-1.1613621726	-0.6205255263	-1.1949161603	-0.2289549979	-1.1255594116	-1.0325185410	-1.1686090552	-1.4844176843	-0.8850892200	-1.2491942159	-1.2308054120	-0.9175839917	-0.5373825269	-1.0701667576	-0.8188240234	-1.2198199476	-7.080521e-01	-0.9944609843	-0.6974573178	-1.0517515759	-1.2037435302	-0.7788142954	-1.1918204516	-1.4580859840	-0.1970118136	-5.322223e-01	-0.9299551335	-0.7898945777	-5.431456e-01	-0.6575375360	-1.194376e+00	-0.5173902467	-0.5809625261	-0.6795520013	-8.825702e-01	-1.2044234627	-1.0685667726	-0.5921546342	-7.419963e-01	-0.9217335300	-1.297045e+00	-8.831848e-01	-1.1496229488	-0.9653888978	-1.097770e+00	-0.5177662312	-0.9416366716	-0.9795963105	-0.9555644825	-0.7012955539	1.542126e-01	-0.7843769094	-0.7097795894	-1.4352454610	-8.271157e-01	1597	6.599579e-03	1.050846e-02	P15260	217	0.00659958007825118	A	0	0
P15309	other	Sipuleucel-T	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Adjuvants, Immunologic__Antineoplastic and Immunomodulating Agents__Autologous Cellular Immunotherapy__Cancer Vaccines__Cell-mediated Immunity__Complex Mixtures__Intercellular Adhesion Molecule-1	P15309	7.341808e-01	0.7442705384	0.8754410512	0.9835012980	0.1044120267	-0.2429259947	0.7167655720	-0.0699329198	0.4635692761	7.126710e-01	0.7935781346	0.9234511313	0.6470312702	0.1486907996	0.3585205814	0.6266443827	0.0668216610	-0.2815728102	-1.029227e-01	-0.3763664359	-0.0394627373	0.2292969808	0.2220836509	0.9745754068	-0.1828639778	0.5312223671	0.4101995534	0.1545341550	0.0975981993	-3.158713e-01	0.2393554794	-0.0602931997	0.5518815740	0.0069240742	-0.5523820396	-0.3454865186	0.4508940156	-0.0955828381	-0.7935476005	0.2010227213	-0.0619086387	0.1578941460	0.6235422172	0.4424538439	0.3388074823	-0.3252786879	-0.2764475709	-0.0021669723	-0.1328364042	-4.272287e-01	-0.0512736552	0.0757562057	-0.3459844790	-0.8912712306	-0.0679920569	0.7488278573	0.0879885897	0.0187335235	4.464377e-01	0.9510387220	-0.4880634911	-1.049218e-01	-0.2428202511	1.078344e-02	-0.2719290294	-0.5934008378	-0.2063521947	-1.492455e-01	-0.7201773766	-0.1397887153	-0.2079045464	7.988938e-04	-0.8244533564	-6.764780e-01	-4.315671e-02	-0.0552153741	-0.1602480457	8.942388e-02	0.2160528898	1.5463417483	-0.0094318467	-0.0218933940	0.4783982209	-3.805850e-01	0.2159211749	0.0898994716	-0.5957148340	3.439193e-01	1600	4.871760e-03	5.415790e-03	P15309	219	0.00487175940878126	A	0	0
P16444	inhibitor	Cilastatin	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Cycloparaffins__Cyclopropanes__Dipeptidase Inhibitors__Enzyme Inhibitors__OAT1/SLC22A6 inhibitors__OAT3/SLC22A8 Inhibitors__Protease Inhibitors__Renal Dehydropeptidase Inhibitor	P16444	1.418400e-01	0.0864303486	0.0129566554	1.0636861679	-1.8906664811	0.6714713619	-0.3815367520	-0.0758189792	0.8066331928	7.419920e-01	-0.0581591906	0.2805396123	1.6291646547	0.0803827191	0.4387052911	0.2955996589	0.6019242524	1.1489410168	9.919854e-01	1.6416309849	1.8027117466	0.1451314434	0.9997436782	-0.0253288172	0.4961446553	1.6586637440	2.5444408482	1.0320287701	1.0553866848	4.977407e-01	0.4042627232	2.2252308859	0.7696779757	2.4233801247	0.5631035330	1.0188722424	0.4036675387	1.2046438500	0.9421550528	1.2148204988	1.8153263490	1.6382041754	1.7558176243	0.5376425097	0.7509632075	2.0337370935	0.7953018800	2.1937925335	1.1020719271	7.107063e-01	1.0877935866	2.0280721740	0.6009618157	1.2417374716	1.4948576378	-0.1445588308	2.4249480613	-0.2180599691	3.274023e-01	0.4959082685	1.6641081735	1.585079e-01	1.8001405543	9.425102e-01	2.6738845758	0.1514767871	0.5590155114	1.887078e+00	1.4771327551	2.3069723869	1.0043803552	2.462891e-01	2.1970488062	3.598320e-01	7.527739e-01	1.5610007363	1.9818659080	3.626892e-01	0.0140993851	1.1397269969	1.0945007985	1.9663604974	0.2226787881	4.892441e-01	2.0212003583	0.7825631069	1.9609054262	1.929239e+00	1648	2.281988e-03	4.367723e-03	P16444	224	0.00228198781411812	A	B	0
P17252	antagonist;inhibitor	Midostaurin;Tamoxifen	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Alkaloids__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Carbazoles__Cytochrome P-450 CYP1A2 Inducers__Cytochrome P-450 CYP1A2 Inducers (strength unknown)__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strong)__Cytochrome P-450 CYP2B6 Inducers__Cytochrome P-450 CYP2B6 Inducers (strength unknown)__Cytochrome P-450 CYP2C19 Inducers__Cytochrome P-450 CYP2C19 Inducers (strength unknown)__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 Inhibitors (weak)__Cytochrome P-450 CYP2C8 Inducers__Cytochrome P-450 CYP2C8 Inducers (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inducers__Cytochrome P-450 CYP2C9 Inducers (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strong)__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strong)__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A Inducers (strong)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 CYP3A4 Inducers (strong)__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strong)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Inducers__Cytochrome P-450 CYP3A5 Inducers (strength unknown)__Cytochrome P-450 CYP3A7 Inducers__Cytochrome P-450 CYP3A7 Inducers (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Heterocyclic Compounds, Fused-Ring__Indole Alkaloids__Indoles__Kinase Inhibitor__Protein Kinase C, antagonists &amp; inhibitors__Protein Kinase Inhibitors__Receptor Tyrosine Kinase Inhibitors__Tyrosine Kinase Inhibitors__	P17252	-9.638908e-01	-0.4723953065	-0.6315321501	-0.4065272271	-0.1203811369	-0.4472729444	-0.8427036839	-0.3327107021	-0.5434575983	-1.020005e+00	-0.4054001522	-0.7291913125	-0.6867288084	-0.7442121610	-0.8488324234	-0.9452552589	-0.7562368102	-0.7363614517	-8.288580e-01	-0.8856438458	-0.7172506505	-1.0532857010	-1.0738910837	-0.6412284218	-0.5038820281	-0.8139850262	-0.3975511691	0.1459800903	-0.3052669968	-7.013890e-01	-0.6527711230	0.1289588992	-0.3188628054	0.1813404634	-0.4643821809	-0.7278896871	-0.2664298686	-0.5765598047	-0.3965047998	-0.6122650082	-0.1291525748	-0.4441897728	0.1642482655	-0.6293225196	0.1241122788	-0.1298873410	0.2636014151	-0.7436364495	-0.5957593092	-6.212841e-01	-0.1437090651	-0.2499944811	-0.2135022035	0.2054360783	-0.2172019129	-0.7712103826	-0.5668166863	-0.3867744780	-3.725355e-01	-1.0423610651	-0.6316284304	-8.735149e-01	-0.6059673106	-6.149045e-01	-0.8681270040	-0.7535195065	-0.7448550191	-7.327264e-01	-0.1041960009	-0.2540693433	-0.1807594499	-6.206787e-01	-0.4362640546	-5.515706e-01	-1.001303e+00	-0.4203771146	-0.6544467863	-9.965106e-01	-1.0934316977	-1.0050353539	-0.7584788652	-0.4059348072	-0.8468027997	-3.142443e-01	-0.1476528227	-0.5819782719	-0.3807079824	-4.931866e-01	1670	1.100447e-02	8.830539e-03	P17252	228	0.011004470882694	A	0	0
P19838	antagonist;translocation inhibito	Thalidomide;Triflusal;Glycyrrhizic acid	yes	TRUE	TRUE	TRUE	FALSE	FALSE	TRUE	Acids, Carbocyclic__Angiogenesis Inhibitors__Angiogenesis Modulating Agents__Anti-Bacterial Agents__Anti-Infective Agents__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Cardiotoxic antineoplastic agents__Central Nervous System Depressants__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A5 Inducers__Cytochrome P-450 CYP3A5 Inducers (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Decreased Immunologically Active Molecule Activity__Growth Inhibitors__Growth Substances__Heterocyclic Compounds, Fused-Ring__Hypotensive Agents__Imides__Immunologic Factors__Immunomodulatory Agents__Immunosuppressive Agents__Isoindoles__Leprostatic Agents__Myelosuppressive Agents__Noxae__Phthalic Acids__Phthalimides__Piperidines__Piperidones__Teratogens__Toxic Actions__Acids, Carbocyclic__Anticoagulants__Antiplatelet agents__Benzene Derivatives__Benzoates__Blood and Blood Forming Organs__Hematologic Agents__Hydroxy Acids__Hydroxybenzoates__Phenols__Platelet Aggregation Inhibitors Excl. Heparin__	P19838	-1.433315e-01	-0.4943977778	-0.2851801781	0.0194350367	0.2775075822	0.0044981676	-0.1771242486	-0.0807089559	-0.0383918159	-1.453811e-01	0.0806773133	0.0510846217	-0.1924839395	-0.1779377512	-0.0600970050	-0.0351303818	0.3631554498	0.1928286855	-1.333258e-01	0.1064460047	0.2259297338	0.2617807124	0.1236763376	-0.0491060507	-0.1247668367	0.0761514863	-0.0729674711	0.1595425618	0.4796207976	3.821015e-01	-0.1749548825	0.0023941794	0.2974460107	0.1661156717	-0.0595219163	0.2155430789	0.1359287233	0.4136794380	-0.1756736456	0.0462489765	0.1952446699	0.0968927882	0.3819239262	0.2012010037	0.1735761552	0.0865362921	0.2808293870	0.1314369065	-0.0997729242	-4.126896e-02	0.0390983129	-0.1855217730	0.4041079256	0.0747498521	0.1662613251	-0.1389638171	0.0158251140	-0.0507025592	-1.438023e-01	0.1251791693	-0.1925349098	3.780127e-01	-0.0093507091	1.944600e-01	0.0551924013	-0.1181740622	0.0416368898	9.614709e-02	0.2385622076	0.3533040123	-0.0753173290	1.156176e-01	-0.0848333673	2.547901e-01	1.988509e-01	0.3413264053	0.0198265248	1.654339e-01	-0.1591093291	0.2244899242	-0.0342563535	0.0342521689	-0.2777355656	-4.666641e-01	-0.0571900184	-0.0045625634	0.1245674609	-5.160994e-02	1745	7.922449e-03	2.417784e-02	P19838	241	0.00792244769306679	0	0	C
P20594	agonist	Erythrityl tetranitrate	yes	TRUE	TRUE	TRUE	FALSE	FALSE	FALSE	Acids__Acids, Noncarboxylic__Alcohols__Anions__Antianginal Agents__Carbohydrates__Cardiac Therapy__Cardiovascular Agents__Electrolytes__Erythritol__Ions__Nitrates__Nitric Acid__Nitrogen Compounds__Organic Nitrates__Sugar Alcohols__Vasodilating Agents__Vasodilators Used in Cardiac Diseases	P20594	-7.205396e-01	-0.7229243965	-0.6239964441	-0.5553965927	-0.5702752350	-0.4067672022	-0.4977489445	-0.6429642661	-0.8039962066	-6.551059e-01	-0.9288884330	-1.0111862192	-0.3366966551	-0.4136194269	-0.6214756543	-0.7164630583	-0.6258043237	-0.6245942638	-5.651448e-01	-0.4913466347	-0.4757942193	-0.6858454955	-0.6531399689	-0.6015708322	-0.4401517662	-0.7951584112	-0.2016260657	-0.0793864138	-0.5676484211	-6.000359e-01	-0.0262348473	0.3151180833	-0.3647435790	0.1765519590	-0.5543005957	-0.4564688347	-0.5225463237	-0.3442914074	-0.4647513079	-0.3687712985	-0.1868734297	-0.3048952609	-0.3328559267	-0.4770798381	0.0920409438	-0.3881109977	0.1436961330	-0.4923725022	-0.5059834413	-5.593462e-01	-0.7026941774	-0.3604003303	-0.1063062550	0.4183904056	-0.1534657226	-0.9391632849	-0.6362827318	-0.8746161077	-1.060301e+00	-1.0465514582	-0.2558870568	-6.189165e-01	-0.5365877625	-5.197853e-01	-0.3268940088	-0.6967637220	-0.7349825093	-7.538431e-01	0.1484255842	-0.2384938141	0.0514505568	-3.150624e-01	-0.0637280651	-7.251372e-01	-7.303060e-01	-0.5613220399	-0.7460991397	-4.960089e-01	-0.6638333383	-0.6013165134	-0.3742250008	-0.0793242894	-0.5046393363	-1.614882e-01	-0.1129191274	-0.4207614755	-0.1421083294	-4.942837e-01	1766	3.250411e-03	1.376639e-03	P20594	245	0.00325040907338548	A	B	0
P20618	inhibitor	Bortezomib;Carfilzomib	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Acids__Acids, Noncarboxylic__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Boron Compounds__Boronic Acids__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (moderate)__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 Inhibitors (weak)__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Hypotensive Agents__Immunosuppressive Agents__Myelosuppressive Agents__Potential QTc-Prolonging Agents__Proteasome Inhibitors__Pyrazines__QTc Prolonging Agents__Amino Acids, Peptides, and Proteins__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Immunosuppressive Agents__Myelosuppressive Agents__P-glycoprotein substrates__Peptides__Proteasome Inhibitors	P20618	-1.160115e-01	0.3620389991	0.1874515828	-0.2672364794	0.1529999915	0.0186393599	0.5381132464	-0.0004967694	0.0353116573	8.870391e-02	0.3773163473	0.2652612816	-0.2054501523	-0.0568526226	0.2004926967	0.0501270750	-0.1230077443	0.5562515950	8.353476e-03	0.1578151264	0.1688441126	0.3386620186	0.0753498326	0.4079428586	-0.0865907678	-0.0956929693	-0.3533596778	-0.2446006078	0.0468226389	2.828903e-01	0.2004344748	-0.2189548403	0.2523093362	-0.1234977431	-0.3680864282	0.1366739629	0.2016512598	0.2140955862	-0.2348914472	-0.1522577999	-0.1428360842	0.1257824901	0.0082286059	0.2260166943	-0.0045567114	-0.0301759520	-0.1612398063	0.1938436813	-0.1640266237	1.834644e-01	0.2410586664	-0.0263954026	-0.1137061917	-0.4736034086	0.0108922955	0.1029555400	0.2607639450	0.0333694097	1.708584e-01	0.2786363150	-0.4131942689	-3.883552e-02	-0.1835179402	1.172078e-01	0.0286353568	-0.1315021426	0.2347769482	1.636700e-02	-0.6623753368	0.2260684512	-0.5827951509	-3.030218e-02	-0.0648844617	-1.155144e-01	-5.442019e-02	0.1629574897	0.0158578225	5.447044e-02	-0.2606421738	0.2301402093	-0.1504419748	-0.2414346943	-0.2018072212	-5.630770e-01	-0.3281491489	-0.2097156298	-0.1642752783	-2.270641e-01	1767	2.114121e-04	3.822831e-04	P20618	246	0.000211412137576393	A	B	C
P20645	binder	Alglucosidase alfa	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Alimentary Tract and Metabolism__alpha-Glucosidases__Enzymes__Enzymes and Coenzymes__Glucosidases__Glycogen Storage Disease Type II__Glycoside Hydrolases__Hydrolases__Hydrolytic Lysosomal Glycogen-specific Enzyme	P20645	1.638060e-01	0.1359288824	-0.1773506285	0.4141516175	-0.0816914620	-0.3387689590	-0.4260700766	0.7126382233	0.0125922684	-3.459381e-01	0.1607687651	-0.5070231112	-0.0636441626	-0.1551415830	-0.1898778893	-0.1741821601	-0.1027145017	-0.0550552232	-2.090499e-01	0.3616508693	-0.2438813288	-0.3723922520	-0.2302956691	-0.2445205957	-0.2731006997	0.3381745973	0.0812365297	0.0362112275	-0.1057546567	-2.450586e-01	-0.2307992990	-0.0070124243	-0.0012242253	-0.0823707478	0.2182039986	-0.0949425104	0.0813594017	-0.3372437096	0.2895593843	-0.2752097672	0.1860880134	-0.0349860404	-0.2165330515	-0.0329132778	-0.0602305488	-0.2614586448	0.2449357658	-0.3756819647	-0.2196496453	5.521590e-02	-0.3896897808	0.3628853157	0.3340386085	0.2347878845	-0.0948836325	-0.2974614267	-0.0353695096	0.1396565610	-4.024100e-01	-0.3397746941	0.1161335529	-9.912011e-02	-0.1419968882	-4.239703e-01	0.2604274176	0.3501963908	-0.3601855036	-2.642390e-01	0.1340573444	-0.2255797825	0.3206112751	4.436891e-02	-0.1739711604	1.137217e-01	-2.598298e-01	-0.0248590462	-0.3150917029	-1.354074e-01	-0.1475292099	-0.2453884350	0.6686421154	1.1986841268	0.2886150961	7.333856e-01	0.6025649845	-0.0342847809	-0.0299289385	-9.543840e-02	1768	7.087186e-04	3.107995e-02	P20645	247	0.000708718562927554	0	B	C
P21397	antagonist;inhibitor	Phentermine;Tranylcypromine;Phenelzine;Minaprine;Moclobemide;Isocarboxazid;Ephedra sinica root;MMDA;Metamfetamine	yes	TRUE	TRUE	TRUE	TRUE	TRUE	FALSE	Adrenergic Agents__Agents producing tachycardia__Agents that produce hypertension__Alimentary Tract and Metabolism__Amines__Amphetamines__Anti-Obesity Agents__Antiobesity Preparations, Excl. Diet Products__Appetite Depressants__Appetite Suppression__Autonomic Agents__Central Nervous System Agents__Centrally Acting Antiobesity Products__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates (strength unknown)__Cytochrome P-450 Substrates__Increased Sympathetic Activity__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Neurotransmitter Agents__Peripheral Nervous System Agents__Phenethylamines__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetic Amine Anorectic__Sympathomimetics__Agents that produce hypertension__Agents that reduce seizure threshold__Amines__Anti-Anxiety Agents__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP2A6 Inhibitors__Cytochrome P-450 CYP2A6 Inhibitors (strong)__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (moderate)__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Hypotensive Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase Inhibitors__Monoamine Oxidase Inhibitors, Non-Selective__Nervous System__Propylamines__Psychoanaleptics__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Tranquilizing Agents__Agents that produce hypertension__Agents that reduce seizure threshold__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Inducers__Cytochrome P-450 CYP2E1 Inducers (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A5 Inhibitors__Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A7 Inhibitors__Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Hydrazines__Hypotensive Agents__Monoamine Oxidase A Substrates__Monoamine Oxidase Inhibitors__Monoamine Oxidase Inhibitors, Non-Selective__Nervous System__Psychoanaleptics__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Agents that produce hypertension__Agents that reduce seizure threshold__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Central Nervous System Stimulants__Cholinesterase Inhibitors__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase Inhibitors__Nervous System__Psychoanaleptics__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Acids, Carbocyclic__Agents that produce hypertension__Agents that reduce seizure threshold__Amides__Antidepressive Agents__Benzamides and benzamide derivatives__Benzene Derivatives__Benzoates__Central Nervous System Agents__Central Nervous System Depressants__Chlorobenzoates__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Monoamine Oxidase A Inhibitors__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase Inhibitors__Nervous System__Psychoanaleptics__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Agents that produce hypertension__Agents that reduce seizure threshold__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Enzyme Inhibitors__Hypotensive Agents__Isoxazoles__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase Inhibitors__Monoamine Oxidase Inhibitors, Non-Selective__Nervous System__Psychoanaleptics__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alpha-and Beta-adrenergic Agonists__Herbs and Natural Products__Hyperglycemia-Associated Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Sympathomimetic (Adrenergic) Agents__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamines__Antidepressive Agents__Central Nervous System Depressants__Ethylamines__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Phenethylamines__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin 5-HT2 Receptor Agonists__Serotonin Agents__Serotonin Receptor Agonists__Sympathomimetics__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic Uptake Inhibitors__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamine Anorectic__Amphetamines__Antidepressive Agents__Appetite Suppression__Autonomic Agents__Central Nervous System Agents__Central Nervous System Depressants__Central Nervous System Stimulants__Central Nervous System Stimulation__Centrally Acting Sympathomimetics__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Dopamine Agents__Dopamine Uptake Inhibitors__Drugs that are Mainly Renally Excreted__Ethylamines__Increased Sympathetic Activity__Membrane Transport Modulators__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Nervous System__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Peripheral Nervous System Agents__Phenethylamines__Psychoanaleptics__Psychostimulants, Agents Used for Adhd and Nootropics__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetics	P21397	-1.726177e+00	-0.8513455947	-1.0946385564	-2.3565167904	-1.4905719111	-1.5089589037	-1.5983484121	-0.6369472016	-1.5619847099	-1.883473e+00	-1.3007157795	-1.6261385868	-0.2298876964	-1.6564030931	-1.5138887886	-1.5347412987	-1.2941435497	-1.1122908298	-1.711787e+00	-2.0005518112	-1.7992175521	-1.7253136549	-1.4566162556	-0.8693889531	-1.5295351676	-0.9998453554	-1.7499308083	-0.6042843529	-0.5775735402	1.395447e+00	-1.5304383330	-1.2191513729	-0.0497938633	-1.3599819172	-0.8788054184	-1.8598806762	-0.5017033741	-0.2972489867	-1.3542330036	-0.9066987787	-1.5626369244	-1.7402166589	-1.0931181996	-1.5553199342	-0.5226804690	-0.6528540034	-1.0382735571	-1.0486722136	-1.4670207907	-1.122563e+00	-1.3915702085	-1.4788355271	-0.8445278196	-1.0934062642	-1.1253874283	-1.3546607733	-1.6084882826	-0.0424332898	-2.542693e-01	-1.3011256979	-1.0404330153	-1.058435e+00	-1.4270564806	-1.542949e+00	-1.5047981896	-0.5725895215	-1.2539906122	-7.289735e-01	-1.0685667726	-1.3107457408	-1.2165243208	-1.137054e+00	-1.5594624854	-1.776337e+00	-1.641113e+00	-1.7809104033	-1.5610391665	-1.306955e+00	-1.4114886325	-1.2331469349	-1.5272743651	-2.0797336567	-1.5411157101	-1.185645e+00	-1.7071210677	-1.5581586511	-1.9470624307	-1.556112e+00	1790	3.534745e-03	8.093848e-04	P21397	251	0.0035347424308521	A	0	C
P22102	inhibitor	Pemetrexed	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids__Amino Acids, Acidic__Amino Acids, Dicarboxylic__Amino Acids, Peptides, and Proteins__Antimetabolites__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index__Enzyme Inhibitors__Folic Acid Analogues__Folic Acid Antagonists__Glutamates__Heterocyclic Compounds, Fused-Ring__Immunosuppressive Agents__Myelosuppressive Agents__Nucleic Acid Synthesis Inhibitors__OAT3/SLC22A8 Substrates__Purines__Purinones	P22102	8.550263e-01	0.8922500615	0.8056810459	0.7504884848	1.2082645901	0.6576215352	1.0149221426	0.5537112339	0.7040602739	8.254260e-01	0.8725537480	0.9045077202	0.6135600260	0.4691362189	1.0029565321	1.1091091233	1.0135056469	0.4744395085	8.230815e-01	0.8537201110	0.8559430638	1.1748064358	0.7615171444	0.9745754068	0.8217514275	0.7551060915	0.4004065608	0.9735179890	0.7326856537	7.874898e-01	0.7913993566	0.3890724487	0.6846391265	0.7859914984	0.3660160534	0.6648340463	1.0886426321	0.9791183422	0.5352055590	0.7565270317	0.6674339699	0.8938798919	0.8555969715	0.8580171105	0.8644915036	0.5845690579	0.8606958221	0.6254979933	0.4504129615	6.023620e-01	0.9224410654	0.6387902807	0.4721291201	0.4661928053	0.9567708063	0.9225409763	0.7799055206	0.7524612857	7.002274e-01	0.7123514084	0.5459604604	6.912179e-01	0.5510149269	8.339460e-01	0.5917711839	0.8566093883	0.7702167499	7.178126e-01	0.4183508996	1.1215641772	0.0929362922	5.993211e-01	0.4102794170	5.026665e-01	8.949068e-01	1.0830722003	0.6997416128	9.764254e-01	0.5398386722	1.1790622869	0.5174579085	0.1219161139	0.7239645715	2.720804e-02	0.2152769385	0.4824651997	0.4871751634	8.942022e-01	1815	2.004731e-04	5.527286e-03	P22102	254	0.000200473174696685	0	B	C
P22897	ligand	Technetium Tc-99m tilmanocept	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Diagnostic Radiopharmaceuticals__Radioactive Diagnostic Agent__Radiopharmaceutical Activity__Technetium (99Mtc) Compounds__Tumour Detection	P22897	-9.732715e-02	0.3372493967	-0.6253096908	-0.5665035218	-0.3418406763	-0.5682208580	-0.8952340345	-0.0914386933	-0.3214596828	-5.637784e-01	-0.6572290921	0.3829709420	-0.1592824823	-0.3885907033	-0.4608466271	-0.4696526353	-0.0881270418	-0.9259033103	-6.163496e-01	-0.3852512091	-0.3743250408	-1.0687887571	-0.7568172860	-0.5243588165	-0.0887109860	0.0542763865	-0.2638759762	1.2238775068	1.5146727740	-4.125230e-01	-0.2773239407	0.1045353012	-0.6279515591	-0.8719729533	0.4947485935	-0.2584758198	-0.2253441176	-0.8760491342	-0.4282619230	0.5755842449	1.2007874352	-0.8359384335	0.5487586091	-0.1680342430	-0.0466391107	0.1447702476	0.4706010137	-0.7848477744	-0.6270127858	-1.586066e-01	-0.6549297708	1.4593508120	0.9629015250	0.2139958376	0.0472097274	-0.9962593501	0.0505387691	0.4205510793	-1.398738e+00	-0.8069424348	0.0226338064	-2.464577e-01	-0.0717734844	-7.479829e-01	-0.2543923279	-0.8318073000	-1.1351791651	-2.975581e-01	0.3258927185	0.1529968920	1.5428156866	1.301872e-01	-0.5345462587	-6.364977e-01	-2.960433e-01	-0.2979669915	-0.1613588530	-3.426866e-01	-0.8999650846	0.4091350558	0.1826807888	1.0375051871	-0.2327322501	6.950422e-01	0.8807568831	-0.1232898290	1.3515658821	-5.491053e-01	1841	4.285807e-03	8.592710e-03	P22897	261	0.00428580686542676	0	B	0
P23219	inhibitor;antagonist	Dihomo-gamma-linolenic acid;Icosapent;Mesalazine;Acetaminophen;Diclofenac;Naproxen;Sulfasalazine;Phenylbutazone;Suprofen;Salicylic acid;Meclofenamic acid;Acetylsalicylic acid;Oxaprozin;Balsalazide;Ibuprofen;Lumiracoxib;Magnesium salicylate;Salsalate;Tiaprofenic acid;Lornoxicam;Aceclofenac;Triflusal;Loxoprofen;Droxicam;Tolfenamic acid;Propacetamol;Trolamine salicylate;Menthyl salicylate;Glycol salicylate;Bufexamac;Acemetacin	yes	TRUE	TRUE	TRUE	TRUE	FALSE	TRUE	Autacoids__Biological Factors__Dietary Supplements__Eicosanoids__Fatty Acids__Fatty Acids, Unsaturated__Inflammation Mediators__Lipids__Supplements__Agents causing hyperkalemia__Agents that produce hypertension__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Autacoids__Biological Factors__Diet, Food, and Nutrition__Dietary Fats__Dietary Fats, Unsaturated__Dietary Supplements__Eicosanoids__Fats__Fatty Acids__Fatty Acids, Omega-3__Fatty Acids, Unsaturated__Fish Oils__Food__Food and Beverages__Hypolipidemic Agents__Inflammation Mediators__Lipids__Nephrotoxic agents__Non COX-2 selective NSAIDS__Oils__Physiological Phenomena__Supplements__Agents causing hyperkalemia__Agents that produce hypertension__Aminosalicylate__Aminosalicylic Acids__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Benzene Derivatives__Hydroxybenzoates__Intestinal Antiinflammatory Agents__Nephrotoxic agents__Non COX-2 selective NSAIDS__Phenols__Salicylates__Acetaminophen and Prodrugs__Amides__Amines__Analgesics__Analgesics, Non-Narcotic__Anilides__Aniline Compounds__Antipyretics__Central Nervous System Agents__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2A6 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (weak)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Methemoglobinemia Associated Agents__Miscellaneous Analgesics and Antipyretics__Nervous System__P-glycoprotein inhibitors__P-glycoprotein substrates__Sensory System Agents__UGT1A1 Substrates__UGT1A6 substrate__UGT1A9 Substrates__Acetic Acid Derivatives and Related Substances__Acids, Carbocyclic__Agents causing angioedema__Agents causing hyperkalemia__Agents that produce hypertension__Amines__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antiinflammatory Preparations, Non-Steroids for Topical Use__Antimigraine Agents, Miscellaneous__Antirheumatic Agents__BSEP/ABCB11 Substrates__Central Nervous System Agents__Cyclooxygenase Inhibitors__Cyclooxygenase-2 (COX-2) Inhibitors__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2B6 Substrates__Cytochrome P-450 CYP2C18 Substrates__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Decreased Prostaglandin Production__Dermatologicals__Enzyme Inhibitors__Ethylamines__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__OAT1/SLC22A6 inhibitors__OAT3/SLC22A8 Inhibitors__OATP1B1/SLCO1B1 Inhibitors__Ophthalmologicals__Other Nonsteroidal Anti-inflammatory Agents__P-glycoprotein inhibitors__Peripheral Nervous System Agents__Phenylacetates__Sensory Organs__Sensory System Agents__Topical Products for Joint and Muscular Pain__UGT1A1 Substrates__UGT1A3 substrates__UGT1A9 Substrates__UGT2B7 substrates__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antigout Preparations__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antiinflammatory Preparations, Non-Steroids for Topical Use__Antiinflammatory Products for Vaginal Administration__Antirheumatic Agents__BSEP/ABCB11 Substrates__Central Nervous System Agents__Cyclooxygenase Inhibitors__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 Substrates__Enzyme Inhibitors__Genito Urinary System and Sex Hormones__Musculo-Skeletal System__Naphthaleneacetic Acids__Naphthalenes__Nephrotoxic agents__Non COX-2 selective NSAIDS__OAT1/SLC22A6 inhibitors__Other Nonsteroidal Anti-inflammatory Agents__P-glycoprotein inhibitors__Peripheral Nervous System Agents__Propionates__Sensory System Agents__Topical Products for Joint and Muscular Pain__UGT1A1 Substrates__UGT1A3 substrates__UGT1A6 substrate__UGT1A9 Substrates__UGT2B7 substrates__Agents causing hyperkalemia__Agents that produce hypertension__Alimentary Tract and Metabolism__Amides__Aminosalicylate__Analgesics__Analgesics, Non-Narcotic__Anti-Infective Agents__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents__Antirheumatic Agents__BCRP/ABCG2 Inhibitors__BCRP/ABCG2 Substrates__Central Nervous System Agents__Gastrointestinal Agents__Genito Urinary System and Sex Hormones__Gynecological Antiinfectives and Antiseptics__Immunosuppressive Agents__Intestinal Antiinflammatory Agents__Methemoglobinemia Associated Agents__Nephrotoxic agents__Non COX-2 selective NSAIDS__OATP1B1/SLCO1B1 Inhibitors__OATP1B3 inhibitors__Peripheral Nervous System Agents__Salicylates__Sensory System Agents__Sulfonamides__Sulfones__Sulfur Compounds__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antiinflammatory Preparations, Non-Steroids for Topical Use__Antirheumatic Agents__Butylpyrazolidines__Central Nervous System Agents__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__OAT1/SLC22A6 inhibitors__OAT3/SLC22A8 Inhibitors__Peripheral Nervous System Agents__Pyrazoles__Pyrazolones__Sensory System Agents__Topical Products for Joint and Muscular Pain__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antirheumatic Agents__Central Nervous System Agents__Cyclooxygenase Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Phenylpropionates__Propionates__Sensory System Agents__UGT1A1 Substrates__UGT2B7 substrates__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Infective Agents__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antifungal Agents__Antifungals for Dermatological Use__Antifungals for Topical Use__Benzene Derivatives__Benzoates__Central Nervous System Agents__Cyclooxygenase Inhibitors__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 Substrates__Dermatologicals__Enzyme Inhibitors__Hydroxy Acids__Hydroxybenzoates__Keratolytic Agents__Nephrotoxic agents__Nervous System__Nitrogen Binding Agent__Non COX-2 selective NSAIDS__OAT1/SLC22A6 inhibitors__OAT3/SLC22A8 Inhibitors__Ophthalmologicals__Peripheral Nervous System Agents__Phenols__Salicylates__Salicylic Acid and Derivatives__Sclerosing Solutions__Sensory Organs__Sensory System Agents__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Amines__Aminobenzoates__Analgesics__Analgesics, Non-Narcotic__Aniline Compounds__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antiinflammatory Preparations, Non-Steroids for Topical Use__Antirheumatic Agents__Benzene Derivatives__Benzoates__Central Nervous System Agents__Cyclooxygenase Inhibitors__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Fenamates__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__OAT1/SLC22A6 inhibitors__ortho-Aminobenzoates__Peripheral Nervous System Agents__Sensory System Agents__Thyroxine-binding globulin substrates__Topical Products for Joint and Muscular Pain__Acids, Carbocyclic__Agents causing angioedema__Agents causing hyperkalemia__Agents that produce hypertension__Alimentary Tract and Metabolism__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Anticoagulants__Antiinflammatory and Antirheumatic Products__Antiplatelet agents__Antipyretics__Benzene Derivatives__Blood and Blood Forming Organs__Cardiovascular Agents__Cyclooxygenase Inhibitors__Cytochrome P-450 CYP2C19 Inducers__Cytochrome P-450 CYP2C19 Inducers (strength unknown)__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Substrates__Decreased Platelet Aggregation__Decreased Prostaglandin Production__Drugs that are Mainly Renally Excreted__Hematologic Agents__Hydroxybenzoates__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__OAT1/SLC22A6 inhibitors__OAT3/SLC22A8 Inhibitors__P-glycoprotein inducers__P-glycoprotein substrates__Peripheral Nervous System Agents__Platelet Aggregation Inhibitors Excl. Heparin__Salicylates__Salicylic Acid and Derivatives__Sensory System Agents__Stomatological Preparations__UGT1A6 substrate__Acids, Acyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antirheumatic Agents__Central Nervous System Agents__Cyclooxygenase Inhibitors__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Fatty Acids__Fatty Acids, Volatile__Lipids__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__Other Nonsteroidal Anti-inflammatory Agents__Oxazoles__Peripheral Nervous System Agents__Propionates__Sensory System Agents__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Alimentary Tract and Metabolism__Aminobenzoates__Aminosalicylate__Aminosalicylic Acids__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents__Benzene Derivatives__Benzoates__Central Nervous System Agents__Colitis, Ulcerative__Gastrointestinal Agents__Hydrazines__Hydroxy Acids__Hydroxybenzoates__Inflammatory Bowel Diseases__Intestinal Antiinflammatory Agents__meta-Aminobenzoates__Nephrotoxic agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Phenols__Prodrugs__Salicylates__Sensory System Agents__Acids, Carbocyclic__Agents causing angioedema__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antiinflammatory Preparations, Non-Steroids for Topical Use__Antiinflammatory Products for Vaginal Administration__Antirheumatic Agents__Central Nervous System Agents__COX-1 Inhibitors__COX-2 Inhibitors__Cyclooxygenase Inhibitors__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Nephrotoxic agents__Nervous System__Non COX-2 selective NSAIDS__OAT1/SLC22A6 inhibitors__OAT3/SLC22A8 Inhibitors__Other Nonsteroidal Anti-inflammatory Agents__P-glycoprotein inhibitors__P-glycoprotein substrates__Peripheral Nervous System Agents__Phenylpropionates__Propionates__Sensory System Agents__Throat Preparations__Topical Products for Joint and Muscular Pain__UGT1A1 Substrates__UGT1A3 substrates__UGT1A9 Substrates__UGT2B7 substrates__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antirheumatic Agents__Central Nervous System Agents__COX-2 Inhibitors__Cyclooxygenase Inhibitors__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 Substrates__Enzyme Inhibitors__Musculo-Skeletal System__Nephrotoxic agents__Peripheral Nervous System Agents__Phenylacetates__Selective Cyclooxygenase 2 Inhibitors (NSAIDs)__Sensory System Agents__UGT1A9 Substrates__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antirheumatic Agents__Benzene Derivatives__Benzoates__Central Nervous System Agents__Cyclooxygenase Inhibitors__Enzyme Inhibitors__Hydroxy Acids__Hydroxybenzoates__Magnesium Compounds__Magnesium Salts__Metal cations__Metal divalent cations__Nephrotoxic agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Phenols__Sensory System Agents__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antirheumatic Agents__Benzene Derivatives__Benzoates__Central Nervous System Agents__Hydroxy Acids__Hydroxybenzoates__Nephrotoxic agents__Nervous System__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Phenols__Salicylic Acid and Derivatives__Sensory System Agents__Acids, Acyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antirheumatic Agents__Central Nervous System Agents__Fatty Acids__Fatty Acids, Volatile__Lipids__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__Other Nonsteroidal Anti-inflammatory Agents__Peripheral Nervous System Agents__Photosensitizing Agents__Propionates__Prostaglandin Antagonists__Sensory System Agents__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antirheumatic Agents__Central Nervous System Agents__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 Substrates__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__Oxicams__Peripheral Nervous System Agents__Sensory System Agents__Sulfur Compounds__Thiazines__Acetic Acid Derivatives and Related Substances__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antiinflammatory Preparations, Non-Steroids for Topical Use__Antirheumatic Agents__Central Nervous System Agents__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Musculo-Skeletal System__Nephrotoxic agents__Peripheral Nervous System Agents__Phenylacetates__Selective Cyclooxygenase 2 Inhibitors (NSAIDs)__Sensory System Agents__Topical Products for Joint and Muscular Pain__Acids, Carbocyclic__Anticoagulants__Antiplatelet agents__Benzene Derivatives__Benzoates__Blood and Blood Forming Organs__Hematologic Agents__Hydroxy Acids__Hydroxybenzoates__Phenols__Platelet Aggregation Inhibitors Excl. Heparin__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Antirheumatic Agents__Central Nervous System Agents__Nephrotoxic agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Sensory System Agents__UGT2B7 substrates__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antirheumatic Agents__Central Nervous System Agents__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__Oxicams__Peripheral Nervous System Agents__Sensory System Agents__Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Aminobenzoates__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Antiarrhythmic agents__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antirheumatic Agents__Benzene Derivatives__Benzoates__Bradycardia-Causing Agents__Calcium Channel Blockers__Calcium-Regulating Hormones and Agents__Cardiovascular Agents__Central Nervous System Agents__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__Fenamates__Hormone Antagonists__Hormones, Hormone Substitutes, and Hormone Antagonists__Membrane Transport Modulators__Migraine Disorders, drug therapy__Musculo-Skeletal System__Nephrotoxic agents__Neurotransmitter Agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Prostaglandin Antagonists__Sensory System Agents__Acetaminophen and Prodrugs__Acetanilides__Agents causing hyperkalemia__Agents that produce hypertension__Amides__Amines__Analgesics__Analgesics, Non-Narcotic__Anilides__Aniline Compounds__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Antirheumatic Agents__Central Nervous System Agents__Cholinesterase substrates__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2A6 Substrates__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Nephrotoxic agents__Nervous System__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Prodrugs__Sensory System Agents__UGT1A1 Substrates__UGT1A6 substrate__UGT1A9 Substrates__Acids, Carbocyclic__Agents causing hyperkalemia__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Benzene Derivatives__Benzoates__Hydroxy Acids__Hydroxybenzoates__Nephrotoxic agents__Non COX-2 selective NSAIDS__Phenols__Salicylates__Sunscreen Agents__Not Available__Acids, Carbocyclic__Benzene Derivatives__Benzoates__Hydroxy Acids__Hydroxybenzoates__Phenols__Acetamides__Acetates__Acetic Acid Derivatives and Related Substances__Acids, Acyclic__Agents causing hyperkalemia__Amides__Amines__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antiinflammatory Preparations, Non-Steroids for Topical Use__Antineoplastic Agents__Antirheumatic Agents__Benzene Derivatives__Benzeneacetamides__Central Nervous System Agents__Fatty Acids__Fatty Acids, Volatile__Histone Deacetylase Inhibitors__Hydroxamic Acids__Hydroxy Acids__Hydroxylamines__Lipids__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Sensory System Agents__Topical Products for Joint and Muscular Pain__Acetic Acid Derivatives and Related Substances__Agents causing hyperkalemia__Agents that produce hypertension__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Antigout Preparations__Antiinflammatory and Antirheumatic Products__Antiinflammatory and Antirheumatic Products, Non-Steroids__Antirheumatic Agents__Central Nervous System Agents__Heterocyclic Compounds, Fused-Ring__Indoles__Musculo-Skeletal System__Nephrotoxic agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Sensory System Agents__UGT2B7 substrates	P23219	-2.250861e-01	0.0098006344	-0.6631619576	0.3166123859	0.0154611419	-1.1192511799	-0.8231289523	-0.2430385485	-0.4716575399	-8.432080e-01	-0.2915569908	-0.9166614052	-0.2816471921	-0.2677942958	-0.4927031610	-0.7334975232	-0.4122755214	-0.7001607086	2.216757e-01	-0.3546104840	-0.3571799194	-0.6444115445	-0.7781895869	-0.6015708322	-0.4743222258	-0.5815958770	0.4486674027	-0.0995576722	0.5235576813	-5.210034e-01	0.5715771595	0.4326951394	-0.3647435790	1.7541822313	-0.2883656690	-0.4574447155	-0.0784937029	-0.7130801715	-0.1803634834	-0.3176116783	0.2230145734	-0.4155703435	0.2151013556	-0.5815822777	-0.3093763326	-0.0443935745	-0.0130788849	-0.8174535426	-0.4610760467	-6.232991e-01	-0.3261450013	-0.0345247040	-0.1582516765	-0.1240689458	-0.2642261228	-0.5503946705	-0.4797855652	0.1074393834	-6.404795e-01	-1.2271662360	-0.1135142265	-4.100298e-01	0.0928597427	-3.489755e-01	-0.2705300878	-0.6256809397	-0.4155652928	-1.360998e-01	0.1009730773	-0.1755953428	0.1380482854	-2.242723e-01	-0.1676797741	-2.449266e-01	-8.091001e-02	-0.3157024259	-0.7061432526	-3.804858e-01	0.0421360888	-0.5219831964	-0.3824007446	0.6536934577	-0.4701172503	1.548918e-01	0.5442704106	0.2782472695	0.2334266701	-6.858074e-01	1846	9.786266e-03	1.320187e-02	P23219	262	0.00978626674442381	0	B	0
P26358	inhibitor	Azacitidine;Decitabine	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Antimetabolites__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Aza Compounds__Carbohydrates__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Glycosides__Immunosuppressive Agents__Myelosuppressive Agents__Noxae__Nucleic Acid Synthesis Inhibitors__Nucleic Acids, Nucleotides, and Nucleosides__Nucleoside Metabolic Inhibitor__Nucleosides__Pyrimidine Analogues__Pyrimidine Nucleosides__Pyrimidines__Ribonucleosides__Toxic Actions__Antimetabolites__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Aza Compounds__Carbohydrates__Enzyme Inhibitors__Glycosides__Immunosuppressive Agents__Myelosuppressive Agents__Noxae__Nucleic Acid Synthesis Inhibitors__Nucleic Acids, Nucleotides, and Nucleosides__Nucleoside Metabolic Inhibitor__Nucleosides__Pyrimidine Analogues__Pyrimidine Nucleosides__Pyrimidines__Ribonucleosides__Toxic Actions	P26358	1.918384e-01	0.5201560058	1.0244485165	0.3799178866	0.2442797577	0.4343969032	0.9182058437	0.2090324626	0.2851823460	9.163212e-01	0.6015142178	0.6715919688	0.4474285922	0.3885044205	0.8674555869	0.8586699480	0.4415560424	0.7070967864	3.923285e-01	0.6298104007	0.5512173937	0.9768297930	0.3829886950	0.1967886089	0.3463814193	0.2178374381	0.0956830587	0.6021629886	0.3623802723	8.300448e-02	0.3760830941	0.3815954344	0.3781583787	0.3760830941	0.1524574333	0.5605047201	0.4401771935	0.4384667981	0.0977396615	0.5082974155	0.3932052645	0.3853832023	0.4849131174	0.5253117657	0.2386539981	0.4925586085	0.2239876563	0.4473728282	0.3195708899	7.463534e-01	0.6494581964	0.4461709629	0.2908573965	0.2372391664	0.6937995199	0.5991685920	0.2275961625	0.5188746906	-1.195999e-01	0.2038902343	0.1944359810	6.474752e-01	0.6849364234	3.386501e-01	0.5388022949	0.5267802780	0.4373562188	7.424929e-01	-0.0398764068	0.5784690828	-0.0676298214	3.140352e-01	0.1394257772	1.215308e-01	4.365770e-01	0.5474255423	0.5234217815	6.931456e-01	0.4882879642	0.3603023127	0.1221479638	0.2556579801	0.3482823129	-4.005926e-02	0.0714187782	0.0273697100	0.2286991819	4.187197e-01	1922	1.123467e-04	9.577089e-04	P26358	281	0.000112346696148824	A	B	0
P27338	antagonist;inhibitor	Phentermine;Tranylcypromine;Phenelzine;Selegiline;Isocarboxazid;Ephedra sinica root;Rasagiline;MMDA;Metamfetamine;Pargyline;Safinamide	yes	TRUE	TRUE	TRUE	TRUE	TRUE	FALSE	Adrenergic Agents__Agents producing tachycardia__Agents that produce hypertension__Alimentary Tract and Metabolism__Amines__Amphetamines__Anti-Obesity Agents__Antiobesity Preparations, Excl. Diet Products__Appetite Depressants__Appetite Suppression__Autonomic Agents__Central Nervous System Agents__Centrally Acting Antiobesity Products__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates (strength unknown)__Cytochrome P-450 Substrates__Increased Sympathetic Activity__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Neurotransmitter Agents__Peripheral Nervous System Agents__Phenethylamines__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetic Amine Anorectic__Sympathomimetics__Agents that produce hypertension__Agents that reduce seizure threshold__Amines__Anti-Anxiety Agents__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP2A6 Inhibitors__Cytochrome P-450 CYP2A6 Inhibitors (strong)__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (moderate)__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Hypotensive Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase Inhibitors__Monoamine Oxidase Inhibitors, Non-Selective__Nervous System__Propylamines__Psychoanaleptics__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Tranquilizing Agents__Agents that produce hypertension__Agents that reduce seizure threshold__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Inducers__Cytochrome P-450 CYP2E1 Inducers (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A5 Inhibitors__Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A7 Inhibitors__Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Hydrazines__Hypotensive Agents__Monoamine Oxidase A Substrates__Monoamine Oxidase Inhibitors__Monoamine Oxidase Inhibitors, Non-Selective__Nervous System__Psychoanaleptics__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Agents that produce hypertension__Agents that reduce seizure threshold__Amines__Anti-Dyskinesia Agents__Anti-Parkinson Drugs__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Compounds used in a research, industrial, or household setting__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2A6 Inhibitors__Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2A6 Substrates__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2B6 Substrates__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (weak)__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dopamine Agents__Enzyme Inhibitors__Ethylamines__Hypotensive Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase B Inhibitors__Monoamine Oxidase Inhibitors__Nervous System__Neuroprotective Agents__P-glycoprotein inhibitors__Phenethylamines__Protective Agents__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Agents that produce hypertension__Agents that reduce seizure threshold__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Enzyme Inhibitors__Hypotensive Agents__Isoxazoles__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase Inhibitors__Monoamine Oxidase Inhibitors, Non-Selective__Nervous System__Psychoanaleptics__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alpha-and Beta-adrenergic Agonists__Herbs and Natural Products__Hyperglycemia-Associated Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Sympathomimetic (Adrenergic) Agents__Agents that produce hypertension__Agents that reduce seizure threshold__Anti-Parkinson Drugs__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Compounds used in a research, industrial, or household setting__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 Substrates__Dopamine Agents__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Hypotensive Agents__Indenes__Monoamine Oxidase B Inhibitors__Monoamine Oxidase Inhibitors__Nervous System__Neuroprotective Agents__Protective Agents__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin Agents__Serotonin Modulators__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamines__Antidepressive Agents__Central Nervous System Depressants__Ethylamines__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Phenethylamines__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin 5-HT2 Receptor Agonists__Serotonin Agents__Serotonin Receptor Agonists__Sympathomimetics__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic Uptake Inhibitors__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamine Anorectic__Amphetamines__Antidepressive Agents__Appetite Suppression__Autonomic Agents__Central Nervous System Agents__Central Nervous System Depressants__Central Nervous System Stimulants__Central Nervous System Stimulation__Centrally Acting Sympathomimetics__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Dopamine Agents__Dopamine Uptake Inhibitors__Drugs that are Mainly Renally Excreted__Ethylamines__Increased Sympathetic Activity__Membrane Transport Modulators__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Nervous System__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Peripheral Nervous System Agents__Phenethylamines__Psychoanaleptics__Psychostimulants, Agents Used for Adhd and Nootropics__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetics__Agents that produce hypertension__Agents that reduce seizure threshold__Amines__Antidepressive Agents__Antihypertensive Agents__Benzene Derivatives__Benzyl Compounds__Benzylamines__Cardiovascular Agents__Central Nervous System Depressants__Enzyme Inhibitors__MAO Inhibitors and Diuretics__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase Inhibitors__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Agents that produce hypertension__Agents that reduce seizure threshold__Amines__Amino Acids__Amino Acids, Peptides, and Proteins__Anti-Parkinson Drugs__Antidepressive Agents__BCRP/ABCG2 Inhibitors__Benzene Derivatives__Benzyl Compounds__Breast Cancer Resistance Protein Inhibitors__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Inhibitors__Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dopamine Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Monoamine Oxidase B Inhibitors__Monoamine Oxidase Inhibitors__Nervous System__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome	P27338	-1.885996e+00	-1.7432648022	-1.1369586402	-0.5060308373	-0.5101191944	-0.9406182448	-1.1508905213	-0.7533791427	-0.9178502937	-1.741242e+00	-1.4771008855	-2.1304518107	-0.9638057066	-1.6063082204	-1.2426349785	-1.5616281356	-1.1185608784	-0.7276702476	-1.144920e+00	-0.9685389662	-0.8784520465	-1.4654124406	-1.3515032625	-1.3319536668	-1.2378359575	-1.5632983445	-0.4352105307	-0.2620253290	-0.1982002853	2.378845e-01	-0.8958558691	0.4186432652	-0.3298768426	0.7615009587	-0.1792770190	-1.0564119221	-0.6934510383	-0.8325561003	-0.4870936231	-0.7438192731	-0.2393998756	-0.9562570491	-0.6060297550	-1.0134814515	-0.3473780557	-0.3561544737	0.0163830486	-0.8683897147	-0.6347828375	-8.242493e-01	-0.8798326192	-1.1699521568	-0.4039708163	0.6721206426	-0.2220245086	-1.1143202027	-0.9178502937	-0.8127456718	-2.563227e-01	-2.1304518107	-0.5235454676	-8.926130e-01	-0.6734043262	-4.000219e-01	-1.2014854465	-0.8678903798	-1.6036604098	-9.724745e-01	0.0300017872	-0.5413491043	-0.0135661593	-4.297194e-01	-1.0504369453	-8.610312e-01	-1.163326e+00	-0.7905253440	-0.6255211549	-1.024412e+00	-1.4622744952	-1.2539201881	-0.7572914760	-0.4620636465	-1.8840403744	-6.482325e-01	-0.5327259749	-0.8291357777	-0.8472358114	-6.277386e-01	1941	2.351489e-04	2.469583e-04	P27338	285	0.000235149001125498	A	0	0
P27707	agonist	Fludarabine	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Adenine Nucleotides__Antimetabolites__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Arabinonucleosides__Arabinonucleotides__Carbohydrates__Cardiotoxic antineoplastic agents__DNA (Cytosine-5-)-Methyltransferases, antagonists &amp; inhibitors__Enzyme Inhibitors__Glycosides__Heterocyclic Compounds, Fused-Ring__Immunologic Factors__Immunosuppressive Agents__Myeloablative Agonists__Myelosuppressive Agents__Noxae__Nucleic Acid Synthesis Inhibitors__Nucleic Acids, Nucleotides, and Nucleosides__Nucleoside Metabolic Inhibitor__Nucleosides__Nucleotides__Purine Analogues__Purine Nucleosides__Purine Nucleotides__Purines__Ribonucleosides__Ribonucleotides__Toxic Actions	P27707	1.245819e+00	0.8354345188	0.7897073936	1.0204971267	0.4102979733	1.0940254936	1.2284676276	0.7974758259	0.7645557833	7.769764e-01	1.1175491576	1.1303539318	0.2355374783	0.8572388316	1.2026682024	1.3547511993	1.2772764682	1.3881589632	4.176183e-01	1.3834358206	1.1330015277	1.3002874214	1.1314067023	0.7063830122	0.8015352725	0.6255584107	0.2113157474	1.3342056424	1.1655209084	6.992722e-01	0.9011182214	0.0266542387	0.6530220001	0.7980807321	0.6023731343	1.2259327762	0.8316355416	0.9903759253	0.8146074204	1.1957608030	0.7652029836	1.5580551613	0.9249213757	1.0432689410	0.9344305073	0.3368273341	0.6785339452	1.1807406894	0.7110745563	9.267665e-01	1.0542293941	0.6916108155	0.7519536393	0.2005622694	1.0535909562	0.8682559884	0.6816076885	0.8086900524	3.149441e-01	0.8189257827	0.6402835283	6.800444e-01	1.1418046821	8.872133e-01	0.6451752765	0.4902506921	1.0135056469	1.411717e+00	0.3300977898	0.7189746820	0.0982552937	5.797976e-01	0.0232516079	8.964055e-01	1.178755e+00	0.8043745950	0.5753313815	1.223967e+00	0.8637026026	0.6947222971	0.0028016228	0.4082072947	0.7073892362	2.815980e-01	0.4627446631	0.4904779293	0.5546666299	3.551777e-01	1953	7.345700e-04	3.777533e-04	P27707	287	0.00073456929429782	A	B	0
P27816	UnKnown	Paclitaxel;Docetaxel	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Agents Causing Muscle Toxicity__Antimitotic Agents__Antineoplastic Agents__Antineoplastic Agents, Phytogenic__Antineoplastic and Immunomodulating Agents__BSEP/ABCB11 Inhibitors__BSEP/ABCB11 Substrates__BSEP/ABCB11 Substrates with Narrow Therapeutic Index__Cardiotoxic antineoplastic agents__Cyclodecanes__Cycloparaffins__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Substrates__Diterpenes__Hypotensive Agents__Immunosuppressive Agents__Microtubule Inhibition__Microtubule Inhibitors__Mitosis Modulators__Myelosuppressive Agents__Narrow Therapeutic Index Drugs__Neurotoxic agents__OATP1B3 substrates__P-glycoprotein inhibitors__P-glycoprotein substrates__P-glycoprotein substrates with narrow therapeutic index__Taxane Derivatives__Taxoids__Terpenes__Tubulin Modulators__Agents Causing Muscle Toxicity__Antimitotic Agents__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__Cardiotoxic antineoplastic agents__Cyclodecanes__Cycloparaffins__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Diterpenes__Hepatotoxic Agents__Immunosuppressive Agents__Microtubule Inhibition__Microtubule Inhibitors__Mitosis Modulators__Myelosuppressive Agents__OATP1B3 substrates__P-glycoprotein substrates__Taxane Derivatives__Taxoids__Terpenes__Tubulin Modulators	P27816	-4.612526e-01	0.2784570076	-0.3922482041	-0.7922011968	-0.3849008092	-0.5108836968	-0.2685400612	-0.0239808635	-0.1140614214	1.655328e-01	-0.4523509597	0.4300018928	-0.2433353045	-0.2920083789	-0.2994080467	-0.0861339630	-0.2146566406	-0.2249177244	1.801626e-02	-0.3163770690	-0.1638108865	-0.0455554329	0.2511156464	-0.6882375651	-0.4716578233	-0.5713228203	-0.7969037016	-0.8978754673	-0.6747260945	-5.307906e-01	-0.2725583092	-0.8309830974	-0.3702192582	-0.9141064133	-0.9917398334	-0.5446451758	-0.7681894745	-0.7658474312	-0.8246765577	-0.7792982878	-0.8694548334	-0.2484195094	-0.7014074635	-0.2805870993	-1.0222184758	-0.8803133894	-0.7407043076	-0.4264521827	-0.3139471765	-3.692434e-01	-0.7026941774	-0.3974812796	-0.7087393243	-0.6284929843	-0.5462283663	-0.2523884416	-0.8177972249	-0.0045207348	3.883004e-01	0.1981855076	-0.6846928593	3.136689e-01	-0.4900715121	-1.849307e-01	-0.4307116624	-0.1242639675	0.1491564790	-3.978499e-01	-0.5330716776	-0.8424155531	-0.7463220625	-3.648081e-01	-0.3235156718	-5.766804e-01	3.032965e-01	-0.4142848091	-0.1602480457	-4.324171e-01	-0.1292522476	-0.0755874322	-0.4214004712	-0.3063897997	0.0457741711	5.196487e-01	-0.6297139657	-0.3352219666	-0.0430680355	-5.642178e-01	1956	7.479027e-04	4.413068e-04	P27816	289	0.000747902747292653	A	0	0
P28065	inhibitor	Carfilzomib	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Immunosuppressive Agents__Myelosuppressive Agents__P-glycoprotein substrates__Peptides__Proteasome Inhibitors	P28065	-5.179490e-01	0.1093745607	0.2783028405	0.0564600831	0.4125756287	0.3440848791	0.7226492554	0.1991652848	0.1856897064	2.590735e-01	0.7918660062	-0.2243053543	-0.3308914694	-0.1193913037	0.2638253063	0.1228370995	-0.2760424281	0.6496685025	9.396062e-03	0.5190857438	0.2816008402	0.3317306954	0.3420071076	0.0203342439	-0.1000356049	0.0149508530	-0.5280165006	-0.2518611540	-0.3516986705	1.326350e-01	0.1075310679	-0.3784815756	0.2400557166	-0.1177483667	-0.9804389319	0.2912660201	0.0309937282	-0.0575297646	-0.3664526627	-0.3889774468	-0.0041613681	0.5136133705	-0.1603793059	0.3344423757	0.1289615761	0.1214191847	0.0911029400	0.1645745786	-0.2964448149	4.313449e-01	0.1894637602	0.0284125950	-0.0260381955	-0.4029471448	0.1601281784	0.0761626306	0.5494729801	-0.0747042088	-2.717370e-01	0.1455645919	-0.6575713217	1.501988e-01	-0.1199179021	1.700923e-01	0.0617975837	-0.1997620662	0.3204125896	-5.631949e-02	-0.9868858770	0.1626341941	-0.6432411513	5.074747e-01	-0.3437881354	-2.247829e-01	-1.169066e-02	0.1447918126	0.0609106611	3.471729e-01	-0.4229747178	0.1697060485	-0.5484858299	0.1113929929	-0.1260873628	-3.379978e-01	0.1248198534	-0.0264302930	-0.1820331110	-1.945856e-01	1962	8.701046e-03	6.909045e-03	P28065	290	0.00870104681872124	A	0	0
P30044	inhibitor	Auranofin	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Antiinflammatory and Antirheumatic Products__Antirheumatic Agents__Drugs that are Mainly Renally Excreted__Gold Compounds__Gold Preparations__Musculo-Skeletal System__Organogold Compounds__Organometallic Compounds__Specific Antirheumatic Agents	P30044	3.502327e-01	0.7131113138	0.6826169426	-0.0439154604	0.9659588990	0.8516933582	0.1845061338	0.1417895141	0.7332194771	-1.517933e-02	0.2637922609	0.5944874881	0.7260237244	0.1964341060	0.0915164406	0.0998155914	0.2159614744	0.5786778360	6.060293e-01	0.2715644839	0.3957273390	0.2455532390	1.0439855358	1.2871072761	0.8927966767	0.6412154930	0.3734266841	0.3446003246	0.9160008502	9.853835e-01	1.2145877069	1.2894815989	0.6039281304	0.2559487957	0.4242633194	0.3702701652	1.0346305850	0.4090896424	0.5364325264	0.9964545088	0.1067234804	0.3953223071	0.8488962129	0.7418522667	0.9111670362	1.0174707872	0.3541290863	0.6119206826	0.6424587938	5.317060e-01	0.7141377615	0.7280731779	0.1297822878	-0.4152590579	0.8494708614	0.4908544233	0.5230560054	0.8305512479	9.387029e-01	0.4338757394	0.5360705363	2.782326e-01	0.7216850623	1.784837e-01	0.5202102172	0.1217454190	0.3250043037	4.847044e-01	0.6393612953	0.5381575758	0.2127081428	8.053487e-01	0.1992689785	8.566153e-03	6.160361e-01	0.7857822827	0.7797363884	6.503618e-01	0.5642597954	1.2379371622	0.1476437755	0.0783008485	-0.1911357559	3.468246e-02	0.3286776898	0.1710023434	0.2890838794	6.297504e-02	2024	8.128022e-04	6.498144e-04	P30044	307	0.000812802236648532	0	0	C
P30273	agonist	Benzylpenicilloyl polylysine	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Acetamides__Acetates__Acids, Acyclic__Amides__Anti-Bacterial Agents__Antibacterials for Systemic Use__Antiinfectives for Systemic Use__Benzene Derivatives__beta-Lactams__Drug Hypersensitivity__Fatty Acids__Fatty Acids, Volatile__Heterocyclic Compounds, Fused-Ring__Lactams__Lipids__Penicillins__Sulfur Compounds	P30273	4.072180e-01	1.0273654641	-0.2767248624	1.3274637495	0.6804928267	-0.0045045529	0.0951699206	1.8839603221	0.1366643690	1.637211e-01	2.7137049114	-0.4402377778	0.1173935943	1.3424257191	1.4285135975	0.6096463126	0.1348725083	0.4853548762	8.681175e-02	0.9726842698	0.9152125420	0.3744830465	-0.0247734673	0.1143159409	-0.2041549364	0.2235593032	0.6841008319	-0.3164768146	0.2372936033	-9.327667e-01	1.0162394178	-1.0531186009	-0.0645065576	-0.5233435323	0.4457662277	0.4919740425	-0.2468235286	-0.0447469306	0.1465230993	-0.1277131529	0.6046026539	0.2996068129	0.1791112398	0.1850285524	-0.7418186907	-0.0331962231	0.9702751716	0.2254756761	0.1439257797	8.414363e-01	-0.4857874943	0.8983227673	0.3028102307	-0.2119460015	0.0177476242	-0.2178088699	0.4571977739	0.2340793097	-1.332512e+00	-0.7289237917	0.7633282431	4.928417e-01	0.4577220963	-3.651317e-02	-0.1610875832	0.3588973423	0.1445075127	7.331473e-01	-0.7176382604	-0.6675288032	0.7306439986	-2.304358e-02	0.0450079190	3.876683e-01	4.003302e-01	0.2506765733	-1.2021363990	8.314975e-01	0.3266053400	0.2827834755	1.2173097987	0.6903813573	1.3728057466	1.021078e+00	0.8978201237	1.1315969010	0.7920826390	1.564161e-01	2038	2.449824e-04	1.089581e-03	P30273	312	0.000244982538704941	A	0	C
P30530	inhibitor	Gilteritinib	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amines__Antineoplastic Agents__BCRP/ABCG2 Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates (strength unknown)__Cytochrome P-450 Substrates__MATE 1 Inhibitors__MATE inhibitors__Moderate Risk QTc-Prolonging Agents__OCT1 inhibitors__P-glycoprotein substrates__QTc Prolonging Agents__Tyrosine Kinase Inhibitors	P30530	-4.958541e-01	-0.1902148633	-0.0816020949	-0.1252704279	0.0715810779	-0.2371729589	0.2015811684	0.0171054673	-0.3039290492	-2.860694e-01	-0.2031279230	-0.2811755399	-0.3654046618	-0.2138003823	-0.2313997903	-0.2804297581	-0.3723575325	-0.3130346342	2.308816e-01	-0.1315577453	-0.3457878042	-0.3007555319	-0.4257477109	-0.4288519234	-0.0907238957	-0.3034422986	-0.0998917047	-0.2980545202	-0.3871745791	-3.846412e-01	0.1569464084	-0.0384829111	-0.3549457566	-0.0310885305	0.1544423371	-0.0459276102	-0.0290854848	-0.3277057000	-0.2208372698	-0.2604100567	-0.0347968212	-0.5311919577	-0.1232291418	-0.1145439859	-0.3059110069	0.0558106450	-0.0057307146	-0.2957336921	-0.1314112153	3.722333e-02	0.1021669807	0.0573662202	0.0547597180	0.2120666515	-0.1140348373	-0.0965286755	-0.3734147867	-0.0925608515	-7.323024e-01	-0.6013151643	-0.4304527812	-6.716146e-02	-0.0036521707	1.438319e-02	-0.1313747608	-0.2704746901	-0.3571140225	-8.327934e-02	-0.2052469147	0.2047196282	-0.1703419150	-8.642617e-02	-0.2113466271	-1.077576e-01	-2.315894e-01	-0.3506646148	-0.2368533121	-7.488718e-02	-0.2629832852	-0.0573494720	-0.1551917863	0.1258671532	-0.1109829143	2.743944e-01	0.4603482981	0.1165706814	0.2258937864	-2.097517e-01	2046	7.088160e-04	4.872371e-03	P30530	315	0.000708816137223602	0	B	C
P33402	inducer;agonist;antagonist	Nitric Oxide;Isosorbide mononitrate;Riociguat;Methylene blue;Plecanatide	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Anions__Anti-Asthmatic Agents__Antioxidants__Autonomic Agents__Bronchodilator Agents__Cardiovascular Agents__Compounds used in a research, industrial, or household setting__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Drugs that are Mainly Renally Excreted__Electrolytes__Endothelium-Dependent Relaxing Factors__Free Radical Scavengers__Free Radicals__Gases__Gasotransmitters__Hypotensive Agents__Ions__Methemoglobinemia Associated Agents__Neurotransmitter Agents__Nitrates and Nitrites__Nitric Oxide, antagonists &amp; inhibitors__Nitrogen Compounds__Nitrogen Oxides__Nitroso Compounds__Oxides__Oxygen Compounds__Peripheral Nervous System Agents__Protective Agents__Reactive Nitrogen Species__Respiratory System Agents__Vasodilating Agents__Alcohols__Antianginal Agents__Carbohydrates__Cardiac Therapy__Cardiovascular Agents__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 Substrates__Delayed-Action Preparations__Drugs that are Mainly Renally Excreted__Hypotensive Agents__Methemoglobinemia Associated Agents__Nitrate Vasodilator__Nitrates and Nitrites__Nitric Oxide Donors__Organic Nitrates__Sugar Alcohols__Vasodilating Agents__Vasodilation__Vasodilators Used in Cardiac Diseases__Antihypertensive Agents__Antihypertensives for Pulmonary Arterial Hypertension__BCRP/ABCG2 Substrates__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__Enzyme Activators__Guanylate Cyclase__Guanylate Cyclase Stimulators__Hypotensive Agents__Soluble Guanylate Cyclase Stimulator__Vasodilating Agents__Agents that produce hypertension__Agents that reduce seizure threshold__Antidepressive Agents__Antidotes__Antipsychotic Agents__Central Nervous System Depressants__Diagnostic Agents__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Gastric Function__Heterocyclic Compounds, Fused-Ring__Miscellaneous Therapeutic Agents__Monoamine Oxidase Inhibitors__Neurotoxic agents__Oxidation-Reduction Agent__Phenothiazines__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sulfur Compounds__Tests for Gastric Secretion__Alimentary Tract and Metabolism__Amino Acids, Peptides, and Proteins__Drugs for Constipation__Enzyme Activators__Gastrointestinal Agents__Guanylate Cyclase Activators__Guanylate Cyclase-C Agonist__Guanylyl Cyclase C Agonists__Hormones__Hormones, Hormone Substitutes, and Hormone Antagonists__Laxatives__Peptide Hormones__Peptides__Receptors, Guanylate Cyclase-Coupled, agonists	P33402	-7.026619e-01	-0.8370510287	-0.8402246547	-1.1245124449	-0.7135175609	-1.1368094280	-0.8023013267	-0.8690913938	-0.7429602339	-9.019521e-01	-1.2035662181	-0.9492405379	-0.8995134038	-1.3045877812	-1.3151270781	-1.2493783839	-1.5385699036	-0.5048443382	-8.480437e-01	-0.9081334646	-0.6197394921	-0.8026402490	-1.0334965324	-1.2420530067	-1.0007411792	-0.9644215877	-0.8744262662	-0.9177551231	-0.9173648799	-7.949090e-01	-1.4746031827	-0.9584424630	-0.1872701199	-1.2696163789	-0.6255361930	-0.5644357045	-0.8028444582	-0.5897872300	-1.0400396686	-1.0225315823	-0.6005637378	-1.1008365863	-0.5671134050	-0.9807931463	-0.5560218237	-0.8563628855	-0.5092060633	-0.8038751064	-1.3395749954	-7.943924e-01	-0.7350739172	-0.8907835142	-1.4326393886	-0.8070118393	-0.7324877657	-0.8949443948	-1.2828825492	-0.4240522791	-7.960409e-01	-0.6548904809	-1.4171572004	-9.917372e-01	-1.2649241967	-1.302758e+00	-0.6013497031	-0.9727606923	-0.8305082605	-1.157968e+00	-1.1834798044	-0.7123236542	-0.7639161737	-7.594493e-01	-1.1212325371	-7.745980e-01	-7.902574e-01	-0.6139242202	-0.6399691006	-9.393300e-01	-1.2788890390	-0.8085304736	-1.0454133463	-1.1030608609	-1.1239519498	-1.314583e+00	-1.2960628398	-1.4433187016	-1.1888499792	-1.186858e+00	2105	6.228246e-03	6.812060e-03	P33402	325	0.00622825339385958	0	B	C
P40306	inhibitor	Carfilzomib	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Immunosuppressive Agents__Myelosuppressive Agents__P-glycoprotein substrates__Peptides__Proteasome Inhibitors	P40306	-3.007405e-01	0.3296772408	0.3339838706	0.2469538895	0.3571149152	0.2583161657	0.5427720029	0.5014445729	0.0703444652	3.272251e-01	0.9054611314	0.0011722905	-0.4093432258	-0.1355568706	0.4122610483	0.2226294285	-0.2707928112	0.9788894623	-1.377341e-01	0.3321222881	0.5610741456	0.3560949772	0.3187243619	0.1164535631	-0.0693783053	0.0281484990	-0.7146475442	-0.0348499002	-0.2014584540	1.294701e-01	0.1337801431	-0.0499199126	0.4224088831	0.0187424628	-0.5465799573	0.2155430789	-0.1337064010	0.0027019483	-0.0301582381	-0.0919189465	0.0633321880	0.6834316913	-0.0369667029	0.3411985538	0.0815998038	0.2008281850	-0.0171085975	0.3463079163	-0.0542708579	4.476232e-01	0.3181561353	0.0207159016	0.0010315724	-0.2308168988	0.1764343169	-0.0461005248	0.3723661161	-0.0731686552	-5.819243e-02	-0.1036670466	-0.5904290515	2.954582e-01	-0.0195250376	2.577873e-01	0.1048533460	-0.2184785802	0.2080120859	7.429994e-02	-1.3935583289	0.1835975633	-0.7722281298	1.596133e-01	-0.4478140989	-4.635060e-01	2.141806e-02	0.0901886638	0.0198265248	3.127321e-01	-0.1771800865	0.1863150618	-0.4557852357	0.0168800186	-0.2931411055	-1.005257e-01	-0.0856969535	0.0987865472	-0.3741877165	-3.369648e-01	2231	1.875024e-03	1.130741e-03	P40306	352	0.00187502414369939	A	B	0
P41743	inhibitor	Tamoxifen	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE		P41743	8.229069e-02	-0.0344377893	0.2968491823	-0.0010250152	0.0002580744	-0.0526287482	0.2120748264	-0.1678533990	-0.0227576731	1.427183e-01	-0.2841222433	0.2699267641	0.1956778575	0.0596534047	-0.0256874499	-0.0608311308	0.3280083634	0.2133657183	1.503707e-01	0.0519872159	-0.2358017019	0.1526380555	-0.0591847823	0.6147632450	0.0188991394	-0.0244250172	-0.0196351829	-0.1830468397	0.2305000880	3.703638e-01	0.0308968042	0.2312217915	0.1277364572	0.1195863933	0.2368496147	0.0081431880	0.2186560722	0.4563885376	0.0890923945	0.1449690871	0.1081339488	-0.3570998732	-0.1413255538	-0.0679416405	-0.2007718430	0.3005624874	-0.0956225750	0.2810520041	-0.4426217931	-1.705151e-01	-0.0242639739	-0.0609769090	-0.0244718005	-0.6027552788	-0.2526303157	0.1502582138	-0.1092227422	0.5551923787	3.907407e-01	0.2530737596	-0.0435840488	-8.187481e-02	0.1101761702	1.333130e-01	-0.1570047916	-0.0428132239	0.2306194329	1.464841e-01	0.0978972402	0.1005176991	-0.0357040894	4.855748e-02	0.2214590250	-2.632882e-01	1.969175e-01	0.2116029396	0.3264740775	5.531976e-02	0.2758031200	0.1503906976	-0.4809768508	-0.6204460892	-0.0411134474	-5.248022e-01	0.0254521837	-0.1640448861	-0.2711801648	-1.125244e-01	2263	3.944782e-03	1.260650e-02	P41743	358	0.00394478334712007	0	B	C
P48637	stimulator	Acetylcysteine	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids__Amino Acids, Neutral__Amino Acids, Peptides, and Proteins__Amino Acids, Sulfur__Anti-Infective Agents__Antidote for Acetaminophen Overdose__Antidotes__Antioxidants__Compounds used in a research, industrial, or household setting__Cough and Cold Preparations__Cysteine__Decreased Respiratory Secretion Viscosity__Expectorants__Free Radical Scavengers__Increased Glutathione Concentration__OATP1B1/SLCO1B1 Inhibitors__Ophthalmologicals__Protective Agents__Reduction Activity__Respiratory System Agents__Sensory Organs__Sulfhydryl Compounds__Sulfur Compounds	P48637	4.985434e-01	0.9443421274	0.6063970232	0.3279995022	0.9425333809	0.5656085044	1.4596311274	-0.0813259718	0.3256214695	8.638261e-01	0.3912302034	1.0153559385	0.6075869634	0.3265000950	0.7430264656	0.6311312714	0.6246148561	0.6969048197	8.594475e-01	0.6602057932	0.5942752741	1.2723680247	0.7952640296	1.0317855543	0.8592449862	0.6752454635	0.3409964830	0.6928616438	0.8927826877	9.947580e-01	0.9169432387	0.4656699823	0.6325360426	1.2883429001	0.2969032829	0.6116587219	0.4547340503	0.6738082185	0.7155636932	1.0421352725	0.7037149121	0.5112107744	0.8516884463	0.8637869591	0.6441153398	0.7104838060	0.8563405179	0.7859914984	0.5745129731	6.444656e-01	0.9825751357	0.8166272281	0.6481909381	0.3752850556	0.6324235273	1.0578741575	1.1264167811	0.1345811618	9.523566e-01	0.7215029680	0.2354162637	1.046776e+00	0.7118818121	5.787098e-01	0.4782641423	0.3209682920	0.9101720095	5.919776e-01	0.4950622955	0.8513214290	-0.1721780757	5.179728e-01	0.7502989625	4.606054e-01	8.435027e-01	1.0830722003	0.5805912640	1.079321e+00	0.5846331514	0.7618601694	0.4956750941	0.0439416853	0.2477003861	4.536185e-01	0.4593076539	0.3829622719	0.1428650591	5.448694e-01	2394	5.677011e-03	3.265941e-03	P48637	375	0.00567701123922433	0	B	C
P49327	inhibitor	Cerulenin;Orlistat	yes	TRUE	TRUE	TRUE	FALSE	FALSE	FALSE	Amides__Anti-Infective Agents__Antifungal Agents__Fatty Acid Synthesis Inhibitors__Hypolipidemic Agents__Lipid Regulating Agents__Noxae__Toxic Actions__Alimentary Tract and Metabolism__Anti-Obesity Agents__Antiobesity Preparations, Excl. Diet Products__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 Enzyme Inducers__Enzyme Inhibitors__Intestinal Lipase Inhibitor__Lactones__Lipase Inhibitors__Lipid Regulating Agents__Miscellaneous GI Drugs__Peripherally Acting Antiobesity Products	P49327	2.494392e-02	0.1066071298	0.1532558549	0.0284948155	0.6523190604	0.1697240353	0.9616414121	0.1130183314	0.9885381805	4.125140e-01	0.2686609200	0.4990363368	0.1876824501	0.0814353141	1.0379318694	1.0835914079	0.9536043972	0.3598319742	1.544086e-01	0.3107440886	0.0130300784	1.4071904893	0.3898949297	0.9624541795	0.5519380780	-0.1074202483	-0.6056970735	0.1110030615	0.8779164576	4.082362e-01	-0.0202378023	0.0919765153	0.1647177796	0.7146791767	0.7061606317	0.0836621430	0.4104590554	0.7782170535	-0.1196283130	0.5975519012	0.0140858955	0.0784672429	0.2120075618	0.4253310622	0.2281003512	1.2187905858	0.3674019264	0.1036789915	0.6940791019	5.335778e-01	0.0348564544	-0.3462892993	-0.3568420212	-0.5361159384	0.2824453551	0.5887029531	0.1231830803	0.0050037548	1.483850e-01	0.7308185786	0.4448617388	1.209332e+00	0.1018889185	2.497773e-01	-0.0621532970	0.3948674531	0.2459180939	4.200630e-01	0.4920173969	0.2480133025	0.4508902530	1.221159e-01	0.2201382512	-4.382788e-01	5.486864e-01	0.7600569616	1.7459508861	7.707701e-01	0.1056929760	0.4986177334	-0.1392172469	-0.6539920511	-0.4622702573	-5.414198e-01	0.6256602889	-0.2255411402	-0.1461886033	1.672636e-01	2421	4.742650e-03	1.584175e-02	P49327	380	0.00474265083047047	0	B	C
P49721	inhibitor	Carfilzomib	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Immunosuppressive Agents__Myelosuppressive Agents__P-glycoprotein substrates__Peptides__Proteasome Inhibitors	P49721	-1.300032e-01	0.2998462471	0.2158461636	-0.1051023423	0.3752412125	0.1285705056	0.7365647251	-0.1843712853	0.0260026469	3.137987e-01	0.5173926289	0.1120206809	-0.1474755377	-0.0863976177	0.2302194491	0.1914329427	-0.0853886035	0.3739681211	-6.537926e-03	0.2451344475	0.2006552773	0.3580116057	0.0815713292	0.3461640918	-0.2632528781	-0.1736780101	-0.5015479256	-0.1725834538	0.0292835403	1.948601e-01	0.1148112164	-0.2272194524	0.3949726262	-0.0153017754	-0.1342191529	0.2248290850	0.1513431678	0.2607259718	-0.1031223556	-0.1634114010	-0.0619086387	0.0505701152	-0.1591621999	0.2766772116	0.1943338483	-0.0020575911	0.0947675160	0.2394307386	-0.2431602021	2.057490e-01	0.3083493861	0.0682459435	-0.0004648724	-0.4011386624	-0.0117029423	0.0374802432	0.2196455399	-0.0507025592	8.115908e-02	0.2594956851	-0.4393484986	2.412795e-01	-0.0692666429	2.250606e-01	-0.1738061349	-0.1063528687	0.2223211577	1.758840e-01	-0.8451199957	0.4258891265	-0.6525350778	2.021993e-01	-0.1366123649	-1.288115e-01	-6.401063e-02	0.1491470965	0.0029543790	1.183071e-01	-0.1889131746	0.2962104858	-0.2640362684	-0.2088562959	-0.1344965536	-5.240587e-01	-0.3383628647	-0.2604753368	-0.1633279486	-8.431636e-02	2443	6.249573e-04	7.395849e-04	P49721	385	0.000624957473724571	A	B	C
P50281	inhibitor	Marimastat	yes	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	Amines__Enzyme Inhibitors__Hydroxy Acids__Hydroxylamines__Metalloendopeptidases, antagonists &amp; inhibitors	P50281	1.086881e+00	0.8729739429	0.3332320296	0.7563277069	-0.2461810716	0.6069131920	0.0297257593	0.5229145532	-0.1537523329	6.899177e-01	0.5063238691	0.7650396176	0.0696100976	1.2552299533	0.6905779581	0.6355172641	0.7753118151	-0.0094084392	7.678713e-01	0.4264094837	0.3724786007	0.3350849078	0.1203489118	0.1290250637	0.6519624409	0.3628459262	1.2661253988	-0.0674785040	0.0008309779	-4.313253e-01	0.8266769859	0.1360371125	-0.1459098099	0.4822339232	0.1942801538	0.2253813051	-0.0743125698	-0.2520246856	0.2429617016	0.3187476557	0.8341849931	0.5136133705	0.1444713791	0.2133185809	-0.1293603303	-0.0175707863	0.0114932053	0.0232798262	0.4966999557	5.199209e-01	0.0405206906	0.6884676833	0.4483355179	0.8893139801	0.0961657742	0.6539483167	0.8150303421	0.0831665238	-7.461265e-02	0.7601221170	0.8404550242	-1.673321e-01	0.8171319801	4.126471e-01	0.4424199146	0.7322824843	0.6574263554	3.167976e-01	0.3243646096	0.1698355062	0.5312002424	-2.344762e-01	0.9447023509	8.032524e-01	5.229206e-01	0.3532880261	-0.3786225203	3.711873e-01	0.5509145499	0.1697060485	0.4594230827	0.3643377194	1.2980424137	5.759277e-01	0.3583103961	1.1370877386	0.8713144321	7.923927e-01	2486	1.018635e-02	2.095237e-02	P50281	390	0.0101863488661475	0	0	C
P51511	inhibitor	Marimastat	yes	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	Amines__Enzyme Inhibitors__Hydroxy Acids__Hydroxylamines__Metalloendopeptidases, antagonists &amp; inhibitors	P51511	3.475239e-01	0.0924575885	0.1791121239	0.1638550430	-0.1516043445	0.1534687163	-0.2168648567	-0.4823043378	-0.1829680130	1.991077e-01	-0.3712667042	-0.4772535577	0.5341114380	-0.0308665005	0.0885665882	-0.1141166436	0.4025467020	-0.1361563802	7.603133e-01	-0.1332897527	-0.0145797651	-0.0546170604	0.2539523985	0.4860404668	0.3858446578	0.3287601459	1.4121557754	0.2278654488	-0.2217391201	1.938317e-01	0.2023983334	0.5900838391	0.0610785635	0.6186542025	-0.2712314125	0.2787016895	-0.3788141284	0.2579095790	0.0154586254	0.3571133942	0.3491002024	-0.4269167248	-0.4324173614	-0.6877552242	0.2073603774	-0.3657309206	-0.3302627679	-0.0418327571	0.0023049542	-8.302953e-01	0.1882901641	0.2396337164	-0.0227415338	0.7356406796	0.2361224158	-0.1148298893	0.4418498780	0.2055732650	1.215708e-01	-0.4320627815	0.7203581542	6.595128e-01	0.5677110015	-6.420918e-02	0.2256119995	0.0831122576	0.3797638562	4.179972e-01	1.1222193222	0.0711066456	0.2739742374	9.092398e-02	0.9274254128	1.169076e-01	-1.395807e-01	-0.0689844670	1.0378825400	9.594426e-03	1.0962038368	0.1590024179	0.4111003165	0.1979744293	0.5624920945	6.094231e-01	0.7968755499	0.8375421003	0.5570572788	8.037600e-01	2527	3.785068e-03	1.542507e-03	P51511	398	0.00378506804132427	0	B	C
P51580	inhibitor	Olsalazine	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Acids, Carbocyclic__Agents causing hyperkalemia__Agents that produce hypertension__Alimentary Tract and Metabolism__Aminosalicylate__Analgesics__Analgesics, Non-Narcotic__Anti-Inflammatory Agents__Anti-Inflammatory Agents, Non-Steroidal__Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents__Benzene Derivatives__Benzoates__Central Nervous System Agents__Gastrointestinal Agents__Hydroxy Acids__Hydroxybenzoates__Intestinal Antiinflammatory Agents__Nephrotoxic agents__Non COX-2 selective NSAIDS__Peripheral Nervous System Agents__Phenols__Salicylates__Sensory System Agents	P51580	1.275139e+00	0.6147632450	1.0468730014	1.3801916695	1.7457187197	1.8454529924	0.9207888234	1.2719474471	1.5834948348	9.994087e-01	1.0489049932	1.1708191669	1.7938896437	1.1602093858	1.4560039766	1.7059065257	1.2546963121	1.6594249563	1.725675e+00	1.4052347277	1.2556216580	1.3972974819	1.7440979033	1.0925565949	1.3654199535	0.7522888161	0.7916702750	1.2466147574	1.7216344753	1.154397e+00	1.3837721754	0.5039296696	1.5019063594	0.4270619430	1.2910035389	1.0422638883	1.4112722813	1.8411405905	1.3173073760	1.7688022925	1.1717514083	1.0222974503	1.3635356277	1.3357329499	1.0232880484	0.9320260630	0.1804967972	1.7368057022	0.7694012462	1.149519e+00	0.9399458436	1.2242974343	0.7627509047	0.2436645347	0.9776537111	0.9398113810	1.4683921780	1.3350135508	1.218460e+00	1.1420036189	1.3300482315	1.183895e+00	1.1058689605	6.212744e-01	1.2805662796	1.1057115447	2.1586101568	1.079748e+00	0.8975754591	1.0933226658	0.3969882447	1.020014e+00	1.1237897592	1.425285e+00	1.321922e+00	1.1553935935	1.2149309381	1.557674e+00	1.0189104479	1.1898262586	0.9949726588	0.2434464550	1.1248386628	5.318030e-01	0.8641504230	0.5180854800	0.5960477657	8.379429e-01	2535	7.540093e-05	1.779214e-04	P51580	399	7.54009467378931e-05	A	B	C
P54289	UnKnown;inhibitor	Pregabalin;Isradipine;Nisoldipine;Nicardipine;Gabapentin;Felodipine;Nitrendipine;Nifedipine;Nilvadipine;Butamben	yes	TRUE	TRUE	FALSE	FALSE	FALSE	TRUE	Acids, Acyclic__Agents causing angioedema__Amino Acids__Amino Acids, Peptides, and Proteins__Aminobutyrates__Analgesics__Anti-Anxiety Agents__Antiarrhythmic agents__Anticonvulsants__Bradycardia-Causing Agents__Butyrates__Central Nervous System Agents__Central Nervous System Depressants__Drugs that are Mainly Renally Excreted__Hypoglycemia-Associated Agents__Membrane Transport Modulators__Miscellaneous Anticonvulsants__Muscle Relaxants__Muscle Relaxants, Centrally Acting Agents__Nervous System__Peripheral Nervous System Agents__Potential QTc-Prolonging Agents__Psychotropic Drugs__QTc Prolonging Agents__Sensory System Agents__Tranquilizing Agents__Vasodilating Agents__Agents causing hyperkalemia__Antiarrhythmic agents__Antihypertensive Agents__Bradycardia-Causing Agents__BSEP/ABCB11 Substrates__Calcium Channel Blockers__Calcium Channel Blockers (Dihydropyridine)__Calcium-Regulating Hormones and Agents__Cardiovascular Agents__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (moderate)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dihydropyridine Derivatives__Dihydropyridines__Drugs that are Mainly Renally Excreted__Hypotensive Agents__Membrane Transport Modulators__P-glycoprotein inhibitors__Potential QTc-Prolonging Agents__Pyridines__QTc Prolonging Agents__Selective Calcium Channel Blockers With Mainly Vascular Effects__Vasodilating Agents__Agents causing hyperkalemia__Antiarrhythmic agents__Antihypertensive Agents__Bradycardia-Causing Agents__Calcium Channel Blockers__Calcium Channel Blockers (Dihydropyridine)__Calcium-Regulating Hormones and Agents__Cardiovascular Agents__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Substrates__Decreased Blood Pressure__Dihydropyridine Derivatives__Dihydropyridines__Drugs that are Mainly Renally Excreted__Hypotensive Agents__Membrane Transport Modulators__P-glycoprotein inhibitors__Pyridines__Selective Calcium Channel Blockers With Mainly Vascular Effects__Vasodilating Agents__Adrenergic alpha-1 Receptor Antagonists__Adrenergic alpha-Antagonists__Adrenergic Antagonists__Agents causing hyperkalemia__Agents producing tachycardia__Antiarrhythmic agents__Anticholinergic Agents__Antihypertensive Agents__Bradycardia-Causing Agents__BSEP/ABCB11 Substrates__Calcium Channel Blockers__Calcium Channel Blockers (Dihydropyridine)__Calcium-Regulating Hormones and Agents__Cardiovascular Agents__Cytochrome P-450 CYP2B6 Inducers__Cytochrome P-450 CYP2B6 Inducers (strength unknown)__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (moderate)__Cytochrome P-450 CYP2C8 Substrates__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors (strong)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (moderate)__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (moderate)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Inhibitors__Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dihydropyridine Derivatives__Dihydropyridines__Hypotensive Agents__Membrane Transport Modulators__Muscarinic Antagonists__OATP1B1/SLCO1B1 Inhibitors__P-glycoprotein inhibitors__P-glycoprotein substrates__Potential QTc-Prolonging Agents__Pyridines__QTc Prolonging Agents__Selective Calcium Channel Blockers With Mainly Vascular Effects__Vasodilating Agents__Acids, Acyclic__Acids, Carbocyclic__Amines__Amino Acids__Amino Acids, Peptides, and Proteins__Aminobutyrates__Analgesics__Anti-epileptic Agent__Anticonvulsants__Butyrates__Central Nervous System Agents__Central Nervous System Depressants__Cyclohexanecarboxylic Acids__Cyclohexanes__Cycloparaffins__Decreased Central Nervous System Disorganized Electrical Activity__Miscellaneous Anticonvulsants__Nervous System__Neurotransmitter Agents__Peripheral Nervous System Agents__Psychotropic Drugs__Sensory System Agents__Tranquilizing Agents__ACE Inhibitors and Calcium Channel Blockers__Agents causing hyperkalemia__Antiarrhythmic agents__Antihypertensive Agents__Beta blocking agents and calcium channel blockers__Bradycardia-Causing Agents__BSEP/ABCB11 Substrates__Calcium Channel Blockers__Calcium Channel Blockers (Dihydropyridine)__Calcium-Regulating Hormones and Agents__Cardiovascular Agents__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strong)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dihydropyridine Derivatives__Dihydropyridines__Hypotensive Agents__Membrane Transport Modulators__P-glycoprotein inhibitors__Potential QTc-Prolonging Agents__Pyridines__QTc Prolonging Agents__Selective Calcium Channel Blockers With Mainly Vascular Effects__Vasodilating Agents__ACE Inhibitors and Calcium Channel Blockers__Agents causing hyperkalemia__Antiarrhythmic agents__Antihypertensive Agents__Bradycardia-Causing Agents__BSEP/ABCB11 Substrates__Calcium Channel Blockers__Calcium-Regulating Hormones and Agents__Cardiovascular Agents__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dihydropyridine Derivatives__Dihydropyridines__Hypotensive Agents__Membrane Transport Modulators__P-glycoprotein inhibitors__Potential QTc-Prolonging Agents__Pyridines__QTc Prolonging Agents__Selective Calcium Channel Blockers With Mainly Vascular Effects__Vasodilating Agents__Adrenal Cortex Hormones__Agents causing hyperkalemia__Antiarrhythmic agents__Beta blocking agents and calcium channel blockers__Bradycardia-Causing Agents__BSEP/ABCB11 Substrates__Calcium Channel Blockers__Calcium Channel Blockers (Dihydropyridine)__Calcium Channel Blockers and Diuretics__Calcium-Regulating Hormones and Agents__Cardiovascular Agents__Contraceptive Agents, Male__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2A6 Substrates__Cytochrome P-450 CYP2B6 Inducers__Cytochrome P-450 CYP2B6 Inducers (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inducers__Cytochrome P-450 CYP2C9 Inducers (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 CYP3A7 Substrates__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dihydropyridine Derivatives__Dihydropyridines__Drugs that are Mainly Renally Excreted__Hormonal Contraceptives for Systemic Use__Hypotensive Agents__Membrane Transport Modulators__Moderate Risk QTc-Prolonging Agents__OATP1B1/SLCO1B1 Inhibitors__P-glycoprotein inducers__P-glycoprotein inhibitors__P-glycoprotein substrates__Pyridines__QTc Prolonging Agents__Reproductive Control Agents__Selective Calcium Channel Blockers With Mainly Vascular Effects__Tocolytic Agents__Vasodilating Agents__Agents causing hyperkalemia__Antiarrhythmic agents__Antihypertensive Agents__Bradycardia-Causing Agents__Calcium Channel Blockers__Calcium-Regulating Hormones and Agents__Cardiovascular Agents__Cytochrome P-450 CYP2A6 Inhibitors__Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 Inhibitors (weak)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (moderate)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dihydropyridine Derivatives__Dihydropyridines__Hypotensive Agents__Membrane Transport Modulators__Moderate Risk QTc-Prolonging Agents__Pyridines__QTc Prolonging Agents__Selective Calcium Channel Blockers With Mainly Vascular Effects__Vasodilating Agents__	P54289	-1.065066e+00	-0.0834774907	-0.4037196956	-0.3515919475	-0.4199238825	-0.3039959911	0.0309837096	-0.2979815638	-0.4108692247	-3.535028e-01	-0.6867082115	-0.7183240111	-0.5479789595	-0.8850058255	-0.6689227141	-0.6731524397	-0.4468511048	-0.5245759894	-6.833275e-01	-0.8049408763	-0.5015713601	-1.0594224827	-0.7225680785	-1.2140746962	-0.6925380408	-0.6436395142	0.2885323974	-0.5700368196	-0.0402436377	-4.564266e-01	-0.8834182705	0.2422020695	-0.1849799397	-0.0439668838	-0.3003805011	-0.7219889781	-0.7368900340	-0.6054029868	-0.5555351521	-0.4651974694	0.0633321880	-0.0699375675	-0.1899838654	-0.2851219439	0.0418770077	-0.1191638822	-0.2764475709	-0.5695685269	-0.5013101913	-5.510220e-01	0.0153384131	-0.7054929041	0.2705826104	0.6564395428	-0.1827363192	-0.9245745413	-0.6184907391	-0.2041315550	-7.154260e-01	-0.5630322870	-0.4617828043	-4.970498e-01	-0.6635640262	-5.621132e-02	-0.3306125630	-0.7276717181	-0.6766389476	-5.421083e-01	-0.4152688766	-0.2615516877	-0.4775400405	-3.534512e-01	-0.8486253471	-3.871637e-01	-4.754369e-01	-0.1300466573	-0.5988068291	-8.331633e-01	-0.4448657269	-0.9064248614	-0.6177948290	0.5831070743	-0.4721887356	5.879690e-02	0.2550794729	-0.4084128659	0.0420927805	-6.606638e-01	2642	8.417240e-03	3.270995e-02	P54289	419	0.0084172414004735	0	B	0
Q00534	inhibitor;antagonist	Palbociclib;Ribociclib;Abemaciclib	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Inhibitors__BCRP/ABCG2 Substrates__Cyclin-Dependent Kinases, antagonists &amp; inhibitors__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (weak)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Enzyme Inhibitors__Immunosuppressive Agents__Kinase Inhibitor__Myelosuppressive Agents__OCT1 inhibitors__P-glycoprotein inhibitors__P-glycoprotein substrates__Protein Kinase Inhibitors__Amines__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strong)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Heterocyclic Compounds, Fused-Ring__Highest Risk QTc-Prolonging Agents__Kinase Inhibitor__Protein Kinase Inhibitors__Pyridines__QTc Prolonging Agents__Amines__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Inhibitors__BCRP/ABCG2 Substrates__Cytochrome P-450 CYP1A2 Inhibitors__Cytochrome P-450 CYP1A2 Inhibitors (strength unknown)__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP2D6 Inhibitors__Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Heterocyclic Compounds, Fused-Ring__Kinase Inhibitor__MATE 1 Inhibitors__MATE 1 Substrates__MATE 1 Substrates with a Narrow Therapeutic Index__MATE 2 Inhibitors__MATE inhibitors__MATE substrates__OCT2 Inhibitors__P-glycoprotein inhibitors__P-glycoprotein substrates__Protein Kinase Inhibitors__Pyridines	Q00534	2.837970e-01	0.4410947298	0.0615107534	0.4409616073	0.1939580222	0.0495793255	0.1807832952	-0.0098906237	0.0160709076	1.212028e-01	-0.0195318241	0.3672979408	-0.2088626439	-0.0681199155	0.2614683967	0.3246968793	0.1737394275	0.3847648235	5.361422e-01	0.3388230571	0.5864639459	0.3346441648	0.2526019493	0.5354246744	0.2261486920	0.0941102324	0.1676373414	0.2559556501	0.1756995847	1.240580e-01	0.0579675357	-0.2102288653	0.3469399555	0.0069240742	0.2522685441	0.4728778978	0.2858972787	0.3639160346	0.0863946230	0.2297626295	0.5677838853	0.4124680160	0.5065178642	0.6924190158	0.1465314029	0.0018800623	0.3110817625	0.5443640091	0.1862900445	-4.362395e-02	0.5819167793	0.0002542805	-0.2841324484	0.4062407686	0.2763208837	1.0284467896	0.3854331674	-0.0340273652	6.376637e-01	0.6444977300	-0.2117412058	6.511723e-02	0.1445114567	2.460297e-01	0.1134578089	0.3078301967	0.1344846840	-5.264689e-02	0.0136932001	0.2896623987	0.0149227945	1.939181e-01	0.6203458497	5.951878e-01	2.514302e-01	0.6135897477	0.0012926440	4.295132e-01	-0.2208956983	0.2428802805	0.2378793832	-0.4197330905	-0.2175709593	-2.439743e-01	-0.3964640402	-0.1595441458	0.0702613704	7.089944e-02	3019	1.253781e-04	1.662580e-03	Q00534	478	0.000125378117643064	0	B	C
Q02763	inhibitor	Regorafenib	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Inhibitors__Benzene Derivatives__Bradycardia-Causing Agents__Cytochrome P-450 CYP2B6 Inhibitors__Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C8 Inhibitors__Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)__Cytochrome P-450 CYP2C9 Inhibitors__Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Hepatotoxic Agents__Kinase Inhibitor__P-glycoprotein inhibitors__P-glycoprotein substrates__Protein Kinase Inhibitors__Tyrosine Kinase Inhibitors__UGT1A1 Inhibitors__UGT1A9 Inhibitors__UGT1A9 Substrates	Q02763	-1.298297e+00	-0.7594810398	-1.0093319630	-2.0187995958	-1.1780784826	-1.7804217146	-1.6013693352	-0.5740876540	-0.8767953288	-1.190681e+00	-1.4692832292	-1.6494230221	-1.5471232888	-1.5341521980	-1.5750113112	-1.4935819738	-1.8335687975	-1.3844366814	-1.600251e+00	-1.8363487405	-1.2365305337	-1.3761499550	-1.4325536847	-1.7474766162	-1.6248747417	-1.7201180255	-1.5449302950	-1.8089810110	-1.9039656128	-1.369604e+00	-2.0199120206	-1.7160044418	-1.2518331958	-1.2205313285	-1.5815108801	-2.0915433550	-1.0700471974	-1.8652088473	-1.3896340284	-1.8572004734	-1.7747589349	-1.7148989141	-1.5181939597	-2.0194809236	-1.6846860976	-1.3158030622	-1.8234576576	-1.6519722005	-2.0481381409	-1.789627e+00	-1.4876990893	-1.8167146362	-1.4663700266	-1.5104297393	-1.7044296961	-1.3373470195	-1.9427506698	-0.7391652792	-1.358196e+00	-1.4301436679	-1.7499420622	-1.415405e+00	-1.5507291498	-1.830428e+00	-1.5012094611	-1.5099461687	-1.2590335571	-2.074772e+00	-1.7245066791	-1.7612198868	-1.0329113647	-1.133105e+00	-1.8490576775	-1.649262e+00	-1.896610e+00	-1.9944032063	-1.5175451901	-1.420851e+00	-1.1528337121	-1.7438710210	-2.1282244967	-1.8880003328	-1.7113776718	-1.806139e+00	-2.0806637692	-2.0657093919	-1.8344307950	-1.900288e+00	3082	5.690148e-04	7.631033e-04	Q02763	492	0.000569015548884687	A	B	0
Q03405	UnKnown	Urokinase	yes	TRUE	TRUE	FALSE	FALSE	FALSE	TRUE	Agents causing angioedema__Amino Acids, Peptides, and Proteins__Anticoagulants__Biological Factors__Blood and Blood Forming Organs__Blood Proteins__Endopeptidases__Enzymes__Enzymes and Coenzymes__Fibrinolytic Agents__Hydrolases__Increased Thrombolysis__Peptide Hydrolases__Plasminogen Activators__Proteins__Serine Endopeptidases__Serine Proteases__Urokinase-Type Plasminogen Activator, antagonists &amp; inhibitors	Q03405	1.268443e+00	0.5472958422	-0.0696888535	0.1883408127	-0.1175014019	-0.3955624139	0.4971073458	0.0103322864	-0.1185540107	4.853206e-01	1.7647477128	0.7982842682	-0.2283465289	1.1141850050	0.8126116660	0.3501963908	0.4230520568	-0.1048957303	7.788308e-02	0.2442169031	0.5080758741	0.3866271353	0.2265325095	0.1898242722	-0.4767191997	-0.2134839096	-0.0205245338	0.3232303520	0.0975981993	7.504926e-02	0.1546586298	-0.4583156150	-0.3055034979	-0.3214765225	-0.1165184835	-0.0716841961	-0.0034002373	-0.2611141275	0.0223567692	0.1578073083	-0.2829240483	-0.0467046974	-0.0751530282	-0.2087678934	-0.3024700155	-0.0871954363	-0.1009015770	-0.0700526283	-0.0574163195	-1.779245e-02	0.4678852074	0.4368257357	0.1099054173	-0.3816095829	-0.3722766313	-0.2366952423	0.1072057182	0.0202582527	-6.602453e-01	0.7481070118	0.4187045660	-1.690673e-01	0.0793181358	-2.503041e-01	0.3591822935	-0.0695610068	0.3051922415	-1.264249e-01	-0.0972588476	-0.4667699668	0.1865507797	4.206676e-02	0.3819084784	-5.467006e-01	2.358930e-01	-0.1159857340	-0.3276155630	8.432071e-02	0.1894009326	0.1590024179	0.1716920333	0.0953440099	0.9298239752	5.557328e-02	-0.0280925513	0.4402261576	0.3769876335	-3.405109e-01	3100	7.073359e-05	1.280274e-03	Q03405	497	7.07335858864938e-05	A	0	0
Q15111	inhibitor	Quinacrine	yes	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	Acridines__Aminoacridines__Anti-Infective Agents__Anticestodal Agents__Antimalarials__Antinematodal Agents__Antiparasitic Agents__Antiparasitic Products, Insecticides and Repellents__Antiplatyhelmintic Agents__Antiprotozoals__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 Substrates__Enzyme Inhibitors__Heterocyclic Compounds, Fused-Ring__OCT2 Inhibitors__P-glycoprotein inhibitors	Q15111	-5.587519e-01	-0.7955973192	-0.4547844801	-0.0902534355	0.0255664441	-0.0737800432	0.1181882693	-1.0030104589	-0.6624909024	1.158064e-01	-0.0799576933	-0.4371895316	-0.6134184203	-0.7498296961	-0.4046261914	-0.5566398600	-0.3279395140	0.1672328818	-7.979677e-01	-0.0727453942	-0.0864056006	-0.5318700318	-0.1853684090	-0.0412758186	-0.3731350212	-0.2829315577	-0.1338834412	0.1828309153	0.0220703706	3.599973e-03	-0.3727440280	-1.5890910036	0.1821505482	0.3872795780	0.2718403139	-0.0049987023	-0.5070964479	-0.1355369714	-0.2881603116	0.0281965662	0.0411703872	0.2573344650	0.0373319128	0.2435855007	0.2539159353	-0.2888121921	0.2974356620	-0.0659848195	0.4612080111	-1.524961e-01	0.0941488521	-0.2344212281	0.2946163937	0.2054360783	0.0329441269	-0.3940664068	-0.3879499486	0.3238396785	-2.103223e-01	-0.2250696044	-0.6103268390	-6.469599e-02	-0.1199179021	3.721433e-01	-0.3912475074	-0.5090598619	-0.3778163945	-3.696277e-01	0.2274642500	0.2534712463	-0.2670736107	-1.582119e-01	0.1133116312	4.304334e-02	-4.684490e-01	-0.3934020527	-0.0434771749	1.373386e-01	-0.1049690574	-0.3029946836	-0.0094318467	0.3158152584	-0.3045893543	8.177224e-02	-0.3065068089	-0.0255612453	-0.3679563631	3.946083e-01	3641	5.241511e-03	3.572883e-03	Q15111	574	0.00524151050410981	A	0	0
Q16853	inhibitor	Hydralazine	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Antihypertensive Agents__Arteriolar Smooth Muscle, Agents Acting On__Arteriolar Vasodilation__Arteriolar Vasodilator__Cardiovascular Agents__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Direct Vasodilators__Drugs that are Mainly Renally Excreted__Hydrazinophthalazine Derivatives__Hydrazinophthalazine Derivatives and Diuretics__Hypotensive Agents__Phthalazines__Pyridazines__Vasodilating Agents	Q16853	-1.622652e+00	-1.8180879150	-1.1354217070	-0.9573079495	-0.7865549032	-1.2249821859	-1.1642743298	-1.1771420692	-1.4261107150	-1.835758e+00	-1.7291028514	-2.4475243850	-1.0465464129	-1.7305312093	-1.6703993891	-1.7625949218	-1.4243293437	-1.3052900198	-1.462661e+00	-1.5532602946	-1.6686537934	-1.5914430703	-1.6792404954	-1.5212410273	-1.5249135769	-1.5715639162	-1.1374707197	-0.5501111676	-0.9576556111	-1.063067e+00	-1.3489315819	-0.3754896271	-0.8377411206	-0.8848366155	-0.6484654662	-1.2294944511	-0.7498178754	-0.7544912837	-0.8668991102	-1.1756369775	-0.4715727313	-1.1154337807	-0.9161168047	-1.3077054769	-0.1693860364	-1.1661102811	0.0173198210	-1.4065794027	-1.1389086692	-1.729278e+00	-1.3119313437	-1.4586817422	-0.9559765062	0.0874517599	-0.9213726928	-1.7191451810	-1.2218492071	-0.9715573922	-1.908195e+00	-2.3747116776	-0.9313544269	-1.374389e+00	-1.3576530893	-6.149045e-01	-1.2918925240	-1.5029179725	-1.9565171981	-1.386282e+00	-0.0549294451	-0.5387579755	-0.4016068664	-8.678878e-01	-1.3844366814	-7.306968e-01	-1.921881e+00	-0.8913287184	-0.9919040951	-1.604924e+00	-1.5809135431	-1.9024476331	-1.1374564814	-0.7117091398	-2.0397996789	-1.424161e+00	-0.9742038716	-1.5273940109	-1.2107487636	-9.312832e-01	3819	5.361396e-03	3.673522e-03	Q16853	601	0.00536139666427027	A	0	0
Q16881	inhibitor	Arsenic trioxide	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Anions__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Arsenicals__Cardiotoxic antineoplastic agents__Cytochrome P-450 CYP3A Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors__Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)__Cytochrome P-450 Enzyme Inhibitors__Drugs that are Mainly Renally Excreted__Electrolytes__Highest Risk QTc-Prolonging Agents__Hyperglycemia-Associated Agents__Hypotensive Agents__Immunosuppressive Agents__Ions__Myelosuppressive Agents__Organometallic Compounds__Oxides__Oxygen Compounds__P-glycoprotein substrates__QTc Prolonging Agents	Q16881	7.358362e-01	0.6953736193	1.0904377782	0.2684588451	0.3097374190	0.1712447018	0.5897899285	0.8431138647	0.7494946709	2.319179e-01	0.5542774817	-0.1663448508	0.2470916070	0.3088423523	0.3849342211	0.3448878992	0.8693530015	0.8412812337	1.853966e-01	0.3407929475	0.3711244197	0.4524008935	0.2265325095	0.7914421067	0.1313471423	0.6061162693	0.1124004466	0.6811759656	0.8714562950	5.581993e-01	0.9020659060	0.0037575757	0.9729972050	0.2627221290	0.7655132595	0.1820307689	0.9606557859	0.6382761620	0.7993316100	0.6182203816	0.6616586043	1.6454648092	0.3065968191	1.3561980388	0.8302956596	0.9057682979	0.5488283306	0.4224580277	0.8827285700	6.234438e-01	0.2424456465	0.2244656615	0.7405794596	0.6721206426	0.4414148593	0.0355806211	0.5173309573	0.6153090623	2.432006e-01	1.9626561512	0.4667076626	2.286391e-01	0.0410180954	7.677353e-01	0.1945822230	0.4273006759	0.4047878028	6.029846e-01	0.5797976412	0.4164076173	-0.0623984678	1.475070e-01	0.5343679037	5.308118e-01	4.593476e-01	0.5271385179	0.3459717064	1.005034e+00	0.4530588513	0.7593950684	0.4093211302	0.0310407398	-0.1666874093	1.263831e-01	-0.0111346101	0.3278148767	0.0603698940	2.289459e-01	3824	2.659162e-03	1.189258e-03	Q16881	602	0.00265916199341408	0	B	C
Q7LG56	inhibitor	Cladribine	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	2-Chloroadenosine__Agents Causing Muscle Toxicity__Antimetabolites__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__Carbohydrates__Cardiotoxic antineoplastic agents__Deoxyadenosines__Deoxyribonucleosides__Glycosides__Heterocyclic Compounds, Fused-Ring__Immunologic Factors__Immunosuppressive Agents__Myelosuppressive Agents__Nucleic Acids, Nucleotides, and Nucleosides__Nucleosides__Purine Analogues__Purine Antimetabolite__Purine Nucleosides__Purines__Ribonucleosides__Selective Immunosuppressants	Q7LG56	1.247740e+00	0.0641924612	0.6650222958	0.1705127420	0.6293796551	-0.1514463384	0.6669849730	-0.0827457995	0.3798550131	2.432712e-01	0.4913894705	0.7794188207	0.3425178961	0.1133024136	0.6780467363	0.6875865198	0.5991075100	0.2420525542	3.158769e-01	0.5810344254	0.5349332585	0.9797736492	0.5251597210	0.4454320994	1.2943838108	1.1563205247	0.4504466921	0.9546249149	0.8256932715	1.706665e+00	1.4527235457	1.1406549591	0.7439249141	0.9063585417	0.5372783534	0.1241935049	1.3438149318	2.2099429678	2.6692348141	0.8872451619	0.9002057677	0.4201187322	1.4218878230	0.9540383245	1.2072162273	0.5111592329	1.0267450918	0.2410176722	0.1282779694	5.462515e-01	0.7722527131	1.2849079920	0.6023008699	0.4282036700	1.1446469148	0.5609432376	0.7324881021	1.4313160690	2.760908e-01	0.5017883645	1.4352091736	7.100233e-01	0.4313565468	8.903858e-01	0.3041810447	0.8242398542	0.6675486506	1.060924e+00	1.4245047125	2.1104014045	0.5227639877	4.667942e-01	0.3989214251	1.110839e+00	5.229206e-01	1.1607786662	0.5805912640	5.997679e-01	0.9266624916	0.9657577618	1.5203894589	0.4260069905	0.2920170566	2.629095e-02	0.3749997014	0.5384480558	0.5570572788	1.541855e-02	4462	5.713869e-05	5.077262e-05	Q7LG56	671	5.7138747042753e-05	A	0	C
Q92482	inhibitor	Sennosides	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Alimentary Tract and Metabolism__Anthracenes__Anthraquinones__Biological Products__Complex Mixtures__Contact Laxatives__Drugs for Constipation__Gastrointestinal Agents__Herbs and Natural Products__Laxatives__Pharmaceutical Preparations__Plant Extracts__Plant Preparations__Quinones	Q92482	-2.404671e-01	-0.6750145403	-0.4796762622	-0.1873736760	-0.1297871659	0.0872606602	-0.5658770153	-0.3667130259	-0.3362441180	-1.643780e+00	-0.3988940422	-0.8481801561	1.4112021476	-0.4336987954	-0.9539399818	-0.8876767808	-0.0361061151	0.0267053223	-3.965205e-02	0.0142974953	-0.4103586697	-0.7343155378	-1.0382305251	-0.5258095413	-0.1156371409	-0.4862970646	-0.6914084316	2.2540038364	1.7678016334	-4.488464e-02	-1.0423369196	1.6570621501	1.2747728770	-0.2423195197	0.7912397703	-0.0119141362	0.1473357899	0.3338714894	0.9865125654	0.5890370676	1.4948390746	-0.3187261172	0.3983169387	0.0633695387	0.7709588602	1.1212764008	0.5851406957	-0.1718928061	-0.3059947259	-8.504768e-01	-0.8287216971	-1.0215768385	0.4398797739	-0.3688555850	-0.6687568778	-0.4896939250	-0.2861871875	1.1423254638	-1.699275e+00	0.0286437713	1.0177469188	4.275597e-01	-0.2675360659	-4.964836e-01	-0.0274309001	-0.0083884467	-0.2877132172	1.877315e+00	1.1586576887	1.3776922281	1.2905382310	-3.268157e-01	-0.8129901131	4.367988e-01	-8.673601e-01	-0.0398015388	0.5779659122	-5.562364e-01	1.5356531921	0.0410128604	1.1938400498	-1.0895112404	-0.8235250455	-5.818879e-03	0.6171784606	1.6683775559	-0.6292799910	-4.185815e-01	5281	1.078189e-02	1.228723e-02	Q92482	760	0.0107818887714537	A	0	0
Q969G6	ligand	Riboflavin	yes	TRUE	TRUE	FALSE	TRUE	FALSE	FALSE	Alimentary Tract and Metabolism__Biological Factors__Coenzymes__Dermatologicals__Diet, Food, and Nutrition__Enzymes and Coenzymes__Flavins__Food__Food and Beverages__Growth Substances__Heterocyclic Compounds, Fused-Ring__Micronutrients__OAT1/SLC22A6 inhibitors__Ophthalmologicals__Photosensitizing Agents__Physiological Phenomena__Pigments, Biological__Pteridines__Radiation-Sensitizing Agents__Sensory Organs__Vitamin B Complex__Vitamins	Q969G6	8.210571e-01	0.2802812803	0.9886162262	0.2696409096	0.6181305547	0.7052531131	0.5185395585	0.0502387337	0.6226909968	7.285523e-01	0.6149950846	0.5240247026	0.3005237735	0.5591124919	0.8817086805	0.7866573712	0.5578406972	0.9860491024	3.410379e-01	0.7598487661	0.7360319551	1.4244882163	0.5838916975	1.1650748535	0.6614534143	0.5730567972	0.2490027298	0.6711695084	0.6825043038	4.028741e-01	0.5174122297	-0.1471216147	0.8894203534	0.1195863933	0.8514206818	0.4841726372	0.4317558757	0.8701650430	0.5231617776	0.4666782658	0.4721105401	0.5937540004	0.7458682022	1.0237789764	0.3846577054	0.8152213420	0.3735705090	0.6009734696	0.8091214420	7.888157e-01	0.2133294625	0.4946705527	0.1297822878	0.5968627159	0.6648289230	0.6222154965	0.7421914894	0.8518560940	9.396399e-01	1.0912073697	0.4157329828	8.658688e-01	0.9428645112	9.304175e-01	0.6718638918	0.3597980575	0.2783588715	1.141567e+00	0.5928498279	0.3590124980	0.6029014016	4.083589e-01	0.3495702636	1.527517e-01	3.937350e-01	0.4157279670	0.3552495271	8.579562e-01	0.3156650757	0.8770723900	0.8060525047	0.3314727384	0.1570365877	2.546753e-01	0.2793072502	-0.1529158340	0.1860179725	7.737917e-01	5419	8.501564e-03	1.337051e-02	Q969G6	773	0.00850156459151326	0	B	C
Q96IY4	agonist	Prothrombin	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Biological Factors__Blood Coagulation Factors__Blood Proteins__Enzyme Precursors__Enzymes and Coenzymes__Increased Coagulation Activity__Proteins__Prothrombin, agonists	Q96IY4	1.209836e+00	1.1122983159	-0.7181255027	1.2537910499	-0.0933036018	0.1525177018	0.2963281567	-0.2278862424	-0.5630614333	8.368010e-01	-0.1092579327	0.2699267641	-0.4571425170	1.2739907527	-0.4306099314	-0.4011281759	0.5234462580	-0.1205968287	8.949068e-01	0.2231711903	0.0344731150	-0.3153837012	-0.2077613999	-0.1729413968	0.3490758756	0.1141352440	0.9393812899	0.1955344257	-0.1641259543	-5.223639e-01	0.7073062530	-0.7430372602	0.1951299934	0.5431787876	-0.5645712401	0.1623295523	-0.5082949365	-0.0906323541	0.4517845465	-0.1267354624	-0.0153572493	-0.3422738583	-0.1735961492	-0.3158877381	0.5983864642	-0.5451001881	0.5760793050	0.2503622286	0.1067776764	1.001648e-01	-0.6394909901	0.3240645321	0.4972199386	0.3298935740	-0.8257208393	-0.6006309831	-0.1710271686	-0.3441467519	-5.881369e-01	0.5626715317	0.7122139456	-8.370759e-01	-0.4273756985	5.510149e-01	-0.2402200802	0.2730373022	0.1226463039	4.440565e-02	1.3113590059	-0.1688349663	-0.3590300993	-5.273795e-01	1.1847605887	2.768825e-01	5.586483e-01	0.1204466005	-0.4144158173	-2.262616e-01	2.3541222211	-0.5753893081	0.0075323147	-0.5676325426	2.2541714901	9.676084e-01	0.1248198534	1.9364954693	0.9015290181	7.614092e-01	5656	4.387731e-03	5.013108e-02	Q96IY4	799	0.00438773162888896	0	B	C
Q96SW2	inhibitor	Lenalidomide;Thalidomide;Pomalidomide	yes	TRUE	TRUE	FALSE	FALSE	FALSE	TRUE	Acids, Carbocyclic__Angiogenesis Inhibitors__Angiogenesis Modulating Agents__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Drugs that are Mainly Renally Excreted__Growth Inhibitors__Growth Substances__Heterocyclic Compounds, Fused-Ring__Imides__Immunologic Factors__Immunosuppressive Agents__Isoindoles__Myelosuppressive Agents__P-glycoprotein substrates__Phthalic Acids__Phthalimides__Piperidines__Piperidones__Thalidomide Analog__Acids, Carbocyclic__Angiogenesis Inhibitors__Angiogenesis Modulating Agents__Anti-Bacterial Agents__Anti-Infective Agents__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Cardiotoxic antineoplastic agents__Central Nervous System Depressants__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP2C19 Substrates__Cytochrome P-450 CYP2C9 Substrates__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A5 Inducers__Cytochrome P-450 CYP3A5 Inducers (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Decreased Immunologically Active Molecule Activity__Growth Inhibitors__Growth Substances__Heterocyclic Compounds, Fused-Ring__Hypotensive Agents__Imides__Immunologic Factors__Immunomodulatory Agents__Immunosuppressive Agents__Isoindoles__Leprostatic Agents__Myelosuppressive Agents__Noxae__Phthalic Acids__Phthalimides__Piperidines__Piperidones__Teratogens__Toxic Actions__Acids, Carbocyclic__Angiogenesis Inhibitors__Angiogenesis Modulating Agents__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Central Nervous System Depressants__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Growth Inhibitors__Growth Substances__Heterocyclic Compounds, Fused-Ring__Imides__Immunologic Factors__Immunosuppressive Agents__Isoindoles__Myelosuppressive Agents__P-glycoprotein substrates__Phthalic Acids__Phthalimides__Piperidines__Piperidones__Thalidomide Analog	Q96SW2	-1.363634e-01	-0.7638513799	-0.2380105757	-0.6021085004	-0.1505258077	-0.1309754189	0.0417002470	-0.3927148377	-0.1853367005	-3.008159e-01	-0.1401473350	0.0464427038	-0.2459650122	-0.4045447433	0.1518677233	-0.0403483533	-0.1182085032	-0.0926778538	-1.126854e-01	-0.1147620853	-0.1023826592	-0.0219018624	0.0143737446	-0.1168423327	-0.1278578385	-0.2484714810	-0.3148147710	-0.1708166970	0.1022091207	5.080583e-02	-0.2402912027	-0.1054248062	-0.5428892534	0.4077811747	-0.0912603882	-0.3158019429	-0.2153096038	-0.0709227799	-0.3627006885	-0.3029215024	-0.2805884306	-0.0153514466	-0.0344213982	0.3107592732	-0.2871268164	-0.0768959726	-0.1246703123	0.0654132674	-0.1517839491	1.135997e-01	0.1654287084	-0.2627044404	-0.2603959479	-0.2820825506	0.0951834455	-0.1379729586	-0.2750831015	0.0218469622	-6.607095e-02	0.1241576571	-0.5512528832	-6.319413e-01	-0.4111156179	3.907537e-02	-0.1972424188	-0.0776612889	0.1036115101	1.029922e-03	-0.1912696083	0.2621885562	-0.4491956575	-2.554407e-01	-0.0622266820	8.349492e-02	2.752584e-02	0.1565602681	0.1496560577	-2.494224e-01	-0.1630317861	0.3541644383	0.1087788938	-0.1288753658	-0.3460716183	-5.569142e-01	-0.7020066458	-0.3875282845	-0.2251581743	-2.153881e-01	5826	9.494572e-03	2.037761e-02	Q96SW2	816	0.00949456844539077	0	0	C
Q99571	antagonist;UnKnown	Eslicarbazepine acetate;Eslicarbazepine	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Anticonvulsants__Carboxamide Derivatives__Cardiovascular Agents__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 Inhibitors (moderate)__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (weak)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Heterocyclic Compounds, Fused-Ring__Membrane Transport Modulators__Nervous System__Sodium Channel Blockers__UGT1A1 Substrates__Voltage-Gated Sodium Channel Blockers__Anticonvulsants__Carboxamide Derivatives__Cardiovascular Agents__Central Nervous System Depressants__Cytochrome P-450 CYP2C19 Inhibitors__Cytochrome P-450 CYP2C19 inhibitors (strength unknown)__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A4 Inducers__Cytochrome P-450 CYP3A4 Inducers (strength unknown)__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Heterocyclic Compounds, Fused-Ring__Membrane Transport Modulators__Nervous System__Sodium Channel Blockers__UGT1A1 Substrates__Voltage-Gated Sodium Channel Blockers	Q99571	4.778450e-01	0.1207460809	-0.2130616749	0.7324333938	-0.1297871659	-0.2206583425	0.2260639782	0.2208142639	0.3135579068	-1.938610e-01	-0.1253777621	-0.4514363645	0.7748748620	0.2420635529	-0.0469664060	-0.0797389764	0.4749883450	0.1863282518	4.159513e-01	0.1042572211	-0.0202163912	-0.1664191720	-0.2716123623	0.4033717483	-0.0876329765	0.5118445129	0.4294377198	0.9898913634	0.7292780774	-2.520477e-01	0.0347255557	0.3417357494	0.9430462354	0.5985668529	0.9170567218	-0.0279033538	-0.0075561064	0.1301354543	0.4641904654	0.5745240183	0.5752882452	-0.4869974116	0.3995368275	0.1140523995	0.3825231360	0.1738065342	0.3433229353	-0.1016781129	-0.3855842637	-1.690641e-01	-0.4737229378	0.3964123193	0.8073883548	0.2789015345	-0.0240320981	-0.4291030446	0.1494161322	0.2818786294	-2.315757e-01	-0.3329720192	0.2904702685	-2.936917e-02	0.0342433624	-2.503041e-01	0.4265934393	0.6816302435	-0.4638429056	3.412486e-02	0.7814556350	0.0806438229	0.5422951125	8.639454e-02	0.4819645880	5.189879e-01	2.658324e-02	0.2600515086	0.3080499360	2.520337e-02	0.0182330911	0.5796638137	0.9591388955	0.6199639235	0.8764401298	9.486438e-01	0.7916050006	0.7453867528	0.4622598591	-2.356332e-02	5872	5.469801e-03	7.856500e-03	Q99571	825	0.00546980004671296	0	B	C
Q9GIY3	antagonist	1D09C3	yes	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE		Q9GIY3	-4.940047e-01	-0.4065431247	-0.1592950156	0.6801820170	0.3358770508	-0.8618058052	-0.5694307847	-0.0191189948	0.0968519510	-4.483292e-01	0.0001636345	-0.7418804975	-0.4258003189	-0.3974385680	-0.6024223746	-0.4354463364	-1.1174277161	0.0440149981	-6.314615e-01	-0.3085668482	-0.2671262406	-0.5962732240	-0.3510602322	-0.3243342176	-0.6818488208	-0.3445048706	0.0080149852	-1.2045861291	-0.3692107828	-3.472946e-01	-0.3727440280	-0.8884466863	0.6094808986	-0.3393753026	0.4532559678	-0.3206466284	-0.0315189790	-0.1243606239	0.2829806673	-0.1110325634	0.1332783524	-0.6550182067	-0.8867890017	-0.2287669327	-0.5599095836	-0.2160448571	0.2974356620	-0.5602555441	-1.8580056004	-5.483527e-01	-0.5244233801	-0.0984755462	0.5612850930	0.1442059935	-0.6221382727	-0.7722652117	-0.2910300996	0.3510489956	-5.340825e-01	-0.6509343440	-0.1236563519	-1.317501e-01	-0.3874102683	-8.926130e-01	-0.1313747608	-0.2024099387	-0.6255073369	-4.557546e-01	-0.1553337744	-0.4941989491	-0.5055234470	-2.152690e-01	-0.7431566091	-1.186815e-01	-9.472088e-01	-0.8268177041	-0.3888185436	-4.085956e-01	0.1226684983	-0.6822137252	0.2966712071	0.5019674196	-0.1778417261	8.381879e-01	1.4090370809	-0.0906559245	0.5092966717	2.865637e-01	6245	6.421730e-05	2.460970e-03	Q9GIY3	862	6.421729410203e-05	0	B	C
Q9NZQ7	antibody;binder;antagonist	Atezolizumab;Durvalumab;Avelumab	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Amino Acids, Peptides, and Proteins__Antibodies__Antibodies, Monoclonal__Antibodies, Monoclonal, Humanized__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Blood Proteins__Globulins__Immunoglobulins__Immunoproteins__Programmed Death Receptor-1 Blocking Antibody__Programmed Death Receptor-1-directed Antibody Interactions__Proteins__Serum Globulins__Amino Acids, Peptides, and Proteins__Antibodies__Antibodies, Monoclonal__Antineoplastic Agents__Antineoplastic Agents, Immunological__Antineoplastic and Immunomodulating Agents__Blood Proteins__Globulins__Immunoglobulins__Immunoproteins__Programmed Death Ligand-1 Antagonists__Programmed Death Ligand-1 Blocker__Programmed Death Ligand-1-directed Antibody Interactions__Proteins__Serum Globulins__Amino Acids, Peptides, and Proteins__Antibodies__Antibodies, Monoclonal__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Blood Proteins__Globulins__Immunoglobulins__Immunoproteins__Programmed Death Ligand-1 Antagonists__Programmed Death Ligand-1 Blocker__Programmed Death Ligand-1-directed Antibody Interactions__Proteins__Serum Globulins	Q9NZQ7	-9.732715e-02	0.6551919981	-1.1085173166	-0.5390165842	-0.0736103446	-0.9934457025	-0.3374746303	0.9019899526	-0.3046756545	-2.734985e-01	1.2246028081	-0.2991388374	-0.8446138725	-0.3408953919	-0.3479877434	-0.3925840695	-0.4696063728	-0.3878173735	-8.743843e-01	-0.5883463646	-0.0403014720	-0.2433489010	-0.5184476978	-0.8969654255	-1.1118611495	-0.6952319273	-1.3968440502	-0.7651111106	-1.1818622420	-8.713036e-01	-0.8500804657	-1.4933935779	-1.5831927301	-1.0925508587	-1.0973563262	-0.9904024337	-0.2965168977	-0.8046771915	-0.7199898289	-0.9562255206	-0.4293867968	0.2027300106	-0.4627792182	-0.2098838542	0.0939312590	0.0150856290	-0.6382749761	-0.7067373725	-0.3787293535	-6.210596e-03	0.0121494837	-0.6655963137	-0.3686690512	-1.0228049741	-0.9250509409	-0.2297856553	-0.5384014108	0.2833242626	-6.554563e-01	-0.1844775372	-0.5893018773	-8.132372e-01	-0.6771554497	-4.478346e-01	-0.3690467194	0.9941491920	-0.3203855964	-8.759882e-01	-1.6732635152	-1.1337679594	-0.4601805854	-5.974502e-01	-1.1454319136	-1.067102e+00	-8.020819e-01	-0.7197572432	-1.3656618966	-3.643740e-01	-0.2688833811	-0.6035913481	-1.2932228993	-0.7782923488	0.1137480571	-4.397400e-01	-0.5501963270	-0.3491355858	-0.7327123922	-1.123306e+00	6958	1.078466e-02	1.439773e-02	Q9NZQ7	934	0.0107846666217168	A	0	0
Q9Y2I1	agonist	Agmatine;Moxonidine	yes	TRUE	TRUE	TRUE	FALSE	FALSE	FALSE	Agents causing hyperkalemia__Amidines__Antiarrhythmic agents__Anticholinergic Agents__Bradycardia-Causing Agents__Calcium Channel Blockers__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__Guanidines__Nicotinic Antagonists__NMDA Receptor Antagonists__OCT1 substrates__OCT2 Substrates__OCT2 substrates with narrow therapeutic index__Vasodilating Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Antiadrenergic Agents, Centrally Acting__Antihypertensive Agents__Cardiovascular Agents__Hypotensive Agents__Imidazoline Receptor Agonists__Sympatholytics	Q9Y2I1	-4.103518e-02	0.0193757964	-0.0968415197	-0.1096392474	0.5749063210	0.0794036066	0.2283546395	-0.2478292644	0.2337960725	1.768763e-01	0.0952531537	0.2828111072	-0.0283478114	-0.2716010720	-0.0328619665	-0.0374891623	0.0725786947	0.1460397732	7.619844e-02	0.1081951734	0.2701376150	0.1526380555	0.5551128593	0.2265089079	0.0784750782	-0.0599695256	-0.2868084627	0.2693343958	0.2488937344	3.553297e-01	-0.0746427892	-0.1423446715	0.2625025681	0.3071824182	-0.0934213370	0.0252515458	-0.0533613651	0.4384667981	-0.0036750330	0.1506454010	-0.0197738384	0.0411563349	0.0478662306	0.2251798101	0.3753791461	0.5662213436	0.4560793567	0.1565626535	-0.2383824557	-9.719178e-02	0.2562197796	-0.0812273125	-0.0351908727	-0.0554394329	0.0744510685	-0.0735118648	0.1811960159	0.2340793097	2.951478e-01	0.0426425949	-0.2688952515	3.067164e-01	0.0520534158	3.253810e-01	0.2374126485	0.1320277326	0.0116568262	-1.099437e-01	0.0043580846	0.4598380366	-0.1087579707	2.195132e-01	0.1382626832	9.854418e-02	1.643517e-01	0.4628337702	0.3880938951	2.287778e-01	-0.0027015244	0.2220874269	0.1799515244	-0.2878559412	-0.1778417261	-2.987721e-01	-0.2665683612	-0.2317228295	0.1004426440	9.410566e-02	7435	3.598032e-03	1.101001e-02	Q9Y2I1	996	0.00359803246260522	0	B	C
P00326	inhibitor	Fomepizole	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Antidotes__Compounds used in a research, industrial, or household setting__Cytochrome P-450 CYP2A6 Inhibitors__Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Inducers__Cytochrome P-450 CYP2E1 Inducers (strength unknown)__Cytochrome P-450 CYP2E1 Inhibitors__Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)__Cytochrome P-450 CYP2E1 Substrates__Cytochrome P-450 Enzyme Inducers__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Enzyme Inhibitors__Protective Agents__Pyrazoles	P00326	-8.406523e-01	-0.6206221699	-0.7762187512	0.4901678907	0.9698360899	0.1104125901	0.0492042605	-0.6825683131	-0.3503311357	1.266659e+00	-0.5054434047	-0.1579334158	-0.7242431292	0.8713768026	-0.2678365313	-0.6133261753	0.0915330869	0.7081805858	-6.806954e-01	-0.2795510903	NA	NA	NA	1.0117010985	1.2092069399	1.3275435649	-0.2091817980	0.0828011263	1.1264452797	5.265194e-01	-0.8127624342	1.5821333192	3.6452430567	0.9189432132	-0.4596854567	0.0693206200	-0.2717823487	3.6504734168	4.1210227273	0.3664163670	0.4237872262	-0.2610253777	0.8461776199	2.9044447445	0.5414412767	1.3607999845	1.8726926269	1.6622910148	1.9358517238	9.469130e-01	0.9644530614	0.9873035445	0.6581052378	-0.0669997746	0.5919483919	0.5267057485	1.7805801535	-0.0173538231	2.589524e+00	-1.4352403682	-0.2178093647	3.895256e-02	0.0007840832	1.757354e+00	0.9115456614	2.1575628079	-0.1121272285	2.951438e+00	0.7833992487	0.6631711097	-0.2670736107	-3.021917e-01	1.3553970091	6.222255e-01	1.263113e+00	0.2953849773	0.1304551747	6.504102e-02	-1.0181120106	3.0472178056	NA	1.4849715815	-0.8486992382	-5.588192e-01	0.1598116837	-0.5589074646	-0.2650205285	1.180442e+00	7916	1.268452e-03	6.057427e-04	P00326	1056	0.00126845206727217	A	0	0
Q05940	inhibitor;inducer;UnKnown	Amphetamine;Reserpine;Benzphetamine;Deserpidine;Ephedra sinica root;MMDA;Midomafetamine;4-Methoxyamphetamine;Dextroamphetamine;Metamfetamine;Tetrabenazine;Isometheptene;Propylhexedrine;Rauwolfia serpentina root;Deutetrabenazine	yes	TRUE	TRUE	TRUE	TRUE	TRUE	FALSE	Adrenergic Agents__Adrenergic Uptake Inhibitors__Agents producing tachycardia__Agents that produce hypertension__Agents that reduce seizure threshold__Amines__Amphetamines__Antidepressive Agents__Autonomic Agents__Benzene Derivatives__Biogenic Amines__Biogenic Monoamines__Catechols__Central Nervous System Agents__Central Nervous System Depressants__Central Nervous System Stimulants__Central Nervous System Stimulation__Centrally Acting Sympathomimetics__Cytochrome P-450 CYP2A6 Inhibitors__Cytochrome P-450 CYP2A6 Inhibitors (weak)__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Enzyme Inhibitors__Cytochrome P-450 Substrates__Dopamine Agents__Dopamine Uptake Inhibitors__Drugs that are Mainly Renally Excreted__Membrane Transport Modulators__Monoamine Oxidase Inhibitors__Nervous System__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Peripheral Nervous System Agents__Phenethylamines__Phenols__Psychoanaleptics__Psychostimulants, Agents Used for Adhd and Nootropics__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetics__Adrenergic Agents__Adrenergic Uptake Inhibitors__Alkaloids__Antiadrenergic Agents, Centrally Acting__Antidepressive Agents__Antihypertensive Agents__Antipsychotic Agents__BSEP/ABCB11 Inhibitors__Cardiovascular Agents__Catecholamine-depleting Sympatholytic__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP3A Inducers__Cytochrome P-450 CYP3A5 Inducers__Cytochrome P-450 CYP3A5 Inducers (strength unknown)__Cytochrome P-450 Enzyme Inducers__Decreased Sympathetic Activity__Drugs that are Mainly Renally Excreted__Gastrointestinal Acidifying Agents__Heterocyclic Compounds, Fused-Ring__Hypotensive Agents__Indole Alkaloids__Indoles__Membrane Transport Modulators__Neurotoxic agents__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__OATP1B1/SLCO1B1 Inhibitors__OCT1 inhibitors__OCT2 Substrates__OCT2 substrates with narrow therapeutic index__P-glycoprotein inducers__P-glycoprotein inhibitors__P-glycoprotein substrates__Psychotropic Drugs__Secologanin Tryptamine Alkaloids__Tranquilizing Agents__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic Uptake Inhibitors__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamines__Antidepressive Agents__Appetite Suppression__Autonomic Agents__Central Nervous System Agents__Central Nervous System Depressants__Central Nervous System Stimulants__Cytochrome P-450 CYP2B6 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 Substrates__Dopamine Agents__Dopamine Uptake Inhibitors__Ethylamines__Increased Sympathetic Activity__Membrane Transport Modulators__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Peripheral Nervous System Agents__Phenethylamines__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetic Amine Anorectic__Sympathomimetics__Alkaloids__Antiadrenergic Agents, Centrally Acting__Antihypertensive Agents__Catecholamine-depleting Sympatholytic__Decreased Sympathetic Activity__Heterocyclic Compounds, Fused-Ring__Indole Alkaloids__Indoles__Secologanin Tryptamine Alkaloids__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic beta-2 Receptor Agonists__Adrenergic beta-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alpha-and Beta-adrenergic Agonists__Herbs and Natural Products__Hyperglycemia-Associated Agents__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Sympathomimetic (Adrenergic) Agents__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamines__Antidepressive Agents__Central Nervous System Depressants__Ethylamines__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Phenethylamines__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin 5-HT2 Receptor Agonists__Serotonin Agents__Serotonin Receptor Agonists__Sympathomimetics__Adrenergic Agents__Adrenergic Uptake Inhibitors__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamines__Antidepressive Agents__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Ethylamines__Hallucinogens__Membrane Transport Modulators__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Phenethylamines__Psychotropic Drugs__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Serotonin 5-HT2 Receptor Agonists__Serotonin Agents__Serotonin Receptor Agonists__Sympathomimetics__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Amines__Central Nervous System Agents__Central Nervous System Depressants__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Ethylamines__Hallucinogens__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Phenethylamines__Psychotropic Drugs__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamines__Central Nervous System Agents__Central Nervous System Stimulants__Central Nervous System Stimulation__Centrally Acting Sympathomimetics__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Dopamine Agents__Dopamine Uptake Inhibitors__Ethylamines__Membrane Transport Modulators__Nervous System__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Phenethylamines__Psychoanaleptics__Psychostimulants, Agents Used for Adhd and Nootropics__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetics__Adrenergic Agents__Adrenergic Agonists__Adrenergic alpha-2 Receptor Agonists__Adrenergic alpha-Agonists__Adrenergic Uptake Inhibitors__Agents producing tachycardia__Agents that produce hypertension__Amines__Amphetamine Anorectic__Amphetamines__Antidepressive Agents__Appetite Suppression__Autonomic Agents__Central Nervous System Agents__Central Nervous System Depressants__Central Nervous System Stimulants__Central Nervous System Stimulation__Centrally Acting Sympathomimetics__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Dopamine Agents__Dopamine Uptake Inhibitors__Drugs that are Mainly Renally Excreted__Ethylamines__Increased Sympathetic Activity__Membrane Transport Modulators__Monoamine Oxidase A Inhibitors  for interaction with Monoamine Oxidase A substrates__Nervous System__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__Peripheral Nervous System Agents__Phenethylamines__Psychoanaleptics__Psychostimulants, Agents Used for Adhd and Nootropics__Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome__Sympathomimetics__Adrenergic Agents__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 Substrates__Heterocyclic Compounds, Fused-Ring__Highest Risk QTc-Prolonging Agents__Membrane Transport Modulators__Miscellaneous Central Nervous System Agents__Nervous System__Neurotransmitter Agents__Neurotransmitter Uptake Inhibitors__QTc Prolonging Agents__Quinolizines__Vesicular Monoamine Transporter 2 Inhibitor__Vesicular Monoamine Transporter 2 Inhibitors__Adrenergic Agonists__Adrenergic alpha-1 Receptor Agonists__Adrenergic alpha-Agonists__Agents producing tachycardia__Agents that produce hypertension__Alimentary Tract and Metabolism__Amines__Drugs for Functional Gastrointestinal Disorders__Methemoglobinemia Associated Agents__Amines__Alkaloids__Antiadrenergic Agents, Centrally Acting__Antihypertensive Agents__Heterocyclic Compounds, Fused-Ring__Indole Alkaloids__Indoles__Secologanin Tryptamine Alkaloids__Cytochrome P-450 CYP1A2 Substrates__Cytochrome P-450 CYP2D6 Substrates__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A5 Substrates__Cytochrome P-450 Substrates__Drugs that are Mainly Renally Excreted__Heterocyclic Compounds, Fused-Ring__Highest Risk QTc-Prolonging Agents__QTc Prolonging Agents__Quinolizines	Q05940	3.637440e-01	0.0228312911	-0.3040420553	0.5138987862	0.3387683782	-1.0321829660	-0.3590925015	-0.8387897654	-1.2813510765	-1.316786e+00	-0.8164109133	-0.5563877858	-0.5468558357	-0.9333832087	-0.5024217259	-0.8121495250	-0.8182904384	-0.7315107511	-6.196113e-01	-0.6081772470	-0.4142492118	-1.0272687127	-0.5998082820	0.2477715983	-0.3245869054	-0.9579594108	0.3841942110	0.1517826339	0.5851274263	8.804338e-02	0.1874659155	1.6158220393	-0.2839494395	2.5763254009	-0.8492326488	0.4036675387	0.7726508140	0.4988384914	-0.7502940443	-0.2832618090	0.4237872262	-0.9053735162	0.2814825282	-0.2146214090	0.2396584409	0.6149396183	0.5356621203	-0.7150664500	-0.7258511494	-3.029574e-01	-0.5567463271	NA	-0.2166680409	0.3403768506	-0.1550567981	-0.6527322103	-0.6606487012	0.0152963826	-4.517987e-01	-1.0183862995	-0.2905314147	-4.577680e-01	0.0665346731	8.918345e-02	-0.1988069908	-0.1306672968	-0.3452610072	-2.776289e-01	0.2709342867	-0.0251154219	0.1005835685	2.888514e-01	-1.1743867804	2.326663e-01	-8.547962e-01	-0.0713363904	-0.8013720951	-2.661088e-01	-1.2496970189	-0.5172951681	-0.3230919315	NA	-0.8601966793	-8.522147e-01	-0.1464562732	-0.1881240774	-0.3955385499	-4.675972e-01	7983	7.198475e-03	3.581381e-03	Q05940	1061	0.00719847516994321	A	0	0
P25116	antagonist	Vorapaxar	yes	TRUE	FALSE	FALSE	FALSE	FALSE	FALSE	Anticoagulants__Antiplatelet agents__Blood and Blood Forming Organs__Cytochrome P-450 CYP3A Substrates__Cytochrome P-450 CYP3A4 Substrates__Cytochrome P-450 CYP3A4 Substrates (strength unknown)__Cytochrome P-450 Substrates__Hematologic Agents__P-glycoprotein inhibitors__Platelet Aggregation Inhibitors Excl. Heparin__Protease-activated Receptor-1 Antagonist__Protease-activated Receptor-1 Antagonists__Receptor, PAR-1, antagonists &amp; inhibitors__Receptors, Thrombin, antagonists &amp; inhibitors	P25116	-8.051234e-01	0.0722946330	-0.4427243140	-0.0838859211	-0.6681848527	-0.5132990705	-0.1833302005	0.0293963546	0.3666747684	NA	NA	-0.6427335741	0.0533605747	-0.5791206759	-0.2826858497	-0.4988756255	-0.4652656070	-0.7164779500	-5.517838e-01	-0.0239726105	0.1824661203	-0.0984986081	-1.2563819120	-0.0951954609	-0.3867706523	-0.8294092460	0.9813987332	0.4387379215	0.4469851604	-3.956223e-01	-1.0705563402	0.2097221453	0.6760134122	0.1929080051	0.4636200157	-0.0747242368	0.4342540067	0.2340437272	-0.3387919006	-0.1217084243	0.7800385495	NA	NA	NA	NA	-0.2406659424	-0.2901058930	-0.9487066952	-0.3936701214	-3.931773e-01	0.4121165651	-0.0891300150	-0.0333789122	0.9257913459	-0.0878782024	0.4368722350	-0.1547583806	NA	-6.186220e-01	-0.3492250039	-0.6013306817	-9.117182e-02	-0.3341612558	1.154518e-01	0.6244188783	0.1425745614	-0.3265281800	-7.924162e-01	0.6670619286	0.1595618035	0.6362988224	3.781618e-01	-0.3830410963	-8.673415e-02	-2.149170e-01	0.4057593749	0.7247425929	-1.809023e-01	-0.5074307674	-0.3131235466	-0.4947495326	0.5929320931	-0.1933269436	1.223334e-01	0.0860338277	0.6174473317	0.0976613155	NA	8437	7.634412e-03	7.907285e-03	P25116	1093	0.00763441150931865	A	B	0
P12319	inhibitor;agonist	Omalizumab;Benzylpenicilloyl polylysine	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Agents to Treat Airway Disease__Amino Acids, Peptides, and Proteins__Anti-Allergic Agents__Anti-Asthmatic Agents__Anti-IgE__Antibodies__Antibodies, Monoclonal__Antibodies, Monoclonal, Humanized__Blood Proteins__Decreased IgE Activity__Globulins__IgE-directed Antibody Interactions__Immunoglobulins__Immunoproteins__Proteins__Respiratory Agents, Miscellaneous__Respiratory System Agents__Serum Globulins__Acetamides__Acetates__Acids, Acyclic__Amides__Anti-Bacterial Agents__Antibacterials for Systemic Use__Antiinfectives for Systemic Use__Benzene Derivatives__beta-Lactams__Drug Hypersensitivity__Fatty Acids__Fatty Acids, Volatile__Heterocyclic Compounds, Fused-Ring__Lactams__Lipids__Penicillins__Sulfur Compounds	P12319	4.901096e-01	-1.7647074752	-0.8945038893	0.4335732447	-0.0922489089	0.2341996886	-0.0729888507	-0.5252443381	-0.2404090571	-1.682213e+00	-0.3203096403	NA	-0.1163539021	-1.1716164716	-1.0060232515	-1.1200547015	-0.4481465005	0.2053262460	5.331331e-02	NA	NA	NA	NA	-0.5232668297	-0.1443398913	0.2418523311	1.7184306091	0.6609233149	1.1792933951	-5.424110e-02	0.1518445711	1.7477861697	0.4589316744	1.4326145996	0.8380679279	0.1711006469	0.4463665800	0.1927930973	0.5484815622	0.1997090359	0.7945385871	NA	NA	NA	NA	0.5942893054	0.9802788344	-0.7464901798	0.3431711193	-3.192854e-01	-0.5482273539	0.2346461454	-0.3647656287	0.8434758558	-0.1940951231	-0.1656946902	-0.2780290868	-0.1917840874	NA	NA	-0.0682502028	-1.845098e-01	0.0205866109	1.122707e+00	0.2447005153	-0.5019489327	-0.4657105483	-4.306441e-01	0.8075454961	0.3758885349	1.1778390896	-6.218641e-02	-0.6329662808	1.549289e+00	6.933126e-02	0.7806452485	-0.2530282130	NA	NA	NA	NA	2.2152645021	-1.2930284415	3.596857e-01	2.0343506116	0.0487011763	1.5626734520	1.389460e+00	8824	9.377651e-05	1.246238e-03	P12319	1122	9.3776490957361e-05	A	B	0
P09884	inhibitor	Cladribine;Clofarabine;Fludarabine	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	2-Chloroadenosine__Agents Causing Muscle Toxicity__Antimetabolites__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__BCRP/ABCG2 Substrates__Carbohydrates__Cardiotoxic antineoplastic agents__Deoxyadenosines__Deoxyribonucleosides__Glycosides__Heterocyclic Compounds, Fused-Ring__Immunologic Factors__Immunosuppressive Agents__Myelosuppressive Agents__Nucleic Acids, Nucleotides, and Nucleosides__Nucleosides__Purine Analogues__Purine Antimetabolite__Purine Nucleosides__Purines__Ribonucleosides__Selective Immunosuppressants__Adenine Nucleotides__Antimetabolites__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Arabinonucleosides__BCRP/ABCG2 Substrates__Carbohydrates__Drugs that are Mainly Renally Excreted__Glycosides__Heterocyclic Compounds, Fused-Ring__Hypotensive Agents__Immunosuppressive Agents__Myelosuppressive Agents__Noxae__Nucleic Acid Synthesis Inhibitors__Nucleic Acids, Nucleotides, and Nucleosides__Nucleoside Metabolic Inhibitor__Nucleosides__Nucleotides__Purine Analogues__Purine Nucleotides__Purines__Ribonucleotides__Toxic Actions__Adenine Nucleotides__Antimetabolites__Antineoplastic Agents__Antineoplastic and Immunomodulating Agents__Arabinonucleosides__Arabinonucleotides__Carbohydrates__Cardiotoxic antineoplastic agents__DNA (Cytosine-5-)-Methyltransferases, antagonists &amp; inhibitors__Enzyme Inhibitors__Glycosides__Heterocyclic Compounds, Fused-Ring__Immunologic Factors__Immunosuppressive Agents__Myeloablative Agonists__Myelosuppressive Agents__Noxae__Nucleic Acid Synthesis Inhibitors__Nucleic Acids, Nucleotides, and Nucleosides__Nucleoside Metabolic Inhibitor__Nucleosides__Nucleotides__Purine Analogues__Purine Nucleosides__Purine Nucleotides__Purines__Ribonucleosides__Ribonucleotides__Toxic Actions	P09884	2.763139e-02	NA	0.7327078261	0.3088537911	NA	0.3582579166	0.7937587175	0.2300349172	-0.4314571751	8.271036e-01	0.2185724164	NA	0.2670888464	0.0969416285	0.8987155648	0.5105565086	0.6171014199	-0.5344088830	NA	0.6037363787	0.4349390795	0.9646113312	0.5376771638	NA	-0.0352156102	0.0468044959	-0.1141155815	NA	NA	NA	NA	NA	NA	NA	-0.3656808353	0.5353038832	-0.0366948275	0.2987685089	0.0425318599	0.4943399784	0.2567890122	-0.7594946046	0.2283730842	-0.2262437041	0.1067911712	NA	NA	0.3404573056	-0.3984910387	-4.371950e-01	-0.1463667028	0.0178287000	-0.0523107227	-0.4834040597	0.1201970004	-0.1518558843	-0.2356943434	0.4556589070	NA	NA	0.0673827830	-1.921030e-01	-0.4482751753	-8.537462e-02	0.9941390204	-0.0546123213	0.2634791517	3.969289e-01	-0.1874643140	0.4236699780	-0.3456927091	2.835633e-01	-0.5319523956	-2.367957e-01	NA	NA	NA	4.689150e-01	0.2348342718	0.4737416227	-0.2592789899	-0.1415746053	0.4570942026	-3.259003e-01	-0.1865400873	0.2417033468	0.1196049393	6.901150e-01	9123	2.294832e-03	3.584724e-03	P09884	1146	0.00229483208876442	A	0	0
O00206	ligand	Mifamurtide	yes	TRUE	FALSE	TRUE	FALSE	FALSE	FALSE	Acids, Acyclic__Adjuvants, Immunologic__Alcohols__Amino Acids, Peptides, and Proteins__Amino Sugars__Antineoplastic and Immunomodulating Agents__Carbohydrates__Glycerophosphates__Glycerophospholipids__Glycoconjugates__Glycopeptides__Hydroxy Acids__Immunologic Factors__Lipids__Membrane Lipids__Muramic Acids__Peptides__Phosphatidic Acids__Phospholipids__Sugar Acids__Sugar Alcohols__Sugar Phosphates__Triose Sugar Alcohols	O00206	-2.352937e-01	-0.3323815193	-0.5583785374	0.1552216534	-0.4183194517	NA	NA	-0.1640234668	-0.5401299036	NA	NA	NA	-0.5448721952	-0.2184304284	-0.1929875349	-0.5433412525	-0.4155652928	-0.4696966576	-3.599687e-01	-0.4374729513	-0.1118547557	-0.2563230755	-0.3200010914	0.0101212018	-0.7284543339	-0.7728889092	-0.6713625763	NA	NA	NA	-0.3933318481	-0.6750167438	-0.6125220185	-0.7749196542	-0.7388121658	-0.3082667419	0.0849178362	-0.2680946284	-0.5863932184	-0.7264027903	-0.6635205174	NA	NA	NA	NA	-0.4550421355	-0.2881158756	NA	-0.7810687330	-4.008040e-01	-0.5656676954	-0.1605685537	-0.7853598354	-0.6284929843	-0.1410356347	-0.6920706542	-0.4175049767	NA	NA	NA	-0.1984013645	NA	NA	NA	-0.7805647279	-0.6910058718	-0.4715436820	-3.832717e-01	-0.4767257654	-0.8076833373	-0.5495666314	-3.754172e-01	-0.0659470623	-3.065714e-01	-6.163496e-01	-0.5451979039	-0.7835852902	-5.196684e-01	-0.8020738242	-0.7285354511	-0.6488967779	-0.3493897566	-0.0884754291	-4.616185e-01	-0.5016279536	-0.0706030200	0.0471544044	NA	9147	1.404963e-03	1.410903e-03	O00206	1149	0.00140496287752481	A	0	C
Q01362	inhibitor	Omalizumab	yes	TRUE	TRUE	FALSE	FALSE	FALSE	FALSE	Agents to Treat Airway Disease__Amino Acids, Peptides, and Proteins__Anti-Allergic Agents__Anti-Asthmatic Agents__Anti-IgE__Antibodies__Antibodies, Monoclonal__Antibodies, Monoclonal, Humanized__Blood Proteins__Decreased IgE Activity__Globulins__IgE-directed Antibody Interactions__Immunoglobulins__Immunoproteins__Proteins__Respiratory Agents, Miscellaneous__Respiratory System Agents__Serum Globulins	Q01362	NA	NA	-0.4396681057	0.0763708403	NA	NA	NA	NA	NA	-6.541152e-01	-0.2723661037	NA	-0.2425891146	-0.8156883891	-0.4808488112	-0.6881917714	-0.0444546473	-0.8419253264	-8.068616e-01	-0.4137482214	NA	NA	NA	NA	-0.0204443719	0.3615524195	1.3820478411	0.2789094913	1.0418971416	3.878278e-01	0.0271181624	1.4977576881	-0.5108683944	1.6751712218	-0.1130484254	0.2008203951	0.1638765517	0.2987685089	0.4830556688	0.5501375660	0.7271468925	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	-0.3510743480	0.1314197152	0.2804411300	0.1985154651	NA	NA	0.0522776257	NA	NA	0.4265735807	-6.742184e-01	-0.3156524552	7.256687e-01	-0.4263304930	-0.8540665032	-0.2489527025	-2.458361e-01	-0.2980464658	-0.2011687592	1.2882486919	-1.245543e-01	-0.4290196956	6.778897e-01	-5.060157e-01	0.7336157048	-0.7805420178	-2.892380e-01	-0.3594159118	-0.4287656450	NA	1.3145641535	-1.2697432139	-6.431009e-01	0.5196487293	0.1448361219	0.3229451532	-6.914420e-02	9575	9.837090e-03	4.713110e-03	Q01362	1177	0.00983709034120794	A	0	0
Q15910	inhibitor	Tazemetostat;CPI-1205	yes	FALSE	TRUE	FALSE	FALSE	FALSE	FALSE	Acids, Carbocyclic__Amides__Benzene Derivatives__Benzoates__Pyridines__Enzyme Inhibitors__Heterocyclic Compounds, Fused-Ring	Q15910	2.548114e-01	NA	1.3848961582	0.5304396809	NA	NA	NA	1.0562177091	0.5822951889	6.815236e-01	0.4211971935	NA	0.8012921198	1.1808835612	NA	NA	0.7784691136	NA	2.299490e-01	0.2639893129	NA	NA	NA	NA	-0.0478593738	0.6731022503	0.0241261604	NA	NA	NA	NA	NA	NA	NA	-0.1908904656	0.4573987518	0.5791350587	0.1408362956	0.0523927662	0.1486431041	0.2254716526	NA	NA	NA	NA	NA	NA	NA	0.0457947006	8.207593e-02	-0.0125534150	-0.3801007024	-0.4582263932	-0.1552334712	0.5586455338	0.9436419790	0.0341333043	0.5539894026	NA	NA	1.0874078706	4.790102e-01	1.3376941323	4.557780e-01	NA	NA	0.6872792000	6.696422e-01	NA	NA	NA	NA	NA	NA	3.023742e-01	0.4050685476	-0.0504694784	4.776158e-01	0.2524100943	-0.0024852350	NA	0.2133668305	0.0323966220	-4.481784e-01	-0.3932704295	0.2722705042	0.0136165716	3.513796e-01	9911	1.656185e-03	2.388215e-03	Q15910	1198	0.00165618558142045	A	B	0
